ENTRY       D00001                      Drug
NAME        Water (JP16/USP);
            Purified water (JP16);
            Purified water in containers (JP16);
            Water, purified (USP);
            Sterile purified water in containers (JP16);
            Water for injection (JP16);
            Water for injection in containers (JP16);
            Sterile water (TN)
FORMULA     H2O
EXACT_MASS  18.0106
MOL_WEIGHT  18.0153
ACTIVITY    Pharmaceutic aid [solvent]
REMARK      Same as: C00001
            Therapeutic category: 7131
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             7  Agents not mainly for therapeutic purpose
              71  Dispensing medicines
               713  Solvents
                7131  Purified water
                 D00001  Water (JP16/USP); Purified water (JP16); Purified water in containers (JP16); Water, purified (USP); Sterile purified water in containers (JP16); Water for injection (JP16); Water for injection in containers (JP16)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Water
                D00001  Water (JP16/USP); Purified water (JP16); Purified water in containers (JP16); Water, purified (USP); Sterile purified water in containers (JP16); Water for injection (JP16); Water for injection in containers (JP16)
            Pharmaceutical additives [BR:br08316]
             Base
              D00001  [001370] Purified water
              D00001  [001371] Sterile purified water
             Bonding agent
              D00001  [001341] Water
             Wetting agent
              D00001  [001341] Water
              D00001  [001370] Purified water
             Wetting adjuster
              D00001  [001370] Purified water
             Solubilizer
              D00001  [001341] Water
              D00001  [001370] Purified water
              D00001  [001342] Water for injection
              D00001  [001371] Sterile purified water
             Solubilization agent
              D00001  [001371] Sterile purified water
             Solvent
              D00001  [001341] Water
              D00001  [001370] Purified water
              D00001  [001342] Water for injection
              D00001  [001371] Sterile purified water
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00001  Water
              D00001  Purified water
              D00001  Purified water in containers
              D00001  Sterile purified Water in containers
              D00001  Water for injection
              D00001  Sterile water for injection in containers
DBLINKS     CAS: 7732-18-5
            PubChem: 7847069
            LigandBox: D00001
            NIKKAJI: J43.587B
ATOM        1
            1   O0  O    32.0259  -17.5852
BOND        0
///
ENTRY       D00002                      Drug
NAME        Nadide (JAN/USAN/INN);
            Nicotinamide adenine dinucleotide
FORMULA     C21H28N7O14P2
EXACT_MASS  664.1169
MOL_WEIGHT  664.433
ACTIVITY    Antagonist [to alcohol and narcotics]
REMARK      Same as: C00003
            ATC code: A11HA01
            Drug group: DG00127
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A11 VITAMINS
               A11H OTHER PLAIN VITAMIN PREPARATIONS
                A11HA Other plain vitamin preparations
                 A11HA01 Nicotinamide
                  D00002  Nadide (JAN/USAN/INN)
DBLINKS     CAS: 53-84-9
            PubChem: 7847070
            DrugBank: DB01907
            LigandBox: D00002
            NIKKAJI: J136.554A
ATOM        44
            1   C1y C    15.6100   -9.9400
            2   C1y C    17.0100   -9.9400
            3   C1y C    17.4426   -8.6085
            4   O2x O    16.3100   -7.7856
            5   C1y C    15.1774   -8.6085
            6   O1a O    14.7871  -11.0726
            7   O1a O    17.8329  -11.0726
            8   C1b C    18.7622   -8.1797
            9   N5y N    13.8578   -6.4997 #+
            10  O2b O    20.1622   -8.1797
            11  P1b P    21.5622   -8.1797
            12  O2c O    22.9622   -8.1797
            13  P1b P    24.3622   -8.1797
            14  O2b O    25.7622   -8.1797
            15  O1c O    21.5622   -6.7900
            16  O1c O    24.3622   -6.7900
            17  O1c O    21.5623   -9.5900
            18  O1c O    24.3623   -9.5900
            19  C8x C    15.0702   -5.7997
            20  C8y C    15.0702   -4.3997
            21  C8x C    13.8578   -3.6997
            22  C8x C    12.6453   -4.3997
            23  C8x C    12.6453   -5.7997
            24  C5a C    16.2630   -3.7110
            25  N1a N    17.4576   -4.4009
            26  O5a O    16.2631   -2.3102
            27  C1y C    28.6362   -8.8389
            28  C1y C    29.0799  -10.1666
            29  C1y C    30.4799  -10.1561
            30  C1y C    30.9025   -8.8214
            31  O2x O    29.7637   -8.0071
            32  C1b C    27.1504   -8.2033
            33  N4y N    32.2017   -6.7081
            34  O1a O    28.2641  -11.3086
            35  O1a O    31.2975  -11.2643
            36  C8x C    33.0424   -5.5879
            37  N5x N    32.2360   -4.4434
            38  C8y C    30.8984   -4.8566
            39  C8y C    30.8781   -6.2565
            40  C8y C    29.6963   -4.1391
            41  N5x N    28.4038   -4.8214
            42  C8x C    28.4534   -6.2213
            43  N5x N    29.6556   -6.9388
            44  N1a N    29.6632   -2.7310
BOND        48
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     1   5 1
            6     1   6 1 #Up
            7     2   7 1 #Up
            8     3   8 1 #Down
            9     5   9 1 #Down
            10    8  10 1
            11   10  11 1
            12   11  12 1
            13   12  13 1
            14   13  14 1
            15   11  15 2
            16   13  16 2
            17   11  17 1
            18   13  18 1
            19    9  19 2
            20   19  20 1
            21   20  21 2
            22   21  22 1
            23   22  23 2
            24    9  23 1
            25   20  24 1
            26   24  25 1
            27   24  26 2
            28   27  28 1
            29   28  29 1
            30   29  30 1
            31   30  31 1
            32   27  31 1
            33   27  32 1 #Up
            34   14  32 1
            35   30  33 1 #Up
            36   28  34 1 #Down
            37   29  35 1 #Down
            38   33  36 1
            39   36  37 2
            40   37  38 1
            41   38  39 1
            42   33  39 1
            43   38  40 2
            44   40  41 1
            45   41  42 2
            46   42  43 1
            47   39  43 2
            48   40  44 1
///
ENTRY       D00003                      Drug
NAME        Oxygen (JP16/USP)
FORMULA     O2
EXACT_MASS  31.9898
MOL_WEIGHT  31.9988
ACTIVITY    Gas, medicinal
REMARK      Same as: C00007
            Therapeutic category: 7990
            ATC code: V03AN01
            Drug group: DG01164
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             V VARIOUS
              V03 ALL OTHER THERAPEUTIC PRODUCTS
               V03A ALL OTHER THERAPEUTIC PRODUCTS
                V03AN Medical gases
                 V03AN01 Oxygen
                  D00003  Oxygen (JP16/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             7  Agents not mainly for therapeutic purpose
              79  Other agents not mainly for therapeutic purpose
               799  Miscellaneous
                7990  Miscellaneous
                 D00003  Oxygen (JP16/USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00003  Oxygen
DBLINKS     CAS: 7782-44-7
            PubChem: 7847071
            LigandBox: D00003
            NIKKAJI: J44.420K
ATOM        2
            1   O0  O    24.4255  -17.2137
            2   O0  O    26.1055  -17.2137
BOND        1
            1     1   2 2
///
ENTRY       D00004                      Drug
NAME        Carbon dioxide (JP16/USP);
            Carbon dioxide (TN)
FORMULA     CO2
EXACT_MASS  43.9898
MOL_WEIGHT  44.0095
ACTIVITY    Stimulant [respiratory]
REMARK      Same as: C00011
            Therapeutic category: 7990
            ATC code: V03AN02
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             V VARIOUS
              V03 ALL OTHER THERAPEUTIC PRODUCTS
               V03A ALL OTHER THERAPEUTIC PRODUCTS
                V03AN Medical gases
                 V03AN02 Carbon dioxide
                  D00004  Carbon dioxide (JP16/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             7  Agents not mainly for therapeutic purpose
              79  Other agents not mainly for therapeutic purpose
               799  Miscellaneous
                7990  Miscellaneous
                 D00004  Carbon dioxide (JP16/USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00004  [001465] Carbon dioxide
             pH regulator
              D00004  [001465] Carbon dioxide
             Propellant
              D00004  [001465] Carbon dioxide
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00004  Carbon dioxide
DBLINKS     CAS: 124-38-9
            PubChem: 7847072
            LigandBox: D00004
            NIKKAJI: J43.600C
ATOM        3
            1   C0  C    21.8400  -11.9918
            2   O0  O    20.6288  -12.6940
            3   O0  O    23.0512  -12.6940
BOND        2
            1     1   2 2
            2     1   3 2
///
ENTRY       D00005                      Drug
NAME        Flavin adenine dinucleotide (JAN);
            Adeflavin (TN)
FORMULA     C27H33N9O15P2
EXACT_MASS  785.1571
MOL_WEIGHT  785.5497
REMARK      Same as: C00016
            Therapeutic category: 3131
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              31  Vitamins
               313  Vitamin B preparations
                3131  Vitamin B2 preparations
                 D00005  Flavin adenine dinucleotide (JAN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Flavin adenine dinucleotide
                D00005  Flavin adenine dinucleotide (JAN)
DBLINKS     CAS: 146-14-5
            PubChem: 7847073
            DrugBank: DB03147
            LigandBox: D00005
            NIKKAJI: J39.053D
ATOM        53
            1   N4x N     5.3900   -8.0500
            2   C8y C     5.3900   -9.4500
            3   N5x N     6.6024  -10.1500
            4   C8y C     7.8149   -9.4500
            5   C8y C     7.8149   -8.0500
            6   C8y C     6.6024   -7.3500
            7   N4y N     9.0273  -10.1500
            8   C8y C    10.2397   -9.4500
            9   C8y C    10.2397   -8.0500
            10  N5x N     9.0273   -7.3500
            11  C8x C    11.4522  -10.1500
            12  C8y C    12.6646   -9.4500
            13  C8y C    12.6646   -8.0500
            14  C8x C    11.4522   -7.3500
            15  O5x O     6.6024   -5.9502
            16  O5x O     4.1776  -10.1500
            17  C1a C    13.8811   -7.3477
            18  C1a C    13.8811  -10.1523
            19  C1b C     9.0273  -12.4600
            20  C1c C    10.2418  -13.1612
            21  C1c C    11.4383  -12.4702
            22  C1c C    12.6251  -13.1554
            23  C1b C    13.8166  -12.4672
            24  O2b O    15.0060  -13.1539
            25  O1a O    10.2418  -14.5598
            26  O1a O    12.6253  -14.5598
            27  O1a O    11.4384  -11.0603
            28  P1b P    16.4060  -13.1539
            29  O2c O    17.8060  -13.1539
            30  O1c O    16.4060  -11.7539
            31  O1c O    16.4060  -14.5539
            32  P1b P    19.2060  -13.1539
            33  O2b O    20.6060  -13.1539
            34  O1c O    19.2059  -11.7602
            35  O1c O    19.2061  -14.5598
            36  C1y C    23.0309  -13.1539
            37  C1b C    21.8184  -12.4539
            38  C1y C    23.4423  -14.4920
            39  C1y C    24.8422  -14.5139
            40  C1y C    25.2956  -13.1894
            41  O2x O    24.1761  -12.3488
            42  O1a O    22.6054  -15.6065
            43  O1a O    25.6386  -15.6468
            44  N5x N    23.1000   -9.1000
            45  C8x C    23.1000  -10.5000
            46  N5x N    24.3124  -11.2000
            47  C8y C    25.5249  -10.5000
            48  C8y C    25.5249   -9.1000
            49  C8y C    24.3124   -8.4000
            50  N4y N    26.8564  -10.9326
            51  C8x C    27.6793   -9.8000
            52  N5x N    26.8564   -8.6674
            53  N1a N    24.3124   -7.0002
BOND        58
            1     1   2 1
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 2
            12    8  11 2
            13   11  12 1
            14   12  13 2
            15   13  14 1
            16    9  14 2
            17    6  15 2
            18    2  16 2
            19   13  17 1
            20   12  18 1
            21    7  19 1
            22   19  20 1
            23   20  21 1
            24   21  22 1
            25   22  23 1
            26   23  24 1
            27   20  25 1 #Up
            28   22  26 1 #Up
            29   21  27 1 #Down
            30   24  28 1
            31   28  29 1
            32   28  30 2
            33   28  31 1
            34   29  32 1
            35   32  33 1
            36   32  34 2
            37   32  35 1
            38   36  37 1 #Up
            39   33  37 1
            40   36  38 1
            41   38  39 1
            42   39  40 1
            43   40  41 1
            44   36  41 1
            45   38  42 1 #Down
            46   39  43 1 #Down
            47   44  45 2
            48   45  46 1
            49   46  47 2
            50   47  48 1
            51   48  49 2
            52   44  49 1
            53   47  50 1
            54   50  51 1
            55   51  52 2
            56   48  52 1
            57   40  50 1 #Up
            58   49  53 1
///
ENTRY       D00006                      Drug
NAME        Pyridoxal phosphate hydrate (JAN);
            Pyridoxal phosphate monohydrate;
            Hipyridoxin (TN)
FORMULA     C8H10NO6P. H2O
EXACT_MASS  265.0351
MOL_WEIGHT  265.1571
REMARK      Therapeutic category: 3134
            ATC code: A11HA06
            Drug group: DG00132
COMMENT     See Pyridoxal [CPD:C00250]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A11 VITAMINS
               A11H OTHER PLAIN VITAMIN PREPARATIONS
                A11HA Other plain vitamin preparations
                 A11HA06 Pyridoxal phosphate
                  D00006  Pyridoxal phosphate hydrate (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              31  Vitamins
               313  Vitamin B preparations
                3134  Vitamin B6 preparations
                 D00006  Pyridoxal phosphate hydrate (JAN)
            Classification of Japanese OTC drugs [BR:br08313]
             Nourishing tonics and health supplements
              37 Vitamin B6 based drugs
               D00006  Pyridoxal phosphate hydrate (JAN)
              40 Vitamin B2B6 based drugs
               D00006  Pyridoxal phosphate hydrate (JAN)
              42 Vitamin B1B6B12 based drugs
               D00006  Pyridoxal phosphate hydrate (JAN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Pargyline
                D00006  Pyridoxal phosphate hydrate (JAN)
DBLINKS     CAS: 41468-25-1
            PubChem: 7847074
            DrugBank: DB00114
            LigandBox: D00006
            NIKKAJI: J1.592.622H
ATOM        17
            1   C8y C    31.3003  -17.4936
            2   C8y C    30.0742  -16.7938
            3   C8x C    31.3003  -18.9059
            4   C1b C    32.5071  -16.7872
            5   C8y C    28.8673  -17.4936
            6   C4a C    30.0677  -15.4008
            7   N5x N    30.0742  -19.6183
            8   O2b O    33.7140  -17.4871
            9   C8y C    28.8673  -18.9059
            10  O1a O    27.6540  -16.7938
            11  O4a O    31.2746  -14.6946
            12  P1b P    35.0943  -17.5062
            13  C1a C    27.6540  -19.5991
            14  O1c O    36.4874  -17.5062
            15  O1c O    35.0879  -18.9059
            16  O1c O    35.0943  -16.1133
            17  O0  O    40.6700  -17.6400
BOND        16
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     4   8 1
            8     5   9 1
            9     5  10 1
            10    6  11 2
            11    8  12 1
            12    9  13 1
            13   12  14 1
            14   12  15 1
            15   12  16 2
            16    7   9 2
///
ENTRY       D00007                      Drug
NAME        L-Glutamic acid (JP16);
            Gulutamine (USP)
FORMULA     C5H9NO4
EXACT_MASS  147.0532
MOL_WEIGHT  147.1293
ACTIVITY    Dietary supplement
REMARK      Same as: C00025
INTERACTION  
BRITE       Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Glutamic acid
                D00007  L-Glutamic acid (JP16); Gulutamine (USP)
            Pharmaceutical additives [BR:br08316]
             Buffering agent
              D00007  [003613] L-Glutamic acid
             Flavoring substance
              D00007  [003613] L-Glutamic acid
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00007  L-Glutamic acid
DBLINKS     CAS: 56-86-0
            PubChem: 7847075
            DrugBank: DB00142
            LigandBox: D00007
            NIKKAJI: J9.171E
ATOM        10
            1   C1c C    23.8372  -17.4608
            2   C1b C    25.0252  -16.7233
            3   C6a C    22.6023  -16.7994
            4   N1a N    23.8781  -18.8595
            5   C1b C    26.2601  -17.3788
            6   O6a O    21.4434  -17.5954
            7   O6a O    22.6198  -15.4007
            8   C6a C    27.4482  -16.6414
            9   O6a O    28.6830  -17.3028
            10  O6a O    27.4714  -15.2426
BOND        9
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     3   6 1
            6     3   7 2
            7     5   8 1
            8     8   9 1
            9     8  10 2
///
ENTRY       D00008                      Drug
NAME        Oxydol (JP16);
            Hydrogen peroxide (USP);
            Oxyfull (TN)
FORMULA     H2O2
EXACT_MASS  34.0055
MOL_WEIGHT  34.0147
ACTIVITY    Anti-infective, topical
REMARK      Same as: C00027
            Therapeutic category: 2614
            ATC code: A01AB02 D08AX01 S02AA06
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A01 STOMATOLOGICAL PREPARATIONS
               A01A STOMATOLOGICAL PREPARATIONS
                A01AB Antiinfectives and antiseptics for local oral treatment
                 A01AB02 Hydrogen peroxide
                  D00008  Oxydol (JP16); Hydrogen peroxide (USP)
             D DERMATOLOGICALS
              D08 ANTISEPTICS AND DISINFECTANTS
               D08A ANTISEPTICS AND DISINFECTANTS
                D08AX Other antiseptics and disinfectants
                 D08AX01 Hydrogen peroxide
                  D00008  Oxydol (JP16); Hydrogen peroxide (USP)
             S SENSORY ORGANS
              S02 OTOLOGICALS
               S02A ANTIINFECTIVES
                S02AA Antiinfectives
                 S02AA06 Hydrogen peroxide
                  D00008  Oxydol (JP16); Hydrogen peroxide (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               261  Antimicrobial agents
                2614  Peroxides
                 D00008  Oxydol (JP16); Hydrogen peroxide (USP)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for integumentary system
              54 Disinfectants (incl. special bandages)
               D00008  Oxydol (JP16); Hydrogen peroxide (USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Oxydol
                D00008  Oxydol (JP16); Hydrogen peroxide (USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00008  Oxydol
DBLINKS     CAS: 7722-84-1
            PubChem: 7847076
            LigandBox: D00008
            NIKKAJI: J98.262H
ATOM        2
            1   O1a O    18.3400   -7.5600
            2   O1a O    19.8800   -7.5600
BOND        1
            1     1   2 1
///
ENTRY       D00009                      Drug
NAME        Glucose (JP16);
            D-Glucose
FORMULA     C6H12O6
EXACT_MASS  180.0634
MOL_WEIGHT  180.1559
REMARK      Same as: C00031
            Therapeutic category: 3231
            ATC code: B05CX01 V04CA02 V06DC01
            Drug group: DG00188
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
               B05C IRRIGATING SOLUTIONS
                B05CX Other irrigating solutions
                 B05CX01 Glucose
                  D00009  Glucose (JP16)
             V VARIOUS
              V04 DIAGNOSTIC AGENTS
               V04C OTHER DIAGNOSTIC AGENTS
                V04CA Tests for diabetes
                 V04CA02 Glucose
                  D00009  Glucose (JP16)
              V06 GENERAL NUTRIENTS
               V06D OTHER NUTRIENTS
                V06DC Carbohydrates
                 V06DC01 Glucose
                  D00009  Glucose (JP16)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              32  Nutrients, tonics
               323  Saccharide preparations
                3231  Glucoses
                 D00009  Glucose (JP16)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Glucose
                D00009  Glucose (JP16)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00009  [001540] Glucose
             Buffering agent
              D00009  [001540] Glucose
             Sweetening agent
              D00009  [001540] Glucose
             Flavoring substance
              D00009  [001540] Glucose
             Bonding agent
              D00009  [001540] Glucose
             Coating agent
              D00009  [001540] Glucose
             Tonicity agent
              D00009  [001540] Glucose
             Diluting agent
              D00009  [001540] Glucose
              D00009  [999999] Glucose solution
             Soothing agent
              D00009  [001540] Glucose
             Solubilizer
              D00009  [001540] Glucose
             Solubilization agent
              D00009  [001540] Glucose
             Solvent
              D00009  [001540] Glucose
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00009  Glucose
              D00009  Glucose injection
DBLINKS     CAS: 50-99-7
            PubChem: 7847077
            DrugBank: DB02379
            LigandBox: D00009
            NIKKAJI: J4.109B
ATOM        12
            1   C1y C    24.2781  -16.5372
            2   C1y C    24.2781  -17.9377
            3   O2x O    25.4860  -15.8370
            4   C1b C    23.0643  -15.8370
            5   C1y C    25.4860  -18.6379
            6   O1a O    23.0643  -18.6379
            7   C1y C    26.7055  -16.5372
            8   O1a O    22.0023  -16.7474
            9   C1y C    26.7055  -17.9377
            10  O1a O    25.4860  -20.0383
            11  O1a O    27.9134  -15.8370
            12  O1a O    27.9134  -18.6379
BOND        12
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Up
            4     2   5 1
            5     2   6 1 #Down
            6     3   7 1
            7     4   8 1
            8     5   9 1
            9     5  10 1 #Up
            10    7  11 1 #Either
            11    9  12 1 #Down
            12    7   9 1
///
ENTRY       D00010                      Drug
NAME        Acetic acid (JP16/NF);
            Glacial acetic acid (JP16);
            Acetic acid, glacial (USP);
            Acetasol (TN)
FORMULA     C2H4O2
EXACT_MASS  60.0211
MOL_WEIGHT  60.052
ACTIVITY    Pharmaceutic aid [acidifying agent]
REMARK      Same as: C00033
            Therapeutic category: 2661
            ATC code: G01AD02 S02AA10
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
               G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
                G01AD Organic acids
                 G01AD02 Acetic acid
                  D00010  Acetic acid (JP16/NF); Glacial acetic acid (JP16); Acetic acid, glacial (USP)
             S SENSORY ORGANS
              S02 OTOLOGICALS
               S02A ANTIINFECTIVES
                S02AA Antiinfectives
                 S02AA10 Acetic acid
                  D00010  Acetic acid (JP16/NF); Glacial acetic acid (JP16); Acetic acid, glacial (USP)
            USP drug classification [BR:br08302]
             Antibacterials
              Antibacterials, Other
               Acetic acid
                D00010  Acetic acid (JP16/NF); Glacial acetic acid (JP16); Acetic acid, glacial (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               266  Emollients
                2661  Organic acids
                 D00010  Acetic acid (JP16/NF); Glacial acetic acid (JP16); Acetic acid, glacial (USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Acetic acid
                D00010  Acetic acid (JP16/NF); Glacial acetic acid (JP16); Acetic acid, glacial (USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00010  [001258] Acetic acid
              D00010  [001259] Glacial acetic acid
             Buffering agent
              D00010  [001258] Acetic acid
              D00010  [001259] Glacial acetic acid
             Flavoring substance
              D00010  [001258] Acetic acid
              D00010  [001259] Glacial acetic acid
             pH regulator
              D00010  [001258] Acetic acid
              D00010  [001259] Glacial acetic acid
             Solubilization agent
              D00010  [001259] Glacial acetic acid
             Solvent
              D00010  [001258] Acetic acid
              D00010  [001259] Glacial acetic acid
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00010  Acetic acid
              D00010  Glacial acetic acid
DBLINKS     CAS: 64-19-7
            PubChem: 7847078
            DrugBank: DB03166
            PDB-CCD: ACT ACY
            LigandBox: D00010
            NIKKAJI: J2.355H
ATOM        4
            1   C6a C    24.5700  -15.7500
            2   C1a C    25.7840  -16.4527
            3   O6a O    23.3619  -16.4527
            4   O6a O    24.5700  -14.3503
BOND        3
            1     1   2 1
            2     1   3 1
            3     1   4 2
///
ENTRY       D00011                      Drug
NAME        Glycine (JP16/USP)
FORMULA     C2H5NO2
EXACT_MASS  75.032
MOL_WEIGHT  75.0666
REMARK      Same as: C00037
            ATC code: B05CX03
TARGET      glycine receptor agonist [HSA:2741 2742 8001 2743] [KO:K05193 K05194 K05195 K05196]
  PATHWAY   hsa04080(2741+2742+2743+8001)  Neuroactive ligand-receptor interaction
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
               B05C IRRIGATING SOLUTIONS
                B05CX Other irrigating solutions
                 B05CX03 Glycine
                  D00011  Glycine (JP16/USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Glycine
                D00011  Glycine (JP16/USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00011  [102546] Glycine
             Buffering agent
              D00011  [102546] Glycine
             Sweetening agent
              D00011  [102546] Glycine
             Base
              D00011  [102546] Glycine
             Flavoring substance
              D00011  [102546] Glycine
             Suspending agent
              D00011  [102546] Glycine
             pH regulator
              D00011  [102546] Glycine
             Diluting agent
              D00011  [102546] Glycine
             Solubilization agent
              D00011  [102546] Glycine
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Cys-loop superfamily
               Glycine
                glycine receptor
                 Glycine
                  D00011  Glycine (JP16/USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00011  Glycine
DBLINKS     CAS: 56-40-6
            PubChem: 7847079
            DrugBank: DB00145
            LigandBox: D00011
            NIKKAJI: J1.163K
ATOM        5
            1   O6a O    23.7309  -18.2709
            2   C6a C    24.9434  -17.5708
            3   C1b C    26.1560  -18.2709
            4   O6a O    24.9434  -16.1709
            5   N1a N    27.3867  -17.5601
BOND        4
            1     1   2 1
            2     2   3 1
            3     2   4 2
            4     3   5 1
///
ENTRY       D00012                      Drug
NAME        L-Alanine (JP16);
            Alanine (USP)
FORMULA     C3H7NO2
EXACT_MASS  89.0477
MOL_WEIGHT  89.0932
ACTIVITY    Amino acid
REMARK      Same as: C00041
INTERACTION  
BRITE       Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               L-Alanine
                D00012  L-Alanine (JP16); Alanine (USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00012  [003609] L-Alanine
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00012  L-Alanine
DBLINKS     CAS: 56-41-7
            PubChem: 7847080
            DrugBank: DB00160
            PDB-CCD: ALA
            LigandBox: D00012
            NIKKAJI: J9.168E
ATOM        6
            1   O6a O     4.6200  -11.8300
            2   C6a C     5.8324  -11.1300
            3   C1c C     7.0449  -11.8300
            4   C1a C     8.2573  -11.1300
            5   O6a O     5.8324   -9.7302
            6   N1a N     7.0449  -13.2298
BOND        5
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     2   5 2
            5     3   6 1 #Down
///
ENTRY       D00013                      Drug
NAME        L-Aspartic acid (JP16);
            Aspartic acid (USP/INN)
FORMULA     C4H7NO4
EXACT_MASS  133.0375
MOL_WEIGHT  133.1027
ACTIVITY    Amino acid
REMARK      Same as: C00049
INTERACTION  
BRITE       Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               L-Aspartic acid
                D00013  L-Aspartic acid (JP16); Aspartic acid (USP/INN)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00013  [003608] L-Aspartic acid
             Solubilizing agent
              D00013  [003608] L-Aspartic acid
             Flavoring substance
              D00013  [003608] L-Aspartic acid
             Diluting agent
              D00013  [003608] L-Aspartic acid
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00013  L-Aspartic acid
DBLINKS     CAS: 56-84-8
            PubChem: 7847081
            DrugBank: DB00128
            PDB-CCD: ASP
            LigandBox: D00013
            NIKKAJI: J9.169C
ATOM        9
            1   O6a O    29.0500  -17.5000
            2   C6a C    30.2400  -16.8000
            3   C1c C    31.5000  -17.5000
            4   C1b C    32.6900  -16.8000
            5   C6a C    33.8800  -17.5000
            6   O6a O    35.1400  -16.8000
            7   O6a O    30.2400  -15.4000
            8   N1a N    31.5000  -18.9000
            9   O6a O    33.8800  -18.9000
BOND        8
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     2   7 2
            7     3   8 1 #Down
            8     5   9 2
///
ENTRY       D00014                      Drug
NAME        Glutathione (JP16);
            Glutathione (reduced type);
            Tathion (TN)
FORMULA     C10H17N3O6S
EXACT_MASS  307.0838
MOL_WEIGHT  307.3235
REMARK      Same as: C00051
            Therapeutic category: 1319 3922
            ATC code: V03AB32
            Drug group: DG01158
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             V VARIOUS
              V03 ALL OTHER THERAPEUTIC PRODUCTS
               V03A ALL OTHER THERAPEUTIC PRODUCTS
                V03AB Antidotes
                 V03AB32 Glutathione
                  D00014  Glutathione (JP16)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1319  Others
                 D00014  Glutathione (JP16)
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               392  Antidotes
                3922  Glutathiones
                 D00014  Glutathione (JP16)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00014  Glutathione
DBLINKS     CAS: 70-18-8
            PubChem: 7847082
            DrugBank: DB00143
            LigandBox: D00014
            NIKKAJI: J10.686K
ATOM        20
            1   O6a O     9.3800   -7.8400
            2   C6a C    10.5924   -7.1400
            3   C1c C    11.8049   -7.8400
            4   C1b C    13.0173   -7.1400
            5   C1b C    14.2297   -7.8400
            6   C5a C    15.4422   -7.1400
            7   N1b N    16.6546   -7.8400
            8   C1c C    17.8670   -7.1400
            9   C5a C    19.0795   -7.8400
            10  N1b N    20.2919   -7.1400
            11  C1b C    21.5044   -7.8400
            12  C6a C    22.7168   -7.1400
            13  O6a O    23.9292   -7.8400
            14  O6a O    10.5924   -5.7402
            15  N1a N    11.8049   -9.2398
            16  O5a O    15.4422   -5.7403
            17  C1b C    17.8670   -5.7401
            18  S1a S    19.0667   -5.0474
            19  O5a O    19.0795   -9.2397
            20  O6a O    22.7168   -5.7404
BOND        19
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     6   7 1
            7     7   8 1
            8     8   9 1
            9     9  10 1
            10   10  11 1
            11   11  12 1
            12   12  13 1
            13    2  14 2
            14    3  15 1 #Down
            15    6  16 2
            16    8  17 1 #Up
            17   17  18 1
            18    9  19 2
            19   12  20 2
///
ENTRY       D00015                      Drug
NAME        L-Glutamine (JP16);
            Glutamine (USP);
            Levoglutamide;
            Nutrestore (TN)
FORMULA     C5H10N2O3
EXACT_MASS  146.0691
MOL_WEIGHT  146.1445
ACTIVITY    Dietary supplement
REMARK      Same as: C00064
            Therapeutic category: 2322
            ATC code: A16AA03
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AA Amino acids and derivatives
                 A16AA03 Glutamine
                  D00015  L-Glutamine (JP16); Glutamine (USP)
            USP drug classification [BR:br08302]
             Gastrointestinal Agents
              Gastrointestinal Agents, Other
               Glutamine
                D00015  L-Glutamine (JP16); Glutamine (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              23  Digestive organ agents
               232  Peptic ulcer agents
                2322  Glutamines
                 D00015  L-Glutamine (JP16); Glutamine (USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               L-Glutamine
                D00015  L-Glutamine (JP16); Glutamine (USP)
            Pharmaceutical additives [BR:br08316]
             Diluting agent
              D00015  [003612] L-Glutamine
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00015  L-Glutamine
DBLINKS     CAS: 56-85-9
            PubChem: 7847083
            DrugBank: DB00130
            LigandBox: D00015
            NIKKAJI: J9.170G
ATOM        10
            1   C1c C    23.8378  -17.4606
            2   C1b C    25.0254  -16.7178
            3   C6a C    22.6035  -16.7995
            4   N1a N    23.8787  -18.8587
            5   C1b C    26.2597  -17.3787
            6   O6a O    21.4451  -17.5952
            7   O6a O    22.6209  -15.4015
            8   C5a C    27.4472  -16.6416
            9   N1a N    28.6814  -17.3027
            10  O5a O    27.4704  -15.2435
BOND        9
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     3   6 1
            6     3   7 2
            7     5   8 1
            8     8   9 1
            9     8  10 2
///
ENTRY       D00016                      Drug
NAME        L-Serine (JP16);
            Serine (USP)
FORMULA     C3H7NO3
EXACT_MASS  105.0426
MOL_WEIGHT  105.0926
ACTIVITY    Amino acid
REMARK      Same as: C00065
INTERACTION  
BRITE       Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00016  L-Serine
DBLINKS     CAS: 56-45-1
            PubChem: 7847084
            DrugBank: DB00133
            LigandBox: D00016
            NIKKAJI: J1.195I
ATOM        7
            1   C1c C    23.5961  -17.5357
            2   C6a C    22.4445  -16.7873
            3   C1b C    24.8238  -16.8518
            4   N1a N    23.6370  -18.9388
            5   O6a O    21.2226  -17.4714
            6   O6a O    22.4677  -15.3785
            7   O1a O    26.0339  -17.5708
BOND        6
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     2   6 2
            6     3   7 1
///
ENTRY       D00017                      Drug
NAME        Formalin (JP16);
            Formaldehyde (USP)
FORMULA     CH2O
EXACT_MASS  30.0106
MOL_WEIGHT  30.026
ACTIVITY    Disinfectant
REMARK      Same as: C00067
            Therapeutic category: 2619 2730 7321
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               261  Antimicrobial agents
                2619  Others
                 D00017  Formalin (JP16); Formaldehyde (USP)
              27  Dental preparations
               273  Analgesics and sedatives
                2730  Analgesics and sedatives
                 D00017  Formalin (JP16); Formaldehyde (USP)
             7  Agents not mainly for therapeutic purpose
              73  Public health agents
               732  Germicides and disinfectants
                7321  Alcohols and aldehydes
                 D00017  Formalin (JP16); Formaldehyde (USP)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for sanitation
              81 Disinfectants
               D00017  Formalin (JP16); Formaldehyde (USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00017  [001595] Formalin
             Preserving agent
              D00017  [001595] Formalin
             Solvent
              D00017  [001595] Formalin
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00017  Formalin
DBLINKS     CAS: 50-00-0
            PubChem: 7847085
            DrugBank: DB03843
            LigandBox: D00017
            NIKKAJI: J2.294B
ATOM        2
            1   C2a C    22.4108  -16.0439
            2   O0  O    21.0101  -16.0313
BOND        1
            1     1   2 2
///
ENTRY       D00018                      Drug
NAME        Ascorbic acid (JP16/USP/INN);
            Ascoltin (TN);
            Ascorbicap (TN)
FORMULA     C6H8O6
EXACT_MASS  176.0321
MOL_WEIGHT  176.1241
ACTIVITY    Vitamin [antiscorbutic];
            Acidifier [urinary]
REMARK      Same as: C00072
            Therapeutic category: 3140
            ATC code: A11GA01 G01AD03 S01XA15
            Drug group: DG00126
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A11 VITAMINS
               A11G ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS
                A11GA Ascorbic acid (vitamin C), plain
                 A11GA01 Ascorbic acid (vit C)
                  D00018  Ascorbic acid (JP16/USP/INN)
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
               G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
                G01AD Organic acids
                 G01AD03 Ascorbic acid
                  D00018  Ascorbic acid (JP16/USP/INN)
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01X OTHER OPHTHALMOLOGICALS
                S01XA Other ophthalmologicals
                 S01XA15 Ascorbic acid
                  D00018  Ascorbic acid (JP16/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              31  Vitamins
               314  Vitamin C preparations
                3140  Vitamin C preparations
                 D00018  Ascorbic acid (JP16/USP/INN)
            Classification of Japanese OTC drugs [BR:br08313]
             Nourishing tonics and health supplements
              38 Vitamin C based drugs
               D00018  Ascorbic acid (JP16/USP/INN)
              41 Vitamin EC based drugs
               D00018  Ascorbic acid (JP16/USP/INN)
              43 Vitamin containing supplements
               D00018  Ascorbic acid (JP16/USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Ascorbic acid
                D00018  Ascorbic acid (JP16/USP/INN)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00018  [001008] Ascorbic acid
             Buffering agent
              D00018  [001008] Ascorbic acid
             Flavoring substance
              D00018  [001008] Ascorbic acid
             Antioxidant agent
              D00018  [001008] Ascorbic acid
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00018  Ascorbic acid
              D00018  Ascorbic acid powder
              D00018  Ascorbic acid injection
DBLINKS     CAS: 50-81-7
            PubChem: 7847086
            DrugBank: DB00126
            PDB-CCD: ASC
            LigandBox: D00018
            NIKKAJI: J2.301I
ATOM        12
            1   C1y C    36.8309  -12.5307
            2   C2y C    37.2787  -13.8509
            3   O7x O    37.9650  -11.7163
            4   C2y C    38.6804  -13.8509
            5   C7x C    39.0992  -12.5481
            6   O1a O    39.5121  -14.9793
            7   O6a O    40.0821  -11.5535
            8   C1c C    35.6242  -11.8340
            9   C1b C    34.4173  -12.5307
            10  O1a O    36.4634  -14.9886
            11  O1a O    35.6239  -10.4238
            12  O1a O    33.1846  -11.8191
BOND        12
            1     1   2 1
            2     1   3 1
            3     2   4 2
            4     3   5 1
            5     4   6 1
            6     5   7 2
            7     4   5 1
            8     1   8 1
            9     8   9 1
            10    2  10 1
            11    8  11 1 #Down
            12    9  12 1
///
ENTRY       D00019                      Drug
NAME        L-Methionine (JP16);
            Methionine (USP);
            L-Methionine Z (TN)
FORMULA     C5H11NO2S
EXACT_MASS  149.051
MOL_WEIGHT  149.2113
ACTIVITY    Amino acid
REMARK      Same as: C00073
            Therapeutic category: 3929
            ATC code: V03AB26
            Drug group: DG01157
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             V VARIOUS
              V03 ALL OTHER THERAPEUTIC PRODUCTS
               V03A ALL OTHER THERAPEUTIC PRODUCTS
                V03AB Antidotes
                 V03AB26 Methionine
                  D00019  L-Methionine (JP16); Methionine (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               392  Antidotes
                3929  Others
                 D00019  L-Methionine (JP16); Methionine (USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Methionine
                D00019  L-Methionine (JP16); Methionine (USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00019  [001621] L-Methionine
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00019  L-Methionine
DBLINKS     CAS: 63-68-3
            PubChem: 7847087
            DrugBank: DB00134
            LigandBox: D00019
            NIKKAJI: J9.174J
ATOM        9
            1   C1c C    24.5047  -19.4197
            2   C6a C    23.3598  -18.6719
            3   C1b C    25.7313  -18.7361
            4   N1a N    24.5455  -20.8273
            5   O6a O    22.1332  -19.3553
            6   O6a O    23.3772  -17.2641
            7   C1b C    26.9405  -19.4546
            8   S2a S    28.1672  -18.7712
            9   C1a C    29.3647  -19.4896
BOND        8
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     2   6 2
            6     3   7 1
            7     7   8 1
            8     8   9 1
///
ENTRY       D00020                      Drug
NAME        L-Tryptophan (JP16);
            Tryptophan (USP/INN)
FORMULA     C11H12N2O2
EXACT_MASS  204.0899
MOL_WEIGHT  204.2252
ACTIVITY    Amino acid
REMARK      Same as: C00078
            ATC code: N06AX02
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06A ANTIDEPRESSANTS
                N06AX Other antidepressants
                 N06AX02 Tryptophan
                  D00020  L-Tryptophan (JP16); Tryptophan (USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               L-Tryptophan
                D00020  L-Tryptophan (JP16); Tryptophan (USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00020  L-Tryptophan
DBLINKS     CAS: 73-22-3
            PubChem: 7847088
            DrugBank: DB00150
            LigandBox: D00020
            NIKKAJI: J9.181B
ATOM        15
            1   C8y C    21.0700  -16.1000
            2   C8y C    22.4000  -16.3800
            3   C8y C    20.3700  -17.2900
            4   C8x C    20.3700  -14.8400
            5   C1b C    23.4500  -15.5400
            6   C8x C    22.4700  -17.7800
            7   N4x N    21.2100  -18.3400
            8   C8x C    18.9000  -17.2900
            9   C8x C    18.9700  -14.8400
            10  C1c C    24.7100  -16.1700
            11  C8x C    18.2000  -16.1000
            12  N1a N    24.7100  -17.6400
            13  C6a C    25.9000  -15.5400
            14  O6a O    27.0900  -16.2400
            15  O6a O    25.9000  -14.1400
BOND        16
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 1
            5     2   6 2
            6     3   7 1
            7     3   8 1
            8     4   9 2
            9     5  10 1
            10    8  11 2
            11   10  12 1 #Up
            12   10  13 1
            13   13  14 1
            14   13  15 2
            15    6   7 1
            16    9  11 1
///
ENTRY       D00021                      Drug
NAME        L-Phenylalanine (JP16);
            Phenylalanine (USP/INN)
FORMULA     C9H11NO2
EXACT_MASS  165.079
MOL_WEIGHT  165.1891
ACTIVITY    Amino acid
REMARK      Same as: C00079
INTERACTION  
BRITE       Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               L-Phenylalanine
                D00021  L-Phenylalanine (JP16); Phenylalanine (USP/INN)
            Pharmaceutical additives [BR:br08316]
             Diluting agent
              D00021  [002317] L-Phenylalanine
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00021  L-Phenylalanine
DBLINKS     CAS: 63-91-2
            PubChem: 7847089
            DrugBank: DB00120
            LigandBox: D00021
            NIKKAJI: J9.175H
ATOM        12
            1   C8y C    25.3400  -16.0300
            2   C8x C    25.3400  -17.5000
            3   C8x C    24.0800  -18.2000
            4   C8x C    22.8900  -17.5000
            5   C8x C    22.8900  -16.0300
            6   C8x C    24.0800  -15.3300
            7   C1b C    26.5300  -15.3300
            8   C1c C    27.7200  -16.0300
            9   C6a C    28.9100  -15.3300
            10  O6a O    30.1000  -16.0300
            11  O6a O    28.9100  -13.9300
            12  N1a N    27.7200  -17.4300
BOND        12
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    9  11 2
            12    8  12 1 #Up
///
ENTRY       D00022                      Drug
NAME        L-Tyrosine (JP16);
            Tyrosine (USP/INN)
FORMULA     C9H11NO3
EXACT_MASS  181.0739
MOL_WEIGHT  181.1885
ACTIVITY    Amino acid
REMARK      Same as: C00082
INTERACTION  
BRITE       Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00022  L-Tyrosine
DBLINKS     CAS: 60-18-4
            PubChem: 7847090
            DrugBank: DB00135
            LigandBox: D00022
            NIKKAJI: J9.173A
ATOM        13
            1   C8y C    25.0600  -15.8200
            2   C8x C    25.0600  -17.2200
            3   C8x C    23.8700  -17.9200
            4   C8y C    22.6800  -17.2200
            5   C8x C    22.6800  -15.8200
            6   C8x C    23.8700  -15.1200
            7   C1b C    26.3200  -15.1200
            8   O1a O    21.4200  -17.9900
            9   C1c C    27.5100  -15.8200
            10  C6a C    28.7000  -15.1200
            11  O6a O    29.8900  -15.8200
            12  O6a O    28.7000  -13.7200
            13  N1a N    27.5100  -17.2200
BOND        13
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     4   8 1
            9     7   9 1
            10    9  10 1
            11   10  11 1
            12   10  12 2
            13    9  13 1 #Up
///
ENTRY       D00023                      Drug
NAME        Urea (JP16/USP);
            Carbamide;
            Pastaron (TN)
FORMULA     CH4N2O
EXACT_MASS  60.0324
MOL_WEIGHT  60.0553
ACTIVITY    Diuretic
REMARK      Same as: C00086
            Therapeutic category: 2669
            ATC code: B05BC02 D02AE01
            Drug group: DG00183
STR_MAP     map07032  Hypnotics
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
               B05B I.V. SOLUTIONS
                B05BC Solutions producing osmotic diuresis
                 B05BC02 Carbamide
                  D00023  Urea (JP16/USP)
             D DERMATOLOGICALS
              D02 EMOLLIENTS AND PROTECTIVES
               D02A EMOLLIENTS AND PROTECTIVES
                D02AE Carbamide products
                 D02AE01 Carbamide
                  D00023  Urea (JP16/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               266  Emollients
                2669  Others
                 D00023  Urea (JP16/USP)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for integumentary system
              59 Skin emollient (incl. pus extrusion)
               D00023  Urea (JP16/USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Urea
                D00023  Urea (JP16/USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00023  [002286] Urea
             Wetting agent
              D00023  [002286] Urea
             Wetting adjuster
              D00023  [002286] Urea
             Tenacious agent
              D00023  [002286] Urea
             Diluting agent
              D00023  [120238] Purified urea
             Solubilization agent
              D00023  [002286] Urea
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00023  Urea
DBLINKS     CAS: 57-13-6
            PubChem: 7847091
            DrugBank: DB03904
            LigandBox: D00023
            NIKKAJI: J2.322A
ATOM        4
            1   C5a C    24.8500  -19.0400
            2   N1a N    23.6383  -19.7424
            3   N1a N    26.0617  -19.7424
            4   O5a O    24.8500  -17.6411
BOND        3
            1     1   2 1
            2     1   3 1
            3     1   4 2
///
ENTRY       D00024                      Drug
NAME        Sulfur (JP16);
            Sulfur, precipitated (USP);
            Sulfur, sublimed (USP);
            Bensulfoid (TN);
            Sastid (TN)
FORMULA     S
EXACT_MASS  31.9721
MOL_WEIGHT  32.065
ACTIVITY    Scabicide
REMARK      Same as: C00087
            Therapeutic category: 2659
            ATC code: D10AB02
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D10 ANTI-ACNE PREPARATIONS
               D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE
                D10AB Preparations containing sulfur
                 D10AB02 Sulfur
                  D00024  Sulfur (JP16); Sulfur, precipitated (USP); Sulfur, sublimed (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               265  Antiparasitic dermatosis agents
                2659  Others
                 D00024  Sulfur (JP16); Sulfur, precipitated (USP); Sulfur, sublimed (USP)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for integumentary system
              56 Purulent skin remedies
               D00024  Sulfur (JP16)
              58 Ringworm drugs
               D00024  Sulfur (JP16)
              -- Acne remedies
               D00024  Sulfur (JP16)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Sulfur
                D00024  Sulfur (JP16)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00024  [500029] Sulfer
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00024  Sulfur
DBLINKS     CAS: 7704-34-9
            PubChem: 7847092
            NIKKAJI: J3.750H
ATOM        1
            1   S0  S     4.9583  -12.2167
BOND        0
///
ENTRY       D00025                      Drug
NAME        Sucrose (JP16/NF);
            White soft sugar (JP16);
            Sugar, compressible (NF);
            Sugar, confectioner's (NF);
            Sugar spheres (NF);
            Sucrose, purified;
            Sucrose (TN)
FORMULA     C12H22O11
EXACT_MASS  342.1162
MOL_WEIGHT  342.2965
ACTIVITY    Pharmaceutic aid [flavor];
            Pharmaceutic aid [tablet excipient];
            Pharmaceutic aid [vehicle, solid carrier]
REMARK      Same as: C00089 G00370
            Therapeutic category: 7149
TARGET      taste receptor type 1 member 2 (TAS1R2) agonist [HSA:80834] [KO:K04625];
            taste receptor type 1 member 3 (TAS1R3) agonist [HSA:83756] [KO:K04626]
  PATHWAY   hsa04742(80834+83756)  Taste transduction
            hsa04973(80834+83756)  Carbohydrate digestion and absorption
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             7  Agents not mainly for therapeutic purpose
              71  Dispensing medicines
               714  Flavorings, deodorants, coloring agents
                7149  Others
                 D00025  Sucrose (JP16/NF); White soft sugar (JP16); Sugar, compressible (NF); Sugar, confectioner's (NF); Sugar spheres (NF)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               White soft sugar
                D00025  Sucrose (JP16/NF); White soft sugar (JP16); Sugar, compressible (NF); Sugar, confectioner's (NF); Sugar spheres (NF)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00025  [001480] Sucrose
              D00025  [500313] White soft sugar
             Lubricating agent
              D00025  [500313] White soft sugar
             Sweetening agent
              D00025  [110635] Liquid sugar
              D00025  [001480] Sucrose
              D00025  [500313] White soft sugar
             Base
              D00025  [001480] Sucrose
              D00025  [500313] White soft sugar
             Flavoring substance
              D00025  [110635] Liquid sugar
              D00025  [001480] Sucrose
              D00025  [500313] White soft sugar
              D00025  [109287] Powdered sucrose
             Bonding agent
              D00025  [001480] Sucrose
              D00025  [500313] White soft sugar
             Brightening agent
              D00025  [001480] Sucrose
             Coating agent
              D00025  [001480] Sucrose
              D00025  [500313] White soft sugar
              D00025  [109287] Powdered sucrose
             Sugarcoated agent
              D00025  [001480] Sucrose
              D00025  [500313] White soft sugar
             Diluting agent
              D00025  [001480] Sucrose
              D00025  [500313] White soft sugar
              D00025  [109287] Powdered sucrose
             Disintegrant
              D00025  [001480] Sucrose
              D00025  [500313] White soft sugar
             Dampproof agent
              D00025  [001480] Sucrose
             Antiseptic agent
              D00025  [500313] White soft sugar
             Solubilizer
              D00025  [500313] White soft sugar
             Solubilization agent
              D00025  [500313] White soft sugar
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Metabotropic glutamate receptor family
               Chemoreception
                taste receptor type 1
                 Sucrose
                  D00025  Sucrose (JP16/NF); White soft sugar (JP16); Sugar, compressible (NF); Sugar, confectioner's (NF); Sugar spheres (NF)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00025  Sucrose; White soft sugar
DBLINKS     CAS: 57-50-1
            PubChem: 7847093
            DrugBank: DB02772
            LigandBox: D00025
            NIKKAJI: J4.581K
ATOM        23
            1   C1z C    27.5095  -14.6890
            2   O2a O    26.4715  -15.6160
            3   O2x O    28.6757  -13.8492
            4   C1y C    27.9351  -15.9892
            5   C1b C    26.5299  -13.6918
            6   C1y C    25.2645  -16.3158
            7   C1y C    29.8012  -14.6656
            8   C1y C    29.3521  -15.9892
            9   O1a O    27.1130  -17.1263
            10  O1a O    25.2528  -14.2748
            11  O2x O    24.0400  -15.6160
            12  C1y C    25.2645  -17.7153
            13  C1b C    31.1365  -14.2457
            14  O1a O    30.1628  -17.1322
            15  C1y C    22.8387  -16.3217
            16  C1y C    24.0400  -18.4150
            17  O1a O    26.4656  -18.4150
            18  O1a O    31.9762  -15.3711
            19  C1y C    22.8387  -17.7153
            20  C1b C    21.6259  -15.6160
            21  O1a O    24.0400  -19.8145
            22  O1a O    21.6259  -18.4150
            23  O1a O    20.5586  -16.5258
BOND        24
            1     1   2 1 #Down
            2     1   3 1
            3     1   4 1
            4     1   5 1
            5     6   2 1 #Down
            6     3   7 1
            7     4   8 1
            8     4   9 1 #Down
            9     5  10 1
            10    6  11 1
            11    6  12 1
            12    7  13 1 #Down
            13    8  14 1 #Up
            14   11  15 1
            15   12  16 1
            16   12  17 1 #Down
            17   13  18 1
            18   15  19 1
            19   15  20 1 #Up
            20   16  21 1 #Up
            21   19  22 1 #Down
            22   20  23 1
            23    7   8 1
            24   16  19 1
///
ENTRY       D00026                      Drug
NAME        L-Cysteine (JP16);
            Ecolan (TN)
FORMULA     C3H7NO2S
EXACT_MASS  121.0197
MOL_WEIGHT  121.1582
REMARK      Same as: C00097
            Therapeutic category: 3999
INTERACTION  
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D00026  L-Cysteine (JP16)
            Classification of Japanese OTC drugs [BR:br08313]
             Nourishing tonics and health supplements
              45 Protein and amino acid based drugs
               D00026  L-Cysteine (JP16)
              -- Improving drugs for chloasma
               D00026  L-Cysteine (JP16)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               L-Cysteine
                D00026  L-Cysteine (JP16)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00026  [003614] L-Cysteine
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00026  L-Cysteine
DBLINKS     CAS: 52-90-4
            PubChem: 7847094
            DrugBank: DB00151
            LigandBox: D00026
            NIKKAJI: J9.167G
ATOM        7
            1   C1c C    21.0841  -15.4370
            2   C6a C    19.9159  -14.6895
            3   C1b C    22.2989  -14.7361
            4   N1a N    21.1309  -16.8388
            5   O6a O    18.7011  -15.3436
            6   O6a O    19.9159  -13.2877
            7   S1a S    23.5138  -15.4838
BOND        6
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     2   6 2
            6     3   7 1
///
ENTRY       D00027                      Drug
NAME        Uracil (JAN/USAN)
FORMULA     C4H4N2O2
EXACT_MASS  112.0273
MOL_WEIGHT  112.0868
ACTIVITY    Antineoplastic [adjunct]
REMARK      Same as: C00106
DBLINKS     CAS: 66-22-8
            PubChem: 7847095
            DrugBank: DB03419
            LigandBox: D00027
            NIKKAJI: J4.842I
ATOM        8
            1   N4x N    25.4793  -18.6495
            2   C8y C    24.2610  -17.9559
            3   C8y C    25.4793  -20.0543
            4   C8x C    23.0602  -18.6554
            5   O5x O    24.2610  -16.5568
            6   N4x N    24.2726  -20.7598
            7   O5x O    26.6977  -20.7481
            8   C8x C    23.0602  -20.0603
BOND        8
            1     1   2 1
            2     1   3 1
            3     2   4 1
            4     2   5 2
            5     3   6 1
            6     3   7 2
            7     4   8 2
            8     6   8 1
///
ENTRY       D00028                      Drug
NAME        Glycerin (JP16/USP);
            Concentrated glycerin (JP16);
            Glycerin, concentrated (JAN);
            Glycerol (INN)
FORMULA     C3H8O3
EXACT_MASS  92.0473
MOL_WEIGHT  92.0938
ACTIVITY    Pharmaceutic aid [humectant];
            Pharmaceutic aid [solvent]
REMARK      Same as: C00116
            Therapeutic category: 2357 7190
            ATC code: A06AG04 A06AX01
COMMENT     Component of Glyceol (TN) [DR:D04285], Compound iodine glycerin [DR:D04412], Dental iodine glycerin [DR:D04880], Glycerin and potash solution [DR:D04809]
            Osmotic diuretics
INTERACTION  
STR_MAP     map07054  Antiglaucoma agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A06 DRUGS FOR CONSTIPATION
               A06A DRUGS FOR CONSTIPATION
                A06AG Enemas
                 A06AG04 Glycerol
                  D00028  Glycerin (JP16/USP); Concentrated glycerin (JP16); Glycerin, concentrated (JAN); Glycerol (INN)
                A06AX Other drugs for constipation
                 A06AX01 Glycerol
                  D00028  Glycerin (JP16/USP); Concentrated glycerin (JP16); Glycerin, concentrated (JAN); Glycerol (INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              23  Digestive organ agents
               235  Purgatives, clysters
                2357  Glycerins
                 D00028  Glycerin (JP16/USP); Concentrated glycerin (JP16); Glycerin, concentrated (JAN); Glycerol (INN)
             7  Agents not mainly for therapeutic purpose
              71  Dispensing medicines
               719  Miscellaneous
                7190  Miscellaneous
                 D00028  Glycerin (JP16/USP); Concentrated glycerin (JP16); Glycerin, concentrated (JAN); Glycerol (INN)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for digestive organs
              18 Enema
               D00028  Glycerin (JP16/USP); Concentrated glycerin (JP16); Glycerin, concentrated (JAN); Glycerol (INN)
             Agents for integumentary system
              55 Chilblain and chap remedies
               D00028  Glycerin (JP16/USP); Concentrated glycerin (JP16); Glycerin, concentrated (JAN); Glycerol (INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 2
              Inorganic and organic chemicals
               Glycerin
                D00028  Glycerin (JP16/USP); Concentrated glycerin (JP16); Glycerin, concentrated (JAN); Glycerol (INN)
             Category 3
              Inorganic and organic chemicals
               Glycerin
                D00028  Glycerin (JP16/USP); Concentrated glycerin (JP16); Glycerin, concentrated (JAN); Glycerol (INN)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Plasticizer
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Lubricating agent
              D00028  [001223] Glycerin
             Solubilizing agent
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Sweetening agent
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Base
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Flavoring substance
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Bonding agent
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Suspending agent
              D00028  [001223] Glycerin
             Coating agent
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Film
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Wetting agent
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Wetting adjuster
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Sugarcoated agent
              D00028  [001223] Glycerin
             Tonicity agent
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Flexibilizer
              D00028  [001223] Glycerin
             Emulsion
              D00028  [001223] Glycerin
             Adhesive
              D00028  [001223] Glycerin
             Adhesion-enhancing agent
              D00028  [001223] Glycerin
             Tenacious agent
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Diluting agent
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Dispersant
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Disintegrating adjuvant
              D00028  [001223] Glycerin
             Dampproof agent
              D00028  [001223] Glycerin
             Preserving agent
              D00028  [001223] Glycerin
             Solubilizer
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Solubilization agent
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Solvent
              D00028  [001223] Glycerin
              D00028  [001224] Concentrated glycerin
             Fluidizer
              D00028  [001224] Concentrated glycerin
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00028  Glycerin
              D00028  Concentrated glycerin
DBLINKS     CAS: 56-81-5
            PubChem: 7847096
            DrugBank: DB04077
            LigandBox: D00028
            NIKKAJI: J1.916J
ATOM        6
            1   O1a O    19.0400  -16.5200
            2   C1b C    20.2524  -15.8200
            3   C1c C    21.4649  -16.5200
            4   C1b C    22.6773  -15.8200
            5   O1a O    23.8897  -16.5200
            6   O1a O    21.4649  -17.9198
BOND        5
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     3   6 1
///
ENTRY       D00029                      Drug
NAME        Biotin (JP16/USP/INN);
            Bioepiderm (TN)
FORMULA     C10H16N2O3S
EXACT_MASS  244.0882
MOL_WEIGHT  244.3106
ACTIVITY    Vitamin
REMARK      Same as: C00120
            Therapeutic category: 3190
            ATC code: A11HA05
            Drug group: DG00131
COMMENT     Vitamin B7 (Vitamin H)
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A11 VITAMINS
               A11H OTHER PLAIN VITAMIN PREPARATIONS
                A11HA Other plain vitamin preparations
                 A11HA05 Biotin
                  D00029  Biotin (JP16/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              31  Vitamins
               319  Miscellaneous vitamins
                3190  Miscellaneous vitamins
                 D00029  Biotin (JP16/USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Biotin
                D00029  Biotin (JP16/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00029  Biotin
DBLINKS     CAS: 58-85-5
            PubChem: 7847097
            DrugBank: DB00121
            LigandBox: D00029
            NIKKAJI: J94.599D
ATOM        16
            1   C1y C    18.7455  -17.4465
            2   C1y C    17.3492  -17.4348
            3   C1y C    19.1779  -18.7728
            4   N1x N    19.1896  -16.1086
            5   N1x N    16.9110  -16.1086
            6   C1x C    16.9110  -18.7611
            7   S2x S    18.0444  -19.5907
            8   C1b C    20.3931  -19.4680
            9   C5x C    18.0503  -15.2789
            10  C1b C    21.6025  -18.7728
            11  O5x O    18.0503  -13.8709
            12  C1b C    22.8119  -19.4680
            13  C1b C    24.0214  -18.7728
            14  C6a C    25.2308  -19.4680
            15  O6a O    26.4402  -18.7728
            16  O6a O    25.2308  -20.8702
BOND        17
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 1 #Down
            8     4   9 1
            9     8  10 1
            10    9  11 2
            11   10  12 1
            12   12  13 1
            13   13  14 1
            14   14  15 1
            15   14  16 2
            16    5   9 1
            17    6   7 1
///
ENTRY       D00030                      Drug
NAME        L-Leucine (JP16);
            Leucine (USP)
FORMULA     C6H13NO2
EXACT_MASS  131.0946
MOL_WEIGHT  131.1729
ACTIVITY    Amino acid
REMARK      Same as: C00123
INTERACTION  
BRITE       Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               L-Leucine
                D00030  L-Leucine (JP16); Leucine (USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00030  [003619] L-Leucine
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00030  L-Leucine
DBLINKS     CAS: 61-90-5
            PubChem: 7847098
            DrugBank: DB00149
            LigandBox: D00030
            NIKKAJI: J1.167C
ATOM        9
            1   O6a O    21.6300  -12.7400
            2   C6a C    22.8424  -12.0400
            3   C1c C    24.0549  -12.7400
            4   C1b C    25.2673  -12.0400
            5   C1c C    26.4797  -12.7400
            6   C1a C    27.6922  -12.0400
            7   O6a O    22.8424  -10.6402
            8   N1a N    24.0549  -14.1398
            9   C1a C    26.4797  -14.1399
BOND        8
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     2   7 2
            7     3   8 1 #Down
            8     5   9 1
///
ENTRY       D00031                      Drug
NAME        Oxiglutatione (JAN/INN);
            Glutathione (TN)
FORMULA     C20H32N6O12S2
EXACT_MASS  612.152
MOL_WEIGHT  612.6311
REMARK      Same as: C00127
            Therapeutic category: 1319
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1319  Others
                 D00031  Oxiglutatione (JAN/INN)
DBLINKS     CAS: 27025-41-8
            PubChem: 7847099
            DrugBank: DB03310
            LigandBox: D00031
            NIKKAJI: J415.688I
ATOM        40
            1   O6a O     5.2724   -3.7100
            2   C6a C     6.4849   -4.4100
            3   C1c C     7.6973   -3.7100
            4   C1b C     8.9097   -4.4100
            5   C1b C    10.1222   -3.7100
            6   C5a C    11.3346   -4.4100
            7   N1b N    12.5470   -3.7100
            8   C1c C    13.7595   -4.4100
            9   C5a C    14.9719   -3.7100
            10  N1b N    16.1844   -4.4100
            11  C1b C    17.3968   -3.7100
            12  C6a C    18.6092   -4.4100
            13  O6a O    19.8217   -3.7100
            14  O6a O     6.4849   -5.8098
            15  O5a O    11.3346   -5.8100
            16  N1a N     7.6973   -2.3100
            17  C1b C    13.7595   -5.8097
            18  O5a O    14.9719   -2.3100
            19  O6a O    18.6092   -5.8100
            20  S3a S    12.5699   -6.4966
            21  S3a S    12.5699   -7.8966
            22  C1b C    13.8108   -8.6129
            23  C1c C    13.8109  -10.0098
            24  C5a C    15.0077  -10.7008
            25  N1b N    12.5829  -10.7191
            26  N1b N    16.1953  -10.0150
            27  C1b C    17.3866  -10.7028
            28  C6a C    18.5759  -10.0160
            29  O5a O    15.0079  -12.1097
            30  O6a O    19.7663  -10.7033
            31  O6a O    18.5760   -8.6102
            32  C5a C    11.3794  -10.0244
            33  C1b C    10.1962  -10.7076
            34  O5a O    11.3790   -8.6103
            35  C1b C     9.0027  -10.0185
            36  C1c C     7.8145  -10.7047
            37  C6a C     6.6235  -10.0170
            38  N1a N     7.8145  -12.1098
            39  O6a O     5.4341  -10.7039
            40  O6a O     6.6234   -8.6103
BOND        39
            1     1   2 1
            2     3   2 1 #Up
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     6   7 1
            7     7   8 1
            8     8   9 1
            9     9  10 1
            10   10  11 1
            11   11  12 1
            12   12  13 1
            13    2  14 2
            14    6  15 2
            15    3  16 1
            16    8  17 1 #Down
            17    9  18 2
            18   12  19 2
            19   17  20 1
            20   20  21 1
            21   21  22 1
            22   23  22 1 #Up
            23   23  24 1
            24   23  25 1
            25   24  26 1
            26   26  27 1
            27   27  28 1
            28   24  29 2
            29   28  30 1
            30   28  31 2
            31   25  32 1
            32   32  33 1
            33   32  34 2
            34   33  35 1
            35   35  36 1
            36   36  37 1 #Down
            37   36  38 1
            38   37  39 1
            39   37  40 2
///
ENTRY       D00032                      Drug
NAME        L-Histidine (JP16);
            Histidine (USP/INN)
FORMULA     C6H9N3O2
EXACT_MASS  155.0695
MOL_WEIGHT  155.1546
ACTIVITY    Amino acid
REMARK      Same as: C00135
COMMENT     Precursor of Histamine
            essential amino acid
INTERACTION  
BRITE       Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               L-Histidine
                D00032  L-Histidine (JP16); Histidine (USP/INN)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00032  [003617] L-Histidine
             Buffering agent
              D00032  [003617] L-Histidine
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00032  L-Histidine
              D00032  L-Histidine hydrochloride hydrate
DBLINKS     CAS: 71-00-1
            PubChem: 7847100
            DrugBank: DB00117
            LigandBox: D00032
            NIKKAJI: J4.881J
ATOM        11
            1   C8x C    22.2600  -14.5600
            2   N5x N    22.7500  -15.8900
            3   C8y C    24.0800  -15.8900
            4   C8x C    24.5000  -14.4900
            5   N4x N    23.3800  -13.7200
            6   C1b C    25.3400  -16.5200
            7   C1c C    26.5300  -15.8200
            8   C6a C    27.7200  -16.5200
            9   O6a O    28.9800  -15.8200
            10  O6a O    27.7200  -17.9200
            11  N1a N    26.5300  -14.4200
BOND        11
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     1   5 1
            6     3   6 1
            7     6   7 1
            8     7   8 1
            9     8   9 1
            10    8  10 2
            11    7  11 1 #Down
///
ENTRY       D00033                      Drug
NAME        Phenol (JP16/USP);
            Liquefied phenol (JP16);
            Phenol for disinfection (JP16);
            Phenol, liquefied;
            Paoscle (TN);
            Phenol (TN);
            Liquefied phenol (TN);
            Phenol for disinfection (TN)
FORMULA     C6H6O
EXACT_MASS  94.0419
MOL_WEIGHT  94.1112
ACTIVITY    Pharmaceutic aid [preservative];
            Antipruritic [topical]
REMARK      Same as: C00146
            Therapeutic category: 2559 2619 2730 7322
            ATC code: C05BB05 D08AE03 N01BX03 R02AA19
            Drug group: DG00301
COMMENT     Volume percent 88 or more of Phenol is contained in the Liquefied phenol.
            Volume percent 95 or more of Phenol [DR:D00033] is contained in the Phenol for disinfection.
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C05 VASOPROTECTIVES
               C05B ANTIVARICOSE THERAPY
                C05BB Sclerosing agents for local injection
                 C05BB05 Phenol
                  D00033  Phenol (JP16/USP)
             D DERMATOLOGICALS
              D08 ANTISEPTICS AND DISINFECTANTS
               D08A ANTISEPTICS AND DISINFECTANTS
                D08AE Phenol and derivatives
                 D08AE03 Phenol
                  D00033  Phenol (JP16/USP)
             N NERVOUS SYSTEM
              N01 ANESTHETICS
               N01B ANESTHETICS, LOCAL
                N01BX Other local anesthetics
                 N01BX03 Phenol
                  D00033  Phenol (JP16/USP)
             R RESPIRATORY SYSTEM
              R02 THROAT PREPARATIONS
               R02A THROAT PREPARATIONS
                R02AA Antiseptics
                 R02AA19 Phenol
                  D00033  Phenol (JP16/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              25  Urogenital and anal organ agents
               255  Hemorrhoidal preparations
                2559  Others
                 D00033  Phenol (JP16/USP); Liquefied phenol (JP16); Phenol for disinfection (JP16)
              26  Epidermides
               261  Antimicrobial agents
                2619  Others
                 D00033  Phenol (JP16/USP); Liquefied phenol (JP16); Phenol for disinfection (JP16)
              27  Dental preparations
               273  Analgesics and sedatives
                2730  Analgesics and sedatives
                 D00033  Phenol (JP16/USP); Liquefied phenol (JP16); Phenol for disinfection (JP16)
             7  Agents not mainly for therapeutic purpose
              73  Public health agents
               732  Germicides and disinfectants
                7322  Phenols and chlorophenols
                 D00033  Phenol (JP16/USP); Liquefied phenol (JP16); Phenol for disinfection (JP16)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for otolaryngologic use
              71 Ear drops
               D00033  Phenol (JP16/USP)
             Agents for dental and stomatological use
              75 Toothache and pyorrhea remedies
               D00033  Phenol (JP16/USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 2
              Inorganic and organic chemicals
               Phenol
                D00033  Phenol (JP16/USP)
            Pharmaceutical additives [BR:br08316]
             Antiseptic agent
              D00033  [001535] Liquefied phenol
              D00033  [001534] Phenol
             Preserving agent
              D00033  [001535] Liquefied phenol
              D00033  [001534] Phenol
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00033  Phenol
DBLINKS     CAS: 108-95-2
            PubChem: 7847101
            DrugBank: DB03255
            LigandBox: D00033
            NIKKAJI: J2.873H
ATOM        7
            1   C8y C    24.5637  -18.4566
            2   C8x C    23.3622  -19.1533
            3   C8x C    25.7843  -19.1533
            4   O1a O    24.5637  -17.0698
            5   C8x C    23.3622  -20.5592
            6   C8x C    25.7843  -20.5592
            7   C8x C    24.5637  -21.2686
BOND        7
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 2
            6     5   7 2
            7     6   7 1
///
ENTRY       D00034                      Drug
NAME        Adenine (JAN/USP);
            Leucon (TN)
FORMULA     C5H5N5
EXACT_MASS  135.0545
MOL_WEIGHT  135.1267
ACTIVITY    Vitamin
REMARK      Same as: C00147
            Therapeutic category: 4191
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              41  Cellular function activating agents
               419  Miscellaneous
                4191  Adenines
                 D00034  Adenine (JAN/USP)
DBLINKS     CAS: 73-24-5
            PubChem: 7847102
            DrugBank: DB00173
            PDB-CCD: ADE
            LigandBox: D00034
            NIKKAJI: J5.257D
ATOM        10
            1   C8y C    24.4301  -15.4002
            2   C8y C    24.4301  -16.8002
            3   N5x N    25.6426  -17.5002
            4   C8x C    26.8551  -16.8002
            5   N5x N    26.8551  -15.4002
            6   C8y C    25.6426  -14.7002
            7   N5x N    23.0986  -14.9676
            8   C8x C    22.2757  -16.1002
            9   N4x N    23.0986  -17.2328
            10  N1a N    25.6426  -13.3004
BOND        11
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 2
            9     8   9 1
            10    2   9 1
            11    6  10 1
///
ENTRY       D00035                      Drug
NAME        L-Proline (JP16);
            Proline (USP)
FORMULA     C5H9NO2
EXACT_MASS  115.0633
MOL_WEIGHT  115.1305
ACTIVITY    Amino acid
REMARK      Same as: C00148
INTERACTION  
BRITE       Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00035  L-Proline
DBLINKS     CAS: 147-85-3
            PubChem: 7847103
            DrugBank: DB00172
            LigandBox: D00035
            NIKKAJI: J9.117K
ATOM        8
            1   C1x C    22.5400  -17.9900
            2   C1x C    22.9600  -19.2500
            3   C1x C    24.3600  -19.2500
            4   C1y C    24.7800  -17.9200
            5   N1x N    23.6600  -17.0800
            6   C6a C    25.9700  -17.2200
            7   O6a O    27.2300  -17.9200
            8   O6a O    25.9700  -15.8200
BOND        8
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     1   5 1
            6     4   6 1 #Down
            7     6   7 1
            8     6   8 2
///
ENTRY       D00036                      Drug
NAME        Nicotinamide (JP16/INN);
            Niacinamide (USP)
FORMULA     C6H6N2O
EXACT_MASS  122.048
MOL_WEIGHT  122.1246
ACTIVITY    Vitamin [enzyme co-factor]
REMARK      Same as: C00153
            Therapeutic category: 3132
            ATC code: A11HA01
            Drug group: DG00127
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A11 VITAMINS
               A11H OTHER PLAIN VITAMIN PREPARATIONS
                A11HA Other plain vitamin preparations
                 A11HA01 Nicotinamide
                  D00036  Nicotinamide (JP16/INN); Niacinamide (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              31  Vitamins
               313  Vitamin B preparations
                3132  Nicotinic acids
                 D00036  Nicotinamide (JP16/INN); Niacinamide (USP)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for otolaryngologic use
              -- Oral medicine for ear
               D00036  Nicotinamide (JP16/INN); Niacinamide (USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Nicotinamide
                D00036  Nicotinamide (JP16/INN); Niacinamide (USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00036  [001463] Nicotinamide
             Tonicity agent
              D00036  [001463] Nicotinamide
             Solubilization agent
              D00036  [001463] Nicotinamide
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00036  Nicotinamide
            Phytochemicals used as drugs [BR:br08306]
             Alkaloids
              Alkaloids derived from nicotinic acid
               Pyridine alkaloids
                D00036  Nicotinamide (JP15/INN); Niacinamide (USP)
DBLINKS     CAS: 98-92-0
            PubChem: 7847104
            DrugBank: DB02701
            LigandBox: D00036
            NIKKAJI: J3.988H
ATOM        9
            1   C8y C    25.1300  -17.0100
            2   C8x C    23.8700  -16.3100
            3   C8x C    25.1300  -18.4100
            4   C5a C    26.3200  -16.3100
            5   C8x C    22.6800  -17.0100
            6   N5x N    23.8700  -19.1100
            7   N1a N    27.5100  -17.0100
            8   O5a O    26.3200  -14.9100
            9   C8x C    22.6800  -18.4100
BOND        9
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     3   6 1
            6     4   7 1
            7     4   8 2
            8     5   9 1
            9     6   9 2
///
ENTRY       D00037                      Drug
NAME        Anhydrous citric acid (JP16);
            Citric acid anhydrous (JAN);
            Citric acid, anhydrous (USP)
FORMULA     C6H8O7
EXACT_MASS  192.027
MOL_WEIGHT  192.1235
REMARK      Same as: C00158
            ATC code: A09AB04
            Drug group: DG00111
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A09 DIGESTIVES, INCL. ENZYMES
               A09A DIGESTIVES, INCL. ENZYMES
                A09AB Acid preparations
                 A09AB04 Citric acid
                  D00037  Anhydrous citric acid (JP16); Citric acid anhydrous (JAN); Citric acid, anhydrous (USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Anhydrous citric acid
                D00037  Anhydrous citric acid (JP16); Citric acid anhydrous (JAN); Citric acid, anhydrous (USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00037  [001216] Anhydrous citric acid
             Solubilizing agent
              D00037  [001216] Anhydrous citric acid
             Buffering agent
              D00037  [001216] Anhydrous citric acid
             Flavoring substance
              D00037  [001216] Anhydrous citric acid
             Coating agent
              D00037  [001216] Anhydrous citric acid
             Bloating agent
              D00037  [001216] Anhydrous citric acid
             pH regulator
              D00037  [001216] Anhydrous citric acid
             Diluting agent
              D00037  [001216] Anhydrous citric acid
             Disintegrant
              D00037  [001216] Anhydrous citric acid
             Disintegrating adjuvant
              D00037  [001216] Anhydrous citric acid
             Solubilization agent
              D00037  [001216] Anhydrous citric acid
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00037  Anhydrous citric acid
DBLINKS     CAS: 77-92-9
            PubChem: 7847105
            DrugBank: DB04272
            LigandBox: D00037
            NIKKAJI: J2.824J
ATOM        13
            1   O6a O    22.8900  -21.6300
            2   C6a C    24.0800  -20.9300
            3   C1b C    25.2700  -21.6300
            4   C1d C    26.4600  -20.9300
            5   C1b C    27.6500  -21.6300
            6   C6a C    28.8400  -20.9300
            7   O6a O    30.0300  -21.6300
            8   O6a O    24.0800  -19.5300
            9   O6a O    28.8400  -19.6700
            10  C6a C    26.4600  -19.5300
            11  O6a O    27.6500  -18.6900
            12  O6a O    25.2700  -18.6900
            13  O1a O    26.8100  -22.5400
BOND        12
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     6   7 1
            7     2   8 2
            8     6   9 2
            9     4  10 1
            10   10  11 1
            11   10  12 2
            12    4  13 1
///
ENTRY       D00038                      Drug
NAME        Benzoic acid (JP16/USP);
            Benzoic acid (TN)
FORMULA     C7H6O2
EXACT_MASS  122.0368
MOL_WEIGHT  122.1213
ACTIVITY    Pharmaceutic aid [antifungal agent]
REMARK      Same as: C00180
            Therapeutic category: 7319
INTERACTION  
STR_MAP     map07110  Benzoic acid family
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             7  Agents not mainly for therapeutic purpose
              73  Public health agents
               731  Antiseptics
                7319  Others
                 D00038  Benzoic acid (JP16/USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Specified Category 2
              Inorganic and organic chemicals
               Benzoic acid
                D00038  Benzoic acid (JP16/USP)
             Category 2
              Inorganic and organic chemicals
               Benzoic acid
                D00038  Benzoic acid (JP16/USP)
             Category 3
              Inorganic and organic chemicals
               Benzoic acid
                D00038  Benzoic acid (JP16/USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00038  [002023] Benzoic acid
             Buffering agent
              D00038  [002023] Benzoic acid
             Antiseptic agent
              D00038  [002023] Benzoic acid
             Preserving agent
              D00038  [002023] Benzoic acid
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00038  Benzoic acid
DBLINKS     CAS: 65-85-0
            PubChem: 7847106
            DrugBank: DB03793
            LigandBox: D00038
            NIKKAJI: J2.358B
ATOM        9
            1   C8y C    21.2100  -16.9763
            2   C8x C    20.0003  -17.6676
            3   C8x C    22.4262  -17.6676
            4   C6a C    21.2037  -15.5809
            5   C8x C    20.0003  -19.0759
            6   C8x C    22.4262  -19.0759
            7   O6a O    22.4069  -14.8832
            8   O6a O    19.9938  -14.8897
            9   C8x C    21.2100  -19.7863
BOND        9
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 2
            6     4   7 1
            7     4   8 2
            8     5   9 2
            9     6   9 1
///
ENTRY       D00039                      Drug
NAME        L-Valine (JP16);
            Valine (USP)
FORMULA     C5H11NO2
EXACT_MASS  117.079
MOL_WEIGHT  117.1463
ACTIVITY    Amino acid
REMARK      Same as: C00183
INTERACTION  
BRITE       Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               L-Valine
                D00039  L-Valine (JP16); Valine (USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00039  L-Valine
DBLINKS     CAS: 72-18-4
            PubChem: 7847107
            DrugBank: DB00161
            LigandBox: D00039
            NIKKAJI: J9.179K
ATOM        8
            1   C1c C    24.8500  -19.0764
            2   C1c C    26.0666  -18.3804
            3   C6a C    23.6334  -18.3629
            4   N1a N    24.8442  -20.4802
            5   C1a C    27.2716  -19.0881
            6   C1a C    26.0725  -16.9825
            7   O6a O    22.4226  -19.0589
            8   O6a O    23.6392  -16.9707
BOND        7
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 2
///
ENTRY       D00040                      Drug
NAME        Cholesterol (JP16/NF);
            Cholesterol (TN)
FORMULA     C27H46O
EXACT_MASS  386.3549
MOL_WEIGHT  386.6535
ACTIVITY    Pharmaceutic aid [emulsifying agent]
REMARK      Same as: C00187
BRITE       Pharmaceutical additives [BR:br08316]
             Surfactant
              D00040  [001255] Cholesterol
             Base
              D00040  [001255] Cholesterol
             Diluting agent
              D00040  [001255] Cholesterol
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00040  Cholesterol
DBLINKS     CAS: 57-88-5
            PubChem: 7847108
            DrugBank: DB04540
            LigandBox: D00040
            NIKKAJI: J2.804E
ATOM        28
            1   C1y C    26.9492  -18.8344
            2   C1y C    25.7801  -19.5091
            3   C1z C    26.9492  -17.4851
            4   C1x C    29.2871  -18.8344
            5   C1y C    24.6170  -18.8344
            6   C1x C    25.7743  -20.8584
            7   C1y C    28.1298  -16.8105
            8   C1x C    25.7801  -16.8105
            9   C1a C    26.9432  -16.1359
            10  C1x C    29.2871  -17.4851
            11  C1z C    23.4364  -19.5091
            12  C1x C    24.6170  -17.4851
            13  C2x C    24.6170  -21.5331
            14  C1c C    28.1298  -15.4613
            15  C2y C    23.4364  -20.8584
            16  C1x C    22.2733  -18.8344
            17  C1a C    23.4247  -18.1598
            18  C1b C    29.3221  -14.7749
            19  C1a C    26.9316  -14.7693
            20  C1x C    22.2733  -21.5331
            21  C1x C    21.1042  -19.5091
            22  C1b C    30.5143  -15.4669
            23  C1y C    21.1042  -20.8584
            24  C1b C    31.7066  -14.7749
            25  O1a O    19.9236  -21.5331
            26  C1c C    32.9046  -15.4669
            27  C1a C    34.0969  -14.7807
            28  C1a C    32.8988  -17.1242
BOND        31
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 1
            8     3   9 1 #Up
            9     4  10 1
            10    5  11 1
            11    5  12 1
            12    6  13 1
            13    7  14 1
            14   11  15 1
            15   11  16 1
            16   11  17 1 #Up
            17   14  18 1
            18   14  19 1 #Down
            19   15  20 1
            20   16  21 1
            21   18  22 1
            22   20  23 1
            23   22  24 1
            24   23  25 1 #Up
            25   24  26 1
            26   26  27 1
            27   26  28 1
            28    7  10 1
            29    8  12 1
            30   13  15 2
            31   21  23 1
///
ENTRY       D00041                      Drug
NAME        L-Threonine (JP16);
            Threonine (USP)
FORMULA     C4H9NO3
EXACT_MASS  119.0582
MOL_WEIGHT  119.1192
ACTIVITY    Amino acid
REMARK      Same as: C00188
INTERACTION  
BRITE       Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               L-Threonine
                D00041  L-Threonine (JP16); Threonine (USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00041  L-Threonine
DBLINKS     CAS: 72-19-5
            PubChem: 7847109
            DrugBank: DB00156
            LigandBox: D00041
            NIKKAJI: J21.883I
ATOM        8
            1   O6a O    15.3300   -9.7300
            2   C6a C    16.5424   -9.0300
            3   C1c C    17.7549   -9.7300
            4   C1c C    18.9673   -9.0300
            5   C1a C    20.1797   -9.7300
            6   O6a O    16.5424   -7.6302
            7   N1a N    17.7549  -11.1298
            8   O1a O    18.9673   -7.6300
BOND        7
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     2   6 2
            6     3   7 1 #Down
            7     4   8 1 #Down
///
ENTRY       D00042                      Drug
NAME        Cobamamide (JAN/INN);
            Calomide (TN)
FORMULA     C72H100CoN18O17P
EXACT_MASS  1578.6583
MOL_WEIGHT  1579.5818
REMARK      Same as: C00194
            Therapeutic category: 3136
            ATC code: B03BA04
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B03 ANTIANEMIC PREPARATIONS
               B03B VITAMIN B12 AND FOLIC ACID
                B03BA Vitamin B12 (cyanocobalamin and analogues)
                 B03BA04 Cobamamide
                  D00042  Cobamamide (JAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              31  Vitamins
               313  Vitamin B preparations
                3136  Vitamin B12 preparations
                 D00042  Cobamamide (JAN/INN)
DBLINKS     CAS: 13870-90-1
            PubChem: 7847110
            NIKKAJI: J2.221.278H
ATOM        109
            1   Z   Co   15.2166  -11.6347 #+
            2   N2x N    13.8876  -10.3735
            3   N1y N    13.8876  -13.0312 #-
            4   N2x N    16.5904  -10.4185
            5   N2x N    16.5604  -13.0011
            6   N5x N    17.3304  -21.7582
            7   C1z C    12.6641  -10.5685
            8   C2y C    14.1054   -9.1573
            9   C1y C    12.6641  -12.8509
            10  C2y C    14.0903  -14.2548
            11  C2y C    16.3276   -9.1947
            12  C2y C    17.8366  -10.5311
            13  C2y C    16.3427  -14.2097
            14  C2y C    17.8066  -12.8359
            15  C8y C    18.4941  -22.1261
            16  C8x C    16.6171  -22.7493
            17  C1z C    12.1008   -9.4499
            18  C1a C    11.4477  -10.8990
            19  C1y C    12.9943   -8.5790
            20  C2y C    15.2240   -8.7369
            21  C1y C    12.1008  -13.9545
            22  C1z C    12.9943  -14.8330
            23  C2y C    15.2240  -14.6902
            24  C1z C    17.4088   -8.5790
            25  C1y C    18.3322   -9.3974
            26  C2x C    18.2947  -11.6798
            27  C1y C    17.4238  -14.8030
            28  C1z C    18.3322  -13.9545
            29  C8y C    18.4865  -23.3499
            30  C8x C    19.5452  -21.5255
            31  N4y N    17.3304  -23.7327
            32  C1b C     9.2522   -9.4425
            33  C1a C    11.7705   -8.2413
            34  C1b C    13.0168   -7.3404
            35  C1a C    15.2166   -7.4830
            36  C1b C    10.7645  -14.0821
            37  C1b C    12.6293  -17.0442
            38  C1a C    13.8931  -17.5907
            39  C1a C    15.2166  -15.9290
            40  C1b C    17.4012   -7.3254
            41  C1a C    15.9974   -6.2264
            42  C1b C    19.5784   -9.3900
            43  C1b C    17.5514  -16.0416
            44  C1a C    19.5333  -13.6393
            45  C1a C    18.7900  -15.1256
            46  C8x C    19.5452  -23.9580
            47  C8y C    20.6038  -22.1261
            48  C1y C    11.7386  -25.9158
            49  C5a C     8.6441   -8.3689
            50  C1b C    11.9508   -6.7173
            51  C5a C    10.3290  -15.2308
            52  C1b C    11.4081  -17.3873
            53  C5a C    18.4748   -6.7023
            54  C1b C    20.1791   -8.3088
            55  C1b C    18.6775  -16.5521
            56  C8y C    20.6038  -23.3499
            57  C1a C    21.6623  -21.5255
            58  C1y C    11.3707  -24.7447
            59  O2x O    10.6799  -26.5165
            60  N1a N     7.4053   -8.4239
            61  O5a O     9.2672   -7.3027
            62  C5a C    11.9658   -5.4711
            63  N1a N     9.1054  -15.4335
            64  O5a O    11.1100  -16.1768
            65  C5a C    11.4007  -18.6336
            66  N1a N    18.4674   -5.4561
            67  O5a O    19.5560   -7.3178
            68  C5a C    21.4253   -8.3014
            69  C5a C    18.7977  -17.7833
            70  C1a C    21.6623  -23.9580
            71  C1y C    10.1395  -24.7297
            72  O1a O    12.0989  -23.7687
            73  C1y C     9.7641  -25.8858
            74  N1a N    10.8923   -4.8477
            75  O5a O    13.0468   -4.8628
            76  N1b N    10.3271  -19.2567
            77  O5a O    12.4593  -19.2643
            78  N1a N    22.0410   -7.2202
            79  O5a O    22.0558   -9.3824
            80  N1a N    17.7842  -18.4966
            81  O5a O    19.9387  -18.3015
            82  O2b O     9.4336  -23.7312
            83  C1b C     8.5103  -26.3062
            84  C1b C    10.3271  -20.5406
            85  P1b P     8.0748  -23.1306
            86  O1a O     8.2551  -27.5975
            87  C1c C     9.2085  -21.1861
            88  O2b O     9.2159  -22.4700
            89  O1c O     6.9338  -22.4700 #-
            90  O1c O     7.1439  -24.0615
            91  C1a C     8.1049  -20.5406
            92  C1y C    22.8073  -12.6701
            93  O2x O    23.8282  -11.9268
            94  C1y C    23.2050  -13.8713
            95  C1y C    24.8793  -12.7152
            96  C1y C    24.4813  -13.8713
            97  O1a O    22.7922  -15.0874
            98  N4y N    26.0654  -12.3322
            99  O1a O    25.0896  -14.9224
            100 C8y C    27.0491  -13.0154
            101 C8x C    26.5085  -11.0409
            102 C8y C    28.1902  -12.1746
            103 N5x N    27.1691  -14.3293
            104 N5x N    27.8449  -11.0485
            105 C8y C    29.3539  -12.6925
            106 C8x C    28.4003  -14.8697
            107 N5x N    29.5039  -14.0589
            108 N1a N    30.3748  -11.9268
            109 C1b C    21.4859  -11.6156 #-
BOND        119
            1     1   3 1
            2     2   7 1
            3     2   8 2
            4     3   9 1
            5     3  10 1
            6     4  11 1
            7     4  12 2
            8     5  13 2
            9     5  14 1
            10    6  15 1
            11    6  16 2
            12    7  17 1
            13    7  18 1 #Down
            14    8  19 1
            15    8  20 1
            16    9  21 1
            17   10  22 1
            18   10  23 2
            19   11  24 1
            20   12  25 1
            21   12  26 1
            22   13  27 1
            23   14  28 1
            24   15  29 2
            25   15  30 1
            26   16  31 1
            27   17  32 1 #Up
            28   17  33 1 #Down
            29   19  34 1 #Down
            30   20  35 1
            31   21  36 1 #Up
            32   22  37 1 #Down
            33   22  38 1 #Up
            34   23  39 1
            35   24  40 1 #Up
            36   24  41 1 #Down
            37   25  42 1 #Down
            38   27  43 1 #Down
            39   28  44 1
            40   28  45 1
            41   29  46 1
            42   30  47 2
            43   48  31 1 #Up
            44   32  49 1
            45   34  50 1
            46   36  51 1
            47   37  52 1
            48   40  53 1
            49   42  54 1
            50   43  55 1
            51   46  56 2
            52   47  57 1
            53   48  58 1
            54   48  59 1
            55   49  60 1
            56   49  61 2
            57   50  62 1
            58   51  63 1
            59   51  64 2
            60   52  65 1
            61   53  66 1
            62   53  67 2
            63   54  68 1
            64   55  69 1
            65   56  70 1
            66   58  71 1
            67   58  72 1 #Up
            68   73  59 1
            69   62  74 1
            70   62  75 2
            71   65  76 1
            72   65  77 2
            73   68  78 1
            74   68  79 2
            75   69  80 1
            76   69  81 2
            77   71  82 1 #Up
            78   73  83 1 #Down
            79   76  84 1
            80   82  85 1
            81   83  86 1
            82   84  87 1
            83   85  88 1
            84   85  89 1
            85   85  90 2
            86   87  91 1 #Down
            87    7   9 1
            88   11  20 2
            89   13  23 1
            90   14  26 2
            91   17  19 1
            92   21  22 1
            93   24  25 1
            94   27  28 1
            95   29  31 1
            96   47  56 1
            97   71  73 1
            98   87  88 1
            99   92  93 1
            100  92  94 1
            101  93  95 1
            102  94  96 1
            103  94  97 1 #Down
            104  95  98 1 #Up
            105  96  99 1 #Down
            106  98 100 1
            107  98 101 1
            108 100 102 2
            109 100 103 1
            110 101 104 2
            111 102 105 1
            112 103 106 2
            113 105 107 2
            114 105 108 1
            115  95  96 1
            116 102 104 1
            117 106 107 1
            118  92 109 1 #Up
            119   1 109 1
///
ENTRY       D00043                      Drug
NAME        Isoflurophate (USP);
            Fluostigmine;
            Floropryl (TN)
FORMULA     C6H14FO3P
EXACT_MASS  184.0665
MOL_WEIGHT  184.1457
ACTIVITY    Cholinergic [ophthalmic]
REMARK      Same as: C00202
            ATC code: S01EB07
TARGET      acetylcholinesterase (AChE) inhibitor [HSA:43] [KO:K01049];
            butyrylcholinesterase (BChE) inhibitor [HSA:590] [KO:K01050]
  PATHWAY   hsa00564(43)  Glycerophospholipid metabolism
            hsa04725(43)  Cholinergic synapse
INTERACTION  
STR_MAP     map07220  Cholinergic and anticholinergic drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
                S01EB Parasympathomimetics
                 S01EB07 Fluostigmine
                  D00043  Isoflurophate (USP)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases
               acetylcholinesterase (AChE)
                Fluostigmine
                 D00043  Isoflurophate (USP)
               butyrylcholinesterase (BChE)
                Fluostigmine
                 D00043  Isoflurophate (USP)
DBLINKS     CAS: 55-91-4
            PubChem: 7847111
            DrugBank: DB00677
            LigandBox: D00043
            NIKKAJI: J4.564K
ATOM        11
            1   P1b P    23.2694  -15.1480
            2   O2b O    21.8252  -15.1480
            3   O2b O    23.2694  -16.5348
            4   O3b O    23.2183  -13.7549
            5   X   F    24.6114  -15.1545
            6   C1c C    20.3425  -15.1352
            7   C1c C    23.2694  -17.9279
            8   C1a C    19.6268  -14.0802
            9   C1a C    19.6715  -16.3495
            10  C1a C    22.0616  -18.6183
            11  C1a C    24.4709  -18.6183
BOND        10
            1     1   2 1
            2     1   3 1
            3     1   4 2
            4     1   5 1
            5     2   6 1
            6     3   7 1
            7     6   8 1
            8     6   9 1
            9     7  10 1
            10    7  11 1
///
ENTRY       D00044                      Drug
NAME        Maltose (NF);
            Madoros (TN)
FORMULA     C12H22O11
EXACT_MASS  342.1162
MOL_WEIGHT  342.2965
REMARK      Same as: C00208 G00275
            Therapeutic category: 3233
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              32  Nutrients, tonics
               323  Saccharide preparations
                3233  Maltoses
                 D00044  Maltose (NF)
DBLINKS     CAS: 69-79-4
            PubChem: 7847112
            DrugBank: DB03323
            LigandBox: D00044
            NIKKAJI: J4.871B
ATOM        23
            1   C1y C    27.4952  -17.6709
            2   C1y C    27.4952  -16.2679
            3   O2a O    26.2844  -18.3695
            4   C1y C    28.7120  -18.3638
            5   O2x O    28.7120  -15.5692
            6   C1b C    26.2844  -15.5633
            7   C1y C    25.0735  -19.0682
            8   C1y C    29.9231  -17.6709
            9   O1a O    28.7120  -19.7668
            10  C1y C    29.9231  -16.2679
            11  O1a O    25.0735  -16.2679
            12  O2x O    23.8684  -18.3638
            13  C1y C    25.0735  -20.4712
            14  O1a O    31.1340  -18.3638
            15  O1a O    31.1340  -15.5692
            16  C1y C    22.6516  -19.0682
            17  C1y C    23.8684  -21.1641
            18  O1a O    26.2844  -21.1641
            19  C1y C    22.6516  -20.4712
            20  C1b C    21.4348  -18.3638
            21  O1a O    23.8684  -22.5671
            22  O1a O    21.4348  -21.1641
            23  O1a O    20.2239  -19.0682
BOND        24
            1     1   2 1
            2     1   3 1 #Down
            3     1   4 1
            4     2   5 1
            5     2   6 1 #Up
            6     7   3 1 #Down
            7     4   8 1
            8     4   9 1 #Up
            9     5  10 1
            10    6  11 1
            11    7  12 1
            12    7  13 1
            13    8  14 1 #Down
            14   10  15 1 #Either
            15   12  16 1
            16   13  17 1
            17   13  18 1 #Down
            18   16  19 1
            19   16  20 1 #Up
            20   17  21 1 #Up
            21   19  22 1 #Down
            22   20  23 1
            23    8  10 1
            24   17  19 1
///
ENTRY       D00045                      Drug
NAME        Adenosine (JAN/USP);
            Adenocard (TN);
            Adenoscan (TN)
FORMULA     C10H13N5O4
EXACT_MASS  267.0968
MOL_WEIGHT  267.2413
ACTIVITY    Cardiac depressant [anti-arrhythmic]
REMARK      Same as: C00212
            Therapeutic category: 7990
            ATC code: C01EB10
            Drug group: DG00243
TARGET      adenosine A1 receptor agonist [HSA:134] [KO:K04265];
            adenosine A2 receptor agonist [HSA:135 136] [KO:K04266 K04267];
            adenosine A3 receptor agonist [HSA:140] [KO:K04268]
  PATHWAY   hsa04020(135+136)  Calcium signaling pathway
            hsa04080(134+135+136+140)  Neuroactive ligand-receptor interaction
            hsa04270(135+136)  Vascular smooth muscle contraction
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01E OTHER CARDIAC PREPARATIONS
                C01EB Other cardiac preparations
                 C01EB10 Adenosine
                  D00045  Adenosine (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             7  Agents not mainly for therapeutic purpose
              79  Other agents not mainly for therapeutic purpose
               799  Miscellaneous
                7990  Miscellaneous
                 D00045  Adenosine (JAN/USP)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adenosine
                adenosine A1 receptor
                 Adenosine
                  D00045  Adenosine (JAN/USP)
                adenosine A2a receptor
                 Adenosine
                  D00045  Adenosine (JAN/USP)
                adenosine A2b receptor
                 Adenosine
                  D00045  Adenosine (JAN/USP)
                adenosine A3 receptor
                 Adenosine
                  D00045  Adenosine (JAN/USP)
DBLINKS     CAS: 58-61-7
            PubChem: 7847113
            DrugBank: DB00640
            PDB-CCD: ADN
            LigandBox: D00045
            NIKKAJI: J4.501B
ATOM        19
            1   N4y N    27.7735  -15.1762
            2   C8y C    28.7550  -16.0205
            3   C1y C    26.4808  -15.5916
            4   C8x C    28.3947  -13.8350
            5   C8y C    30.0785  -15.2503
            6   N5x N    28.7377  -17.4480
            7   O2x O    25.3403  -14.7435
            8   C1y C    26.0539  -16.8432
            9   N5x N    29.8363  -13.9950
            10  C8y C    31.2648  -15.9301
            11  C8x C    29.9894  -18.1759
            12  C1y C    24.2407  -15.5331
            13  C1y C    24.6677  -16.8432
            14  O1a O    26.4632  -18.1767
            15  N5x N    31.2695  -17.4246
            16  N1a N    32.4508  -15.2334
            17  C1b C    22.9364  -15.1236
            18  O1a O    24.2231  -18.1709
            19  O1a O    21.8253  -15.9600
BOND        21
            1     1   2 1
            2     3   1 1 #Up
            3     1   4 1
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     3   8 1
            8     4   9 2
            9     5  10 1
            10    6  11 2
            11    7  12 1
            12    8  13 1
            13    8  14 1 #Down
            14   10  15 2
            15   10  16 1
            16   12  17 1 #Up
            17   13  18 1 #Down
            18   17  19 1
            19    5   9 1
            20   11  15 1
            21   12  13 1
///
ENTRY       D00046                      Drug
NAME        Anhydrous lactose (JP16);
            Lactose, anhydrous (JAN/NF);
            Lactose (TN)
FORMULA     C12H22O11
EXACT_MASS  342.1162
MOL_WEIGHT  342.2965
ACTIVITY    Pharmaceutic aid [tablet and capsule diluent]
REMARK      Same as: C00243 G10504
BRITE       Pharmaceutical additives [BR:br08316]
             Diluting agent
              D00046  [107790] Anhydrous lactose
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00046  Anhydrous lactose
DBLINKS     CAS: 63-42-3
            PubChem: 7847114
            DrugBank: DB04465
            LigandBox: D00046
            NIKKAJI: J353.435I
ATOM        23
            1   C1y C    39.1122  -21.3617
            2   C1y C    39.1122  -19.9619
            3   O2a O    37.8991  -22.0557
            4   C1y C    40.3136  -22.0557
            5   O2x O    40.3136  -19.2561
            6   C1b C    37.8991  -19.2561
            7   C1y C    36.6801  -22.7616
            8   C1y C    41.5327  -21.3617
            9   O1a O    40.3136  -23.4556
            10  C1y C    41.5327  -19.9619
            11  O1a O    36.8316  -20.1661
            12  O2x O    35.4611  -22.0557
            13  C1y C    36.6801  -24.1613
            14  O1a O    42.7399  -22.0557
            15  O1a O    42.7399  -19.2561
            16  C1y C    34.2537  -22.7616
            17  C1y C    35.4611  -24.8612
            18  O1a O    37.8932  -24.8612
            19  C1y C    34.2537  -24.1613
            20  C1b C    33.0463  -22.0557
            21  O1a O    35.4668  -26.2610
            22  O1a O    33.0463  -24.8612
            23  O1a O    31.9790  -22.9656
BOND        24
            1     1   2 1
            2     1   3 1 #Down
            3     1   4 1
            4     2   5 1
            5     2   6 1 #Up
            6     7   3 1 #Up
            7     4   8 1
            8     4   9 1 #Up
            9     5  10 1
            10    6  11 1
            11    7  12 1
            12    7  13 1
            13    8  14 1 #Down
            14   10  15 1 #Either
            15   12  16 1
            16   13  17 1
            17   13  18 1 #Down
            18   16  19 1
            19   16  20 1 #Up
            20   17  21 1 #Up
            21   19  22 1 #Up
            22   20  23 1
            23    8  10 1
            24   17  19 1
///
ENTRY       D00047                      Drug
NAME        Taurine (JP16/USP/INN);
            Aminoethylsulfonic acid (JAN);
            Taurine (TN)
FORMULA     C2H7NO3S
EXACT_MASS  125.0147
MOL_WEIGHT  125.1469
REMARK      Same as: C00245
            Therapeutic category: 3919
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               391  Liver disease agents
                3919  Others
                 D00047  Taurine (JP16/USP/INN); Aminoethylsulfonic acid (JAN)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for ophthalmologic use
              62 General eye drops
               D00047  Taurine (JP16/USP/INN); Aminoethylsulfonic acid (JAN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Aminoethylsulfonic acid; Taurine
                D00047  Taurine (JP16/USP/INN); Aminoethylsulfonic acid (JAN)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00047  [002019] Taurine
             Buffering agent
              D00047  [002019] Taurine
             Flavoring substance
              D00047  [002019] Taurine
             Bonding agent
              D00047  [002019] Taurine
             Tonicity agent
              D00047  [002019] Taurine
             Diluting agent
              D00047  [002019] Taurine
             Antiseptic agent
              D00047  [002019] Taurine
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00047  Taurine
DBLINKS     CAS: 107-35-7
            PubChem: 7847115
            DrugBank: DB01956
            LigandBox: D00047
            NIKKAJI: J5.056C
ATOM        7
            1   C1b C    26.2740  -17.4876
            2   S4a S    27.4853  -16.7889
            3   C1b C    25.0570  -16.7889
            4   O1d O    28.6964  -17.4876
            5   N1a N    23.8459  -17.4876
            6   O1d O    28.6152  -15.9389
            7   O1d O    26.2729  -16.0889
BOND        6
            1     1   2 1
            2     1   3 1
            3     2   4 1
            4     3   5 1
            5     2   6 2
            6     2   7 2
///
ENTRY       D00048                      Drug
NAME        Thioctic acid amide (JAN);
            Lipoamide
FORMULA     C8H15NOS2
EXACT_MASS  205.0595
MOL_WEIGHT  205.3408
REMARK      Same as: C00248
            ATC code: A16AX01
            Drug group: DG00146
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AX Various alimentary tract and metabolism products
                 A16AX01 Thioctic acid
                  D00048  Thioctic acid amide (JAN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Thioctic acid amide
                D00048  Thioctic acid amide (JAN)
DBLINKS     CAS: 940-69-2
            PubChem: 7847116
            DrugBank: DB00166
            LigandBox: D00048
            NIKKAJI: J25.390A
ATOM        12
            1   S3x S    25.4906   -5.9577
            2   S3x S    24.0896   -5.9577
            3   C1x C    23.6568   -7.2901
            4   C1x C    24.7901   -8.1136
            5   C1y C    25.9235   -7.2901
            6   C1b C    27.1242   -7.9891
            7   C1b C    28.3375   -7.2886
            8   C1b C    29.5507   -7.9891
            9   C1b C    30.7639   -7.2886
            10  C5a C    31.9773   -7.9891
            11  N1a N    33.1905   -7.2886
            12  O5a O    31.9773   -9.3902
BOND        12
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     1   5 1
            6     5   6 1
            7     6   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11   10  11 1
            12   10  12 2
///
ENTRY       D00049                      Drug
NAME        Nicotinic acid (JP16/INN);
            Niacin (USP);
            Niacor (TN);
            Niaspan (TN)
FORMULA     C6H5NO2
EXACT_MASS  123.032
MOL_WEIGHT  123.1094
ACTIVITY    Antihyperlipidemic;
            Vitamin [enzyme co-factor]
REMARK      Same as: C00253
            Therapeutic category: 3132
            ATC code: C04AC01 C10AD02
            Drug group: DG00282
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C04 PERIPHERAL VASODILATORS
               C04A PERIPHERAL VASODILATORS
                C04AC Nicotinic acid and derivatives
                 C04AC01 Nicotinic acid
                  D00049  Nicotinic acid (JP16/INN); Niacin (USP)
              C10 LIPID MODIFYING AGENTS
               C10A LIPID MODIFYING AGENTS, PLAIN
                C10AD Nicotinic acid and derivatives
                 C10AD02 Nicotinic acid
                  D00049  Nicotinic acid (JP16/INN); Niacin (USP)
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Dyslipidemics, Other
               Niacin
                D00049  Nicotinic acid (JP16/INN); Niacin (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              31  Vitamins
               313  Vitamin B preparations
                3132  Nicotinic acids
                 D00049  Nicotinic acid (JP16/INN); Niacin (USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Nicotinic acid
                D00049  Nicotinic acid (JP16/INN); Niacin (USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00049  Nicotinic acid
              D00049  Nicotinic acid injection
            Phytochemicals used as drugs [BR:br08306]
             Alkaloids
              Alkaloids derived from nicotinic acid
               Pyridine alkaloids
                D00049  Nicotinic acid (JP15/INN); Niacin (USP)
DBLINKS     CAS: 59-67-6
            PubChem: 7847117
            DrugBank: DB00627
            LigandBox: D00049
            NIKKAJI: J2.809F
ATOM        9
            1   C8y C    25.1352  -16.9986
            2   C8x C    23.9013  -16.3004
            3   C8x C    25.1469  -18.3372
            4   C6a C    26.3341  -16.2944
            5   C8x C    22.6849  -17.0102
            6   N5x N    23.9013  -19.1114
            7   O6a O    27.5389  -16.9812
            8   O6a O    26.3108  -14.9035
            9   C8x C    22.6908  -18.4130
BOND        9
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     3   6 1
            6     4   7 1
            7     4   8 2
            8     5   9 1
            9     6   9 2
///
ENTRY       D00050                      Drug
NAME        Riboflavin (JP16/USP/INN);
            Bisulase (TN)
FORMULA     C17H20N4O6
EXACT_MASS  376.1383
MOL_WEIGHT  376.3639
ACTIVITY    Vitamin [enzyme co-factor]
REMARK      Same as: C00255
            Therapeutic category: 3131
            ATC code: A11HA04
            Drug group: DG00130
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A11 VITAMINS
               A11H OTHER PLAIN VITAMIN PREPARATIONS
                A11HA Other plain vitamin preparations
                 A11HA04 Riboflavin (vit B2)
                  D00050  Riboflavin (JP16/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              31  Vitamins
               313  Vitamin B preparations
                3131  Vitamin B2 preparations
                 D00050  Riboflavin (JP16/USP/INN)
            Classification of Japanese OTC drugs [BR:br08313]
             Nourishing tonics and health supplements
              36 Vitamin B2 based drugs
               D00050  Riboflavin (JP16/USP/INN)
              40 Vitamin B2B6 based drugs
               D00050  Riboflavin (JP16/USP/INN)
              43 Vitamin containing supplements
               D00050  Riboflavin (JP16/USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Riboflavin
                D00050  Riboflavin (JP16/USP/INN)
            Pharmaceutical additives [BR:br08316]
             Coloring agent
              D00050  [001669] Riboflavin
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00050  Riboflavin
              D00050  Riboflavin powder
DBLINKS     CAS: 83-88-5
            PubChem: 7847118
            DrugBank: DB00140
            LigandBox: D00050
            NIKKAJI: J3.876H
ATOM        27
            1   C8y C    27.5143  -25.3444
            2   C8y C    27.5143  -23.9439
            3   C8x C    26.3239  -23.2436
            4   C8y C    25.0634  -23.9439
            5   C8y C    25.0634  -25.3444
            6   C8x C    26.3239  -26.0447
            7   N5x N    28.7272  -26.0447
            8   C8y C    29.9402  -25.3444
            9   C8y C    29.9402  -23.9439
            10  N4y N    28.7272  -23.2436
            11  C8y C    31.1531  -26.0447
            12  N4x N    32.3659  -25.3444
            13  C8y C    32.3659  -23.9439
            14  N5x N    31.1531  -23.2436
            15  C1b C    28.7272  -21.8433
            16  C1c C    27.4975  -21.1331
            17  C1c C    27.4977  -19.7423
            18  O1a O    26.2930  -21.8285
            19  O1a O    28.7232  -19.0350
            20  C1c C    26.2974  -19.0490
            21  O1a O    25.1074  -19.7359
            22  C1b C    26.2975  -17.6416
            23  O1a O    25.1044  -16.9527
            24  C1a C    23.8563  -23.2336
            25  C1a C    23.8563  -26.0547
            26  O5x O    31.1531  -27.4453
            27  O5x O    33.5640  -23.2521
BOND        29
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 1
            11    2  10 1
            12    8  11 1
            13   11  12 1
            14   12  13 1
            15   13  14 1
            16    9  14 2
            17   10  15 1
            18   15  16 1
            19   16  17 1
            20   16  18 1 #Down
            21   17  19 1 #Up
            22   17  20 1
            23   20  21 1 #Down
            24   20  22 1
            25   22  23 1
            26    4  24 1
            27    5  25 1
            28   11  26 2
            29   13  27 2
///
ENTRY       D00051                      Drug
NAME        Androstenedione (JAN)
FORMULA     C19H26O2
EXACT_MASS  286.1933
MOL_WEIGHT  286.4085
REMARK      Same as: C00280
BRITE       Phytochemicals used as drugs [BR:br08306]
             Terpenoids
              Triterpenoids (C30) and related compounds
               Sterols and steroids
                D00051  Androstenedione (JAN)
DBLINKS     CAS: 63-05-8
            PubChem: 7847119
            DrugBank: DB01536
            PDB-CCD: ASD
            LigandBox: D00051
            NIKKAJI: J38.388K
ATOM        21
            1   C1x C     6.8600  -12.0400
            2   C5x C     6.8600  -13.4400
            3   C2x C     8.0724  -14.1400
            4   C2y C     9.2849  -13.4400
            5   C1z C     9.2849  -12.0400
            6   C1x C     8.0724  -11.3400
            7   C1x C    10.4973  -14.1400
            8   C1x C    11.7097  -13.4400
            9   C1y C    11.7097  -12.0400
            10  C1y C    10.4973  -11.3400
            11  C1y C    12.9222  -11.3400
            12  C1z C    12.9222   -9.9400
            13  C1x C    11.7097   -9.2400
            14  C1x C    10.4973   -9.9400
            15  C1x C    15.3470  -11.3400
            16  C1x C    15.3470   -9.9400
            17  C5x C    14.1346   -9.2400
            18  O5x O     5.6476  -14.1400
            19  O5x O    14.1346   -7.8400
            20  C1a C     9.2849  -10.6400
            21  C1a C    12.9222   -8.5400
BOND        24
            1     1   2 1
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    9  11 1
            13   11  12 1
            14   12  13 1
            15   13  14 1
            16   10  14 1
            17   11  15 1
            18   15  16 1
            19   16  17 1
            20   12  17 1
            21    2  18 2
            22   17  19 2
            23    5  20 1 #Up
            24   12  21 1 #Up
///
ENTRY       D00052                      Drug
NAME        Edetic acid (NF/INN);
            EDTA;
            Versene acid (TN)
FORMULA     C10H16N2O8
EXACT_MASS  292.0907
MOL_WEIGHT  292.2426
ACTIVITY    Pharmaceutic aid [chelating agent]
REMARK      Same as: C00284
            ATC code: V03AB03
            Drug group: DG01152
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             V VARIOUS
              V03 ALL OTHER THERAPEUTIC PRODUCTS
               V03A ALL OTHER THERAPEUTIC PRODUCTS
                V03AB Antidotes
                 V03AB03 Edetates
                  D00052  Edetic acid (NF/INN)
DBLINKS     CAS: 60-00-4
            PubChem: 7847120
            LigandBox: D00052
            NIKKAJI: J4.406G
ATOM        20
            1   N1c N    20.2973  -16.5178
            2   C1b C    21.5147  -15.8222
            3   C1b C    19.0867  -15.8222
            4   C1b C    20.2973  -17.9217
            5   C1b C    22.7253  -16.5178
            6   C6a C    19.0867  -14.4183
            7   C6a C    19.0867  -18.6238
            8   N1c N    23.9427  -15.8222
            9   O6a O    17.8759  -13.7162
            10  O6a O    20.2973  -13.7162
            11  O6a O    19.0867  -20.2313
            12  O6a O    17.8759  -17.9217
            13  C1b C    25.1533  -16.5178
            14  C1b C    23.9427  -14.4183
            15  C6a C    25.1533  -17.9217
            16  C6a C    25.1533  -13.7162
            17  O6a O    26.3641  -18.6238
            18  O6a O    23.9427  -18.6238
            19  O6a O    26.3641  -14.4183
            20  O6a O    25.1533  -12.3187
BOND        19
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 1
            6     4   7 1
            7     5   8 1
            8     6   9 1
            9     6  10 2
            10    7  11 1
            11    7  12 2
            12    8  13 1
            13    8  14 1
            14   13  15 1
            15   14  16 1
            16   15  17 1
            17   15  18 2
            18   16  19 1
            19   16  20 2
///
ENTRY       D00054                      Drug
NAME        Inosine (JAN/INN);
            Inotin (TN)
FORMULA     C10H12N4O5
EXACT_MASS  268.0808
MOL_WEIGHT  268.2261
REMARK      Same as: C00294
            Therapeutic category: 4199
            ATC code: D06BB05 G01AX02 S01XA10
            Drug group: DG00407
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
               D06B CHEMOTHERAPEUTICS FOR TOPICAL USE
                D06BB Antivirals
                 D06BB05 Inosine
                  D00054  Inosine (JAN/INN)
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
               G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
                G01AX Other antiinfectives and antiseptics
                 G01AX02 Inosine
                  D00054  Inosine (JAN/INN)
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01X OTHER OPHTHALMOLOGICALS
                S01XA Other ophthalmologicals
                 S01XA10 Inosine
                  D00054  Inosine (JAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              41  Cellular function activating agents
               419  Miscellaneous
                4199  Others
                 D00054  Inosine (JAN/INN)
DBLINKS     CAS: 58-63-9
            PubChem: 7847122
            LigandBox: D00054
            NIKKAJI: J1.388I
ATOM        19
            1   N4y N    27.9300  -17.9200
            2   C8y C    29.1900  -17.5700
            3   C1y C    26.3900  -18.4800
            4   C8x C    27.0900  -16.8700
            5   C8y C    29.1900  -16.1700
            6   N5x N    30.3800  -18.2000
            7   O2x O    25.2700  -17.6400
            8   C1y C    25.9700  -19.7400
            9   N5x N    27.9300  -15.7500
            10  C8y C    30.3800  -15.4700
            11  C8x C    31.5700  -17.5700
            12  C1y C    24.1500  -18.4800
            13  C1y C    24.5700  -19.7400
            14  O1a O    26.7400  -20.8600
            15  N4x N    31.5700  -16.1700
            16  O5x O    30.3800  -14.1400
            17  C1b C    22.8900  -18.0600
            18  O1a O    23.8000  -20.8600
            19  O1a O    21.8400  -18.9700
BOND        21
            1     1   2 1
            2     3   1 1 #Up
            3     1   4 1
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     3   8 1
            8     4   9 2
            9     5  10 1
            10    6  11 2
            11    7  12 1
            12    8  13 1
            13    8  14 1 #Down
            14   10  15 1
            15   10  16 2
            16   12  17 1 #Up
            17   13  18 1 #Down
            18   17  19 1
            19    5   9 1
            20   11  15 1
            21   12  13 1
///
ENTRY       D00055                      Drug
NAME        Orotic acid (JAN)
FORMULA     C5H4N2O4
EXACT_MASS  156.0171
MOL_WEIGHT  156.0963
REMARK      Same as: C00295
BRITE       Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Orotic acid
                D00055  Orotic acid (JAN)
DBLINKS     CAS: 65-86-1
            PubChem: 7847123
            DrugBank: DB02262
            LigandBox: D00055
            NIKKAJI: J2.359K
ATOM        11
            1   C8y C    25.0601  -16.6614
            2   C8x C    23.8493  -17.3598
            3   N4x N    26.2774  -17.3598
            4   C6a C    25.0538  -15.2711
            5   C8y C    23.8493  -18.7691
            6   C8y C    26.2774  -18.7691
            7   O6a O    26.2581  -14.5729
            8   O6a O    23.8428  -14.5792
            9   N4x N    25.0601  -19.4803
            10  O5x O    22.6384  -19.4609
            11  O5x O    27.4881  -19.4609
BOND        11
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 1
            6     4   7 1
            7     4   8 2
            8     5   9 1
            9     5  10 2
            10    6  11 2
            11    6   9 1
///
ENTRY       D00056                      Drug
NAME        Trypsin (JAN);
            Trypsin, crystallized (USP);
            Parenzyme (TN)
ACTIVITY    Enzyme [proteolytic]
REMARK      Same as: C00298
            ATC code: B06AA07 D03BA01
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B06 OTHER HEMATOLOGICAL AGENTS
               B06A OTHER HEMATOLOGICAL AGENTS
                B06AA Enzymes
                 B06AA07 Trypsin
                  D00056  Trypsin (JAN); Trypsin, crystallized (USP)
             D DERMATOLOGICALS
              D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
               D03B ENZYMES
                D03BA Proteolytic enzymes
                 D03BA01 Trypsin
                  D00056  Trypsin (JAN); Trypsin, crystallized (USP)
            Pharmaceutical additives [BR:br08316]
             Unclassified
              D00056  [107484] Trypsin
DBLINKS     CAS: 9002-07-7
            PubChem: 7847124
            NIKKAJI: J247.642H
///
ENTRY       D00057                      Drug
NAME        Citicoline (JAN/INN);
            Nicholin (TN)
FORMULA     C14H26N4O11P2
EXACT_MASS  488.1073
MOL_WEIGHT  488.324
ACTIVITY    Post-stroke and post-head trauma treatment
REMARK      Same as: C00307
            Therapeutic category: 2190
            ATC code: N06BX06
            Drug group: DG00978
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
                N06BX Other psychostimulants and nootropics
                 N06BX06 Citicoline
                  D00057  Citicoline (JAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               219  Miscellaneous
                2190  Miscellaneous
                 D00057  Citicoline (JAN/INN)
DBLINKS     CAS: 987-78-0
            PubChem: 7847125
            LigandBox: D00057
            NIKKAJI: J55.713G
ATOM        31
            1   C1y C    29.3576  -22.1294
            2   C1y C    30.7274  -22.1294
            3   C1y C    31.1507  -20.8265
            4   O2x O    30.0425  -20.0214
            5   C1y C    28.9343  -20.8265
            6   N4y N    32.3371  -18.7717
            7   C1b C    27.7479  -20.1416
            8   O2b O    26.5616  -20.8265
            9   O1a O    28.5524  -23.2376
            10  O1a O    31.5326  -23.2376
            11  C8x C    33.5234  -18.0868
            12  C8x C    33.5234  -16.7169
            13  C8y C    32.3371  -16.0320
            14  N5x N    31.1508  -16.7169
            15  C8y C    31.1508  -18.0868
            16  O5x O    29.9545  -18.7775
            17  N1a N    32.3371  -14.6640
            18  P1b P    25.1917  -20.8265
            19  O2c O    23.8218  -20.8265
            20  P1b P    22.4520  -20.8265
            21  O2b O    21.0821  -20.8265
            22  O1c O    25.1917  -19.4582
            23  O1c O    25.1917  -22.1978
            24  O1c O    22.4520  -19.4582
            25  O1c O    22.4520  -22.1978 #-
            26  C1b C    19.8958  -20.1416
            27  C1b C    18.7094  -20.8265
            28  N1d N    17.5477  -20.1555 #+
            29  C1a C    16.3782  -19.4798
            30  C1a C    16.8754  -21.3198
            31  C1a C    18.2452  -18.9474
BOND        32
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     1   5 1
            6     3   6 1 #Up
            7     5   7 1 #Up
            8     7   8 1
            9     1   9 1 #Down
            10    2  10 1 #Down
            11    6  11 1
            12   11  12 2
            13   12  13 1
            14   13  14 2
            15   14  15 1
            16    6  15 1
            17   15  16 2
            18   13  17 1
            19    8  18 1
            20   18  19 1
            21   19  20 1
            22   20  21 1
            23   18  22 2
            24   18  23 1
            25   20  24 2
            26   20  25 1
            27   21  26 1
            28   26  27 1
            29   27  28 1
            30   28  29 1
            31   28  30 1
            32   28  31 1
///
ENTRY       D00058                      Drug
NAME        gamma-Aminobutyric acid (JAN);
            Gammalon (TN)
FORMULA     C4H9NO2
EXACT_MASS  103.0633
MOL_WEIGHT  103.1198
REMARK      Same as: C00334
            Therapeutic category: 2190
            ATC code: N03AG03
TARGET      GABAA-receptor (benzodiazepine binding site) agonist [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192];
            GABAB-receptor agonist [HSA:2550 9568] [KO:K04615]
  PATHWAY   hsa04080(2550+2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+9568)  Neuroactive ligand-receptor interaction
            hsa04727(2550+2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879+9568)  GABAergic synapse
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AG Fatty acid derivatives
                 N03AG03 Aminobutyric acid
                  D00058  Gamma-Aminobutyric acid (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               219  Miscellaneous
                2190  Miscellaneous
                 D00058  gamma-Aminobutyric acid (JAN)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Metabotropic glutamate receptor family
               GABA
                GABAB-receptor
                 Aminobutyric acid
                  D00058  Gamma-Aminobutyric acid (JAN)
             Ion channels
              Cys-loop superfamily
               GABA-A
                GABAA-receptor (benzodiazepine binding site)
                 Aminobutyric acid
                  D00058  Gamma-Aminobutyric acid (JAN)
DBLINKS     CAS: 56-12-2
            PubChem: 7847126
            DrugBank: DB02530
            PDB-CCD: ABU
            LigandBox: D00058
            NIKKAJI: J1.375G
ATOM        7
            1   C1b C    21.8376  -18.3787
            2   C6a C    23.0478  -17.6770
            3   C1b C    20.6274  -17.6770
            4   O6a O    24.2580  -18.3850
            5   O6a O    23.0478  -16.2803
            6   C1b C    19.4108  -18.3787
            7   N1a N    18.2006  -17.6770
BOND        6
            1     1   2 1
            2     1   3 1
            3     2   4 1
            4     2   5 2
            5     3   6 1
            6     6   7 1
///
ENTRY       D00059                      Drug
NAME        Levodopa (JP16/USP/INN);
            Dopar (TN)
FORMULA     C9H11NO4
EXACT_MASS  197.0688
MOL_WEIGHT  197.1879
ACTIVITY    Antiparkinsonian [DS:H00057]
REMARK      Same as: C00355
            Therapeutic category: 1164
            ATC code: N04BA01
COMMENT     Dopamine [DR:D07870] precursor
TARGET      dopamine D1 receptor agonist [HSA:1812] [KO:K04144];
            dopamine D2 receptor agonist [HSA:1813] [KO:K04145];
            dopamine D3 receptor agonist [HSA:1814] [KO:K04146];
            dopamine D4 receptor agonist [HSA:1815] [KO:K04147];
            dopamine D5 receptor agonist [HSA:1816] [KO:K05840]
  PATHWAY   hsa04020(1812+1816)  Calcium signaling pathway
            hsa04080(1812+1813+1814+1815+1816)  Neuroactive ligand-receptor interaction
            hsa04728(1812+1813+1814+1815+1816)  Dopaminergic synapse
INTERACTION  
STR_MAP     map07057  Antiparkinsonian agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N04 ANTI-PARKINSON DRUGS
               N04B DOPAMINERGIC AGENTS
                N04BA Dopa and dopa derivatives
                 N04BA01 Levodopa
                  D00059  Levodopa (JP16/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               116  Antiparkinsonian agents
                1164  Levodopas
                 D00059  Levodopa (JP16/USP/INN)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Dopamine
                dopamine D1-receptor
                 Levodopa
                  D00059  Levodopa (JP16/USP/INN)
                dopamine D2-receptor
                 Levodopa
                  D00059  Levodopa (JP16/USP/INN)
                dopamine D3-receptor
                 Levodopa
                  D00059  Levodopa (JP16/USP/INN)
                dopamine D4-receptor
                 Levodopa
                  D00059  Levodopa (JP16/USP/INN)
                dopamine D5-receptor
                 Levodopa
                  D00059  Levodopa (JP16/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00059  Levodopa
DBLINKS     CAS: 59-92-7
            PubChem: 7847127
            DrugBank: DB01235
            LigandBox: D00059
            NIKKAJI: J9.225H
ATOM        14
            1   C8y C    22.9600  -19.2500
            2   C8y C    22.9600  -20.6500
            3   C8x C    24.1500  -18.5500
            4   O1a O    21.7000  -18.5500
            5   C8x C    24.1500  -21.3500
            6   O1a O    21.7000  -21.3500
            7   C8y C    25.3400  -19.2500
            8   C8x C    25.3400  -20.6500
            9   C1b C    26.6000  -18.6200
            10  C1c C    27.7900  -19.2500
            11  C6a C    28.9800  -18.6200
            12  N1a N    27.7900  -20.6500
            13  O6a O    30.2400  -19.2500
            14  O6a O    28.9800  -17.2200
BOND        14
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     5   8 1
            8     7   9 1
            9     9  10 1
            10   10  11 1
            11   10  12 1 #Up
            12   11  13 1
            13   11  14 2
            14    7   8 2
///
ENTRY       D00060                      Drug
NAME        Dextran 1 (USP);
            Dextran (INN)
FORMULA     (C12H20O10)n
REMARK      Same as: C00372 G10502
            ATC code: B05AA05
            Drug group: DG00180
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
               B05A BLOOD AND RELATED PRODUCTS
                B05AA Blood substitutes and plasma protein fractions
                 B05AA05 Dextran
                  D00060  Dextran 1 (USP); Dextran (INN)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00060  [101750] Dextran
DBLINKS     CAS: 9004-54-0
            PubChem: 7847128
            NIKKAJI: J946F
ATOM        24
            1   C1y C    20.6484  -18.3263
            2   C1y C    20.6484  -19.6694
            3   C1y C    21.7901  -20.3410
            4   C1y C    22.9989  -19.6694
            5   C1y C    22.9989  -18.3263
            6   O2x O    21.7901  -17.6547
            7   C1b C    19.5067  -17.6547
            8   O1a O    21.7901  -21.6842
            9   O1a O    19.5067  -20.3410
            10  O1a O    24.1406  -20.3410
            11  O2a O    24.1406  -17.6547
            12  C1b C    25.2823  -18.3263
            13  C1y C    26.4240  -17.6547
            14  O1a O    18.3650  -18.3263
            15  O2x O    27.5657  -18.3263
            16  C1x C    28.7745  -17.6547
            17  C1y C    28.7745  -16.3115
            18  C1y C    27.6328  -15.6399
            19  C1y C    26.4240  -16.3115
            20  O1a O    27.6493  -14.2969
            21  O1a O    25.2664  -15.6303
            22  O1a O    29.9405  -15.6446
            23  Z   *    16.5919  -18.3358
            24  Z   *    32.2814  -19.1988
BOND        25
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     1   7 1 #Up
            8     3   8 1 #Up
            9     2   9 1 #Down
            10    4  10 1 #Down
            11    5  11 1 #Down
            12   11  12 1
            13   13  12 1 #Down
            14    7  14 1
            15   13  15 1
            16   15  16 1
            17   16  17 1
            18   17  18 1
            19   18  19 1
            20   13  19 1
            21   18  20 1 #Down
            22   19  21 1 #Up
            23   17  22 1 #Up
            24   14  23 1
            25   16  24 1
BRACKET     1    17.5700  -21.9100   17.5700  -13.5100
            1    30.8700  -13.5100   30.8700  -21.9100
            1  n
  ORIGINAL  1    1   2   3   4   5   6   7   8   9  10  11  12  13  14  15  16
            1   17  18  19  20  21  22
  REPEAT    1 
///
ENTRY       D00061                      Drug
NAME        Xylitol (JP16/NF);
            Klinit (TN)
FORMULA     C5H12O5
EXACT_MASS  152.0685
MOL_WEIGHT  152.1458
ACTIVITY    Pharmaceutic aid [vehicle, sweetened]
REMARK      Same as: C00379
            Therapeutic category: 3234
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              32  Nutrients, tonics
               323  Saccharide preparations
                3234  Xylitols
                 D00061  Xylitol (JP16/NF)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00061  [004200] Xylitol
             Sweetening agent
              D00061  [004200] Xylitol
             Flavoring substance
              D00061  [004200] Xylitol
             Tonicity agent
              D00061  [004200] Xylitol
             Diluting agent
              D00061  [004200] Xylitol
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00061  Xylitol
              D00061  Xylitol injection
DBLINKS     CAS: 87-99-0
            PubChem: 7847129
            DrugBank: DB01904
            LigandBox: D00061
            NIKKAJI: J3.905E
ATOM        10
            1   C1c C    22.0901  -16.1700
            2   C1c C    22.0901  -14.7662
            3   C1c C    22.0901  -17.5738
            4   O1a O    20.6861  -16.1700
            5   C1b C    22.0901  -13.3687
            6   O1a O    23.4874  -14.7662
            7   C1b C    22.0901  -18.9713
            8   O1a O    23.4874  -17.5738
            9   O1a O    23.3007  -12.6667
            10  O1a O    23.3007  -19.6733
BOND        9
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 1
            8     5   9 1
            9     7  10 1
///
ENTRY       D00062                      Drug
NAME        D-Mannitol (JP16);
            Mannitol (USP);
            Osmitrol (TN);
            Tobrex (TN)
FORMULA     C6H14O6
EXACT_MASS  182.079
MOL_WEIGHT  182.1718
ACTIVITY    Diagnostic aid [renal function determination];
            Diuretic
REMARK      Same as: C00392
            Therapeutic category: 2190
            ATC code: A06AD16 B05BC01 B05CX04 R05CB16
COMMENT     Osmotic diuretics
INTERACTION  
STR_MAP     map07054  Antiglaucoma agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A06 DRUGS FOR CONSTIPATION
               A06A DRUGS FOR CONSTIPATION
                A06AD Osmotically acting laxatives
                 A06AD16 Mannitol
                  D00062  D-Mannitol (JP16); Mannitol (USP)
             B BLOOD AND BLOOD FORMING ORGANS
              B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
               B05B I.V. SOLUTIONS
                B05BC Solutions producing osmotic diuresis
                 B05BC01 Mannitol
                  D00062  D-Mannitol (JP16); Mannitol (USP)
               B05C IRRIGATING SOLUTIONS
                B05CX Other irrigating solutions
                 B05CX04 Mannitol
                  D00062  D-Mannitol (JP16); Mannitol (USP)
             R RESPIRATORY SYSTEM
              R05 COUGH AND COLD PREPARATIONS
               R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
                R05CB Mucolytics
                 R05CB16 Mannitol
                  D00062  D-Mannitol (JP16); Mannitol (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               219  Miscellaneous
                2190  Miscellaneous
                 D00062  D-Mannitol (JP16); Mannitol (USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00062  [009007] D-Mannitol
             Solubilizing agent
              D00062  [009007] D-Mannitol
             Sweetening agent
              D00062  [009007] D-Mannitol
             Base
              D00062  [009007] D-Mannitol
             Flavoring substance
              D00062  [009007] D-Mannitol
             Bonding agent
              D00062  [009007] D-Mannitol
             Suspending agent
              D00062  [009007] D-Mannitol
             Coating agent
              D00062  [009007] D-Mannitol
             Sugarcoated agent
              D00062  [009007] D-Mannitol
             Tonicity agent
              D00062  [009007] D-Mannitol
             Diluting agent
              D00062  [009007] D-Mannitol
             Disintegrant
              D00062  [009007] D-Mannitol
             Solubilization agent
              D00062  [009007] D-Mannitol
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00062  D-Mannitol
              D00062  D-Mannitol injection
DBLINKS     CAS: 69-65-8
            PubChem: 7847130
            DrugBank: DB00742
            LigandBox: D00062
            NIKKAJI: J2.369H
ATOM        12
            1   O1a O    21.5001  -19.4028
            2   C1b C    22.6912  -18.7022
            3   C1c C    23.9524  -19.4028
            4   C1c C    25.1434  -18.7022
            5   C1c C    26.3345  -19.4028
            6   C1c C    27.5957  -18.7022
            7   C1b C    28.7868  -19.4028
            8   O1a O    29.9779  -18.7022
            9   O1a O    23.9524  -20.8041
            10  O1a O    27.5957  -17.3009
            11  O1a O    25.1434  -17.3009
            12  O1a O    26.3345  -20.8041
BOND        11
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     6   7 1
            7     7   8 1
            8     3   9 1 #Down
            9     6  10 1 #Down
            10    4  11 1 #Up
            11    5  12 1 #Up
///
ENTRY       D00063                      Drug
NAME        Tobramycin (JP16/USP);
            TOB;
            Tobi (TN);
            Tobracin (TN);
            Tobrex (TN)
FORMULA     C18H37N5O9
EXACT_MASS  467.2591
MOL_WEIGHT  467.5145
SOURCE      Streptomyces tenebrarius [TAX:1933]
ACTIVITY    Antibacterial
REMARK      Same as: C00397
            Therapeutic category: 1317 6123
            ATC code: J01GB01 S01AA12
            Drug group: DG00608
COMMENT     Natural product
TARGET      16S rRNA of 30S ribosomal subunit, protein synthesis inhibitor [KO:K01977]
  PATHWAY   ko03010(K01977)  Ribosome
INTERACTION  
STR_MAP     map07021  Aminoglycosides
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J01 ANTIBACTERIALS FOR SYSTEMIC USE
               J01G AMINOGLYCOSIDE ANTIBACTERIALS
                J01GB Other aminoglycosides
                 J01GB01 Tobramycin
                  D00063  Tobramycin (JP16/USP)
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01A ANTIINFECTIVES
                S01AA Antibiotics
                 S01AA12 Tobramycin
                  D00063  Tobramycin (JP16/USP)
            USP drug classification [BR:br08302]
             Antibacterials
              Aminoglycosides
               Tobramycin
                D00063  Tobramycin (JP16/USP)
             Respiratory Tract/Pulmonary Agents
              Cystic Fibrosis Agents
               Tobramycin dry-powder inhaler
                D00063  Tobramycin (JP16/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1317  Ophthalmic antibiotics
                 D00063  Tobramycin (JP16/USP)
             6  Agents against pathologic organisms and parasites
              61  Antibiotics
               612  Acting mainly on gram-negative bacteria
                6123  Amino sugars
                 D00063  Tobramycin (JP16/USP)
            Antiinfectives [BR:br08307]
             Antibacterials
              Protein biosynthesis inhibitor
               16S rRNA of 30S ribosomal subunit inhibitor
                Aminoglycosides
                 Tobramycin
                  D00063  Tobramycin (JP16/USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00063  Tobramycin
              D00063 Tobramycin injection
DBLINKS     CAS: 32986-56-4
            PubChem: 7847131
            DrugBank: DB00684
            LigandBox: D00063
            NIKKAJI: J4.533K
ATOM        32
            1   C1y C    20.6560  -20.0968
            2   C1y C    20.6560  -21.4973
            3   C1y C    21.8689  -22.1975
            4   C1y C    23.0818  -21.4973
            5   C1y C    23.0818  -20.0968
            6   O2x O    21.8689  -19.3965
            7   C1b C    19.4432  -19.3965
            8   O1a O    18.2473  -20.0872
            9   O1a O    19.4432  -22.1975
            10  N1a N    21.8689  -23.5978
            11  O1a O    24.3134  -22.2085
            12  O2a O    24.3134  -19.3855
            13  C1y C    25.4878  -18.6963
            14  C1y C    26.7056  -19.3879
            15  C1x C    27.9134  -18.6791
            16  C1y C    27.9035  -17.2786
            17  C1y C    26.6857  -16.5869
            18  C1y C    25.4779  -17.2958
            19  N1a N    26.7157  -20.7965
            20  N1a N    29.0779  -16.5893
            21  O1a O    24.2675  -16.6084
            22  O2a O    26.6757  -15.1950
            23  C1y C    27.8854  -14.4851
            24  O2x O    29.0946  -15.1718
            25  C1y C    30.3025  -14.4631
            26  C1y C    30.2926  -13.0626
            27  C1x C    29.0835  -12.3758
            28  C1y C    27.8755  -13.0846
            29  C1b C    31.5468  -15.1693
            30  N1a N    31.5569  -16.5953
            31  O1a O    31.5060  -12.3503
            32  N1a N    26.6567  -12.3923
BOND        34
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     1   7 1 #Up
            8     7   8 1
            9     2   9 1 #Down
            10    3  10 1 #Up
            11    4  11 1 #Down
            12    5  12 1 #Down
            13   13  12 1 #Down
            14   13  14 1
            15   14  15 1
            16   15  16 1
            17   16  17 1
            18   17  18 1
            19   13  18 1
            20   14  19 1 #Up
            21   16  20 1 #Up
            22   18  21 1 #Up
            23   17  22 1 #Down
            24   23  22 1 #Down
            25   23  24 1
            26   24  25 1
            27   25  26 1
            28   26  27 1
            29   27  28 1
            30   23  28 1
            31   25  29 1 #Up
            32   29  30 1
            33   26  31 1 #Down
            34   28  32 1 #Down
///
ENTRY       D00064                      Drug
NAME        l-Menthol (JP16);
            Levomenthol;
            l-Menthol (TN)
FORMULA     C10H20O
EXACT_MASS  156.1514
MOL_WEIGHT  156.2652
REMARK      Same as: C00400
            Therapeutic category: 7149
TARGET      transient receptor potential cation channel subfamily M member 8 (TRPM8) agonist [HSA:79054] [KO:K04983];
            transient receptor potential cation channel subfamily A member 1 (TRPA1) agonist [HSA:8989] [KO:K04984]
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             7  Agents not mainly for therapeutic purpose
              71  Dispensing medicines
               714  Flavorings, deodorants, coloring agents
                7149  Others
                 D00064  l-Menthol (JP16)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for integumentary system
              57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
               D00064  l-Menthol (JP16)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Menthol
                D00064  l-Menthol (JP16)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00064  [001642] l-Menthol
             Flavoring substance
              D00064  [001642] l-Menthol
             Fragrance
              D00064  [001642] l-Menthol
             Algefacient
              D00064  [001642] l-Menthol
             Favoring agent, Fragrance
              D00064  [001642] l-Menthol
             Refresher
              D00064  [001642] l-Menthol
             Antiseptic agent
              D00064  [001642] l-Menthol
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Related to voltage-gated cation channels
               Transient receptor potential family, TRPM (Melastatin/Long TRP)
                transient receptor potential cation channel, subfamily M, member 8 (TRPM8)
                 Menthol
                  D00064  l-Menthol (JP16)
               Transient receptor potential family, TRPA (ANKTM1)
                transient receptor potential cation channel, subfamily A, member 1 TRPA1
                 Menthol
                  D00064  l-Menthol (JP16)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00064  l-Menthol
            Phytochemicals used as drugs [BR:br08306]
             Terpenoids
              Monoterpenoids (C10)
               D00064  l-Menthol (JP15)
DBLINKS     CAS: 2216-51-5
            PubChem: 7847132
            DrugBank: DB00825
            LigandBox: D00064
            NIKKAJI: J9.251G
ATOM        11
            1   C1y C    21.5486  -17.2256
            2   C1y C    22.7671  -16.5260
            3   C1x C    20.3418  -16.5260
            4   C1c C    21.5486  -18.6364
            5   C1x C    22.7671  -15.1268
            6   O1a O    23.9797  -17.2256
            7   C1x C    20.3418  -15.1268
            8   C1a C    22.7555  -19.3244
            9   C1a C    20.3301  -19.3186
            10  C1y C    21.5486  -14.4212
            11  C1a C    21.5486  -13.0221
BOND        11
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     2   6 1 #Up
            6     3   7 1
            7     4   8 1
            8     4   9 1
            9     5  10 1
            10   10  11 1 #Up
            11    7  10 1
///
ENTRY       D00065                      Drug
NAME        L-Isoleucine (JP16);
            Isoleucine (USP)
FORMULA     C6H13NO2
EXACT_MASS  131.0946
MOL_WEIGHT  131.1729
ACTIVITY    Amino acid
REMARK      Same as: C00407
INTERACTION  
BRITE       Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               L-Isoleucine
                D00065  L-Isoleucine (JP16); Isoleucine (USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00065  L-Isoleucine
DBLINKS     CAS: 73-32-5
            PubChem: 7847133
            DrugBank: DB00167
            LigandBox: D00065
            NIKKAJI: J2.818E
ATOM        9
            1   C1c C    22.4922  -17.1397
            2   C1c C    23.6796  -16.4029
            3   C6a C    21.2581  -16.4789
            4   N1a N    22.5391  -18.5377
            5   C1b C    24.9137  -17.0637
            6   C1a C    23.6387  -15.0049
            7   O6a O    20.1001  -17.2742
            8   O6a O    21.2815  -15.0809
            9   C1a C    26.1069  -16.3268
BOND        8
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     2   6 1 #Up
            6     3   7 1
            7     3   8 2
            8     5   9 1
///
ENTRY       D00066                      Drug
NAME        Progesterone (JP16/USP/INN);
            Crinone (TN);
            Prometrium (TN)
FORMULA     C21H30O2
EXACT_MASS  314.2246
MOL_WEIGHT  314.4617
ACTIVITY    Progestin
REMARK      Same as: C00410
            Therapeutic category: 2477
            ATC code: G03DA04
TARGET      progesterone receptor agonist [HSA:5241] [KO:K08556]
  PATHWAY   hsa04114(5241)  Oocyte meiosis
            hsa04914(5241)  Progesterone-mediated oocyte maturation
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2C19 [HSA:1557]
INTERACTION  
STR_MAP     map07225  Glucocorticoid and meneralocorticoid receptor agonists/antagonists
            map07226  Progesterone, androgen and estrogen receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
               G03D PROGESTOGENS
                G03DA Pregnen (4) derivatives
                 G03DA04 Progesterone
                  D00066  Progesterone (JP16/USP/INN)
            USP drug classification [BR:br08302]
             Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
              Progestins
               Progesterone
                D00066  Progesterone (JP16/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               247  Estrogen and progesterone preparations
                2477  Progesterones
                 D00066  Progesterone (JP16/USP/INN)
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               3-Ketosteroid receptor
                progesterone receptor
                 Progesterone
                  D00066  Progesterone (JP16/USP/INN)
            Cytochrome P450 interactions [BR:br08309]
             Substrates
              CYP2C19
               Progesterone
                D00066  Progesterone (JP16/USP/INN)
              CYP3A4
               Progesterone
                D00066  Progesterone (JP16/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00066  Progesterone
              D00066  Progesterone injection
DBLINKS     CAS: 57-83-0
            PubChem: 7847134
            DrugBank: DB00396
            LigandBox: D00066
            NIKKAJI: J2.329I
ATOM        23
            1   C1y C    23.0350  -18.9936
            2   C1y C    24.2088  -19.6769
            3   C1z C    21.8554  -19.6827
            4   C1x C    23.0233  -17.6271
            5   C1y C    25.4002  -18.9819
            6   C1x C    24.1913  -21.0784
            7   C2y C    21.8554  -21.0375
            8   C1x C    20.6873  -19.0112
            9   C1a C    21.8437  -18.2754
            10  C1x C    24.2030  -16.9322
            11  C1z C    25.4060  -17.6097
            12  C1x C    27.7653  -18.9936
            13  C1x C    23.0409  -21.7092
            14  C2x C    20.6873  -21.7150
            15  C1x C    19.5194  -19.6827
            16  C1y C    26.5974  -16.9263
            17  C1a C    25.3943  -16.2081
            18  C1x C    27.7712  -17.6213
            19  C5x C    19.5194  -21.0375
            20  C5a C    26.6032  -15.5948
            21  O5x O    18.3690  -21.6975
            22  C1a C    25.3885  -14.8823
            23  O5a O    27.8121  -14.8882
BOND        26
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 1
            8     3   9 1 #Up
            9     4  10 1
            10    5  11 1
            11    5  12 1
            12    6  13 1
            13    7  14 2
            14    8  15 1
            15   11  16 1
            16   11  17 1 #Up
            17   12  18 1
            18   14  19 1
            19   16  20 1 #Up
            20   19  21 2
            21   20  22 1
            22   20  23 2
            23    7  13 1
            24   10  11 1
            25   15  19 1
            26   16  18 1
///
ENTRY       D00067                      Drug
NAME        Estrone (JAN/USP/INN);
            Estrone (TN)
FORMULA     C18H22O2
EXACT_MASS  270.162
MOL_WEIGHT  270.3661
ACTIVITY    Estrogen
REMARK      Same as: C00468
            ATC code: G03CA07 G03CC04
            Drug group: DG00464
TARGET      estrogen receptor 1 agonist [HSA:2099] [KO:K08550];
            estrogen receptor 2 agonist [HSA:2100] [KO:K08551]
  PATHWAY   hsa04961(2099)  Endocrine and other factor-regulated calcium reabsorption
INTERACTION Transporter inhibition: ABCG2 [HSA:9429]
STR_MAP     map07226  Progesterone, androgen and estrogen receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
               G03C ESTROGENS
                G03CA Natural and semisynthetic estrogens, plain
                 G03CA07 Estrone
                  D00067  Estrone (JAN/USP/INN)
                G03CC Estrogens, combinations with other drugs
                 G03CC04 Estrone
                  D00067  Estrone (JAN/USP/INN)
            USP drug classification [BR:br08302]
             Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
              Estrogens
               Estrone
                D00067  Estrone (JAN/USP/INN)
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               Estrogen receptor
                estrogen receptor 1
                 Estrone
                  D00067  Estrone (JAN/USP/INN)
                estrogen receptor 2
                 Estrone
                  D00067  Estrone (JAN/USP/INN)
            Phytochemicals used as drugs [BR:br08306]
             Terpenoids
              Triterpenoids (C30) and related compounds
               Sterols and steroids
                D00067  Estrone (JAN/USP/INN)
DBLINKS     CAS: 53-16-7
            PubChem: 7847135
            DrugBank: DB00655
            LigandBox: D00067
            NIKKAJI: J9.114F
ATOM        20
            1   C1y C    24.1346  -17.3254
            2   C1y C    22.9531  -18.0207
            3   C1z C    24.1407  -15.9531
            4   C1x C    26.5099  -17.3377
            5   C1y C    21.7655  -17.3377
            6   C1x C    22.9284  -19.3746
            7   C1x C    22.9408  -15.2762
            8   C5x C    25.3346  -15.2702
            9   C1a C    24.0484  -14.4948
            10  C1x C    26.5159  -15.9654
            11  C8y C    20.5962  -18.0269
            12  C1x C    21.7531  -15.9717
            13  C1x C    21.7778  -20.0576
            14  O5x O    25.3346  -13.9285
            15  C8y C    20.5962  -19.3807
            16  C8x C    19.4209  -17.3561
            17  C8x C    19.4209  -20.0638
            18  C8x C    18.2640  -18.0269
            19  C8y C    18.2640  -19.3807
            20  O1a O    17.1010  -20.0453
BOND        23
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 1
            8     3   9 1 #Up
            9     4  10 1
            10    5  11 1
            11    5  12 1
            12    6  13 1
            13    8  14 2
            14   11  15 2
            15   11  16 1
            16   15  17 1
            17   16  18 2
            18   17  19 2
            19   19  20 1
            20    7  12 1
            21    8  10 1
            22   13  15 1
            23   18  19 1
///
ENTRY       D00068                      Drug
NAME        Anhydrous ethanol (JP16);
            Alcohol (USP);
            Dehydrated ethanol;
            Ethyl alcohol;
            Dehydrated ethanol (TN)
FORMULA     C2H6O
EXACT_MASS  46.0419
MOL_WEIGHT  46.0684
ACTIVITY    Anti-infective, topical;
            Pharmaceutic aid [solvent]
REMARK      Same as: C00469
            Therapeutic category: 2615 4291
            ATC code: D08AX08 V03AB16 V03AZ01
            Drug group: DG00430
COMMENT     Component of Iodine tincture [DR:D04723]
METABOLISM  Enzyme: CYP2D6 [HSA:1565], CYP2E1 [HSA:1571]
INTERACTION CYP induction: CYP2E1 [HSA:1571]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D08 ANTISEPTICS AND DISINFECTANTS
               D08A ANTISEPTICS AND DISINFECTANTS
                D08AX Other antiseptics and disinfectants
                 D08AX08 Ethanol
                  D00068  Anhydrous ethanol (JP16); Alcohol (USP)
             V VARIOUS
              V03 ALL OTHER THERAPEUTIC PRODUCTS
               V03A ALL OTHER THERAPEUTIC PRODUCTS
                V03AB Antidotes
                 V03AB16 Ethanol
                  D00068  Anhydrous ethanol (JP16); Alcohol (USP)
                V03AZ Nerve depressants
                 V03AZ01 Ethanol
                  D00068  Anhydrous ethanol (JP16); Alcohol (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               261  Antimicrobial agents
                2615  Alcohols
                 D00068  Anhydrous ethanol (JP16); Alcohol (USP)
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D00068  Anhydrous ethanol (JP16); Alcohol (USP)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for integumentary system
              54 Disinfectants (incl. special bandages)
               D00068  Anhydrous ethanol (JP16); Alcohol (USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 2
              Inorganic and organic chemicals
               Ethanol
                D00068  Anhydrous ethanol (JP16); Alcohol (USP)
             Category 3
              Inorganic and organic chemicals
               Ethanol
                D00068  Anhydrous ethanol (JP16); Alcohol (USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00068  [001075] Ethanol
             Solubilizing agent
              D00068  [001075] Ethanol
              D00068  [001076] Anhydrous ethanol
             Base
              D00068  [001075] Ethanol
             Flavoring substance
              D00068  [001075] Ethanol
              D00068  [001076] Anhydrous ethanol
             Suspending agent
              D00068  [001075] Ethanol
             Antifoaming agent
              D00068  [001075] Ethanol
             Favoring agent, Fragrance
              D00068  [001075] Ethanol
             Emulsion
              D00068  [001075] Ethanol
             Tenacious agent
              D00068  [001076] Anhydrous ethanol
             Dispersant
              D00068  [001075] Ethanol
             Antiseptic agent
              D00068  [001075] Ethanol
             Preserving agent
              D00068  [001075] Ethanol
             Solubilizer
              D00068  [001075] Ethanol
              D00068  [001076] Anhydrous ethanol
             Solubilization agent
              D00068  [001075] Ethanol
              D00068  [001076] Anhydrous ethanol
             Solvent
              D00068  [001075] Ethanol
              D00068  [110749] 55vol% Ethanol
              D00068  [109570] 70vol% Ethanol
              D00068  [110566] Ethanol 50
              D00068  [001076] Anhydrous ethanol
             Fluidizer
              D00068  [001076] Anhydrous ethanol
            Cytochrome P450 interactions [BR:br08309]
             Substrates
              CYP2D6
               Ethanol
                D00068  Anhydrous ethanol (JP16); Alcohol (USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00068  Anhydrous ethanol
DBLINKS     CAS: 64-17-5
            PubChem: 7847136
            DrugBank: DB00898
            LigandBox: D00068
            NIKKAJI: J1.930E
ATOM        3
            1   C1b C    22.1200  -15.8397
            2   C1a C    20.9088  -16.5419
            3   O1a O    23.3312  -16.5419
BOND        2
            1     1   2 1
            2     1   3 1
///
ENTRY       D00069                      Drug
NAME        Vitamin A oil (JP16);
            Chocola A (TN)
REMARK      Therapeutic category: 2649 3111
METABOLISM  Enzyme: CYP2C8 [HSA:1558]
INTERACTION  
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               264  Analgesics, anti-itchings, astringents, anti-inflammatory agents
                2649  Others
                 D00069  Vitamin A oil (JP16)
             3  Agents affecting metabolism
              31  Vitamins
               311  Vitamins A and D preparations
                3111  Synthetic vitamin A preparations
                 D00069  Vitamin A oil (JP16)
            Classification of Japanese OTC drugs [BR:br08313]
             Nourishing tonics and health supplements
              32 Vitamin A based drugs
               D00069  Vitamin A oil (JP16)
              39 Vitamin AD based drugs
               D00069  Vitamin A oil (JP16)
              43 Vitamin containing supplements
               D00069  Vitamin A oil (JP16)
            Risk category of Japanese OTC drugs [BR:br08312]
             Specified Category 2
              Inorganic and organic chemicals
               Vitamin A oil
                D00069  Vitamin A oil (JP16)
             Category 2
              Inorganic and organic chemicals
               Vitamin A oil
                D00069  Vitamin A oil (JP16)
             Category 3
              Inorganic and organic chemicals
               Vitamin A oil
                D00069  Vitamin A oil (JP16)
            Cytochrome P450 interactions [BR:br08309]
             Substrates
              CYP2C8
               Vitamin A
                D00069  Vitamin A oil (JP16)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00069  Vitamin A oil
              D00069  Vitamin A oil capsules
DBLINKS     PubChem: 7847137
            DrugBank: DB00162
///
ENTRY       D00070                      Drug
NAME        Folic acid (JP16/USP/INN);
            Folicet (TN)
FORMULA     C19H19N7O6
EXACT_MASS  441.1397
MOL_WEIGHT  441.3975
ACTIVITY    Vitamin [hematopoietic] [DS:H00230]
REMARK      Same as: C00504
            Therapeutic category: 3135
            ATC code: B03BB01
            Drug group: DG00176
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B03 ANTIANEMIC PREPARATIONS
               B03B VITAMIN B12 AND FOLIC ACID
                B03BB Folic acid and derivatives
                 B03BB01 Folic acid
                  D00070  Folic acid (JP16/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              31  Vitamins
               313  Vitamin B preparations
                3135  Folic acids
                 D00070  Folic acid (JP16/USP/INN)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for circulatory system and blood
              24 Anemia drugs
               D00070  Folic acid (JP16/USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Folic acid
                D00070  Folic acid (JP16/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00070  Folic acid
              D00070  Folic acid tablets
              D00070  Folic acid injection
DBLINKS     CAS: 59-30-3
            PubChem: 7847138
            DrugBank: DB00158
            LigandBox: D00070
            NIKKAJI: J1.392G
ATOM        32
            1   C8y C    15.5904  -18.4449
            2   C8y C    15.5904  -17.0418
            3   N5x N    16.8180  -19.1464
            4   N5x N    14.3803  -19.1522
            5   N5x N    16.8123  -16.3228
            6   C8y C    14.3803  -16.3461
            7   C8x C    18.0458  -18.4507
            8   C8y C    13.1702  -18.4449
            9   C8y C    18.0341  -17.0301
            10  N4x N    13.1702  -17.0418
            11  O5x O    14.3745  -14.9549
            12  N1a N    11.9659  -19.1347
            13  C1b C    19.2325  -16.3286
            14  N1b N    20.4427  -17.0242
            15  C8y C    21.6528  -16.3228
            16  C8x C    22.8570  -17.0184
            17  C8x C    21.6411  -14.9198
            18  C8x C    24.0672  -16.3111
            19  C8x C    22.8453  -14.2182
            20  C8y C    24.0614  -14.9138
            21  C5a C    25.2715  -14.2123
            22  N1b N    26.4817  -14.9081
            23  O5a O    25.2656  -12.8152
            24  C1c C    27.6916  -14.2065
            25  C1b C    28.9077  -14.9021
            26  C6a C    27.6916  -12.8092
            27  C1b C    30.1179  -14.2006
            28  O6a O    28.8960  -12.1077
            29  O6a O    26.4757  -12.1136
            30  C6a C    31.3280  -14.8964
            31  O6a O    32.5381  -14.1948
            32  O6a O    31.3338  -16.2935
BOND        34
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 2
            7     4   8 2
            8     5   9 2
            9     6  10 1
            10    6  11 2
            11    8  12 1
            12    9  13 1
            13   13  14 1
            14   14  15 1
            15   15  16 2
            16   15  17 1
            17   16  18 1
            18   17  19 2
            19   18  20 2
            20   20  21 1
            21   21  22 1
            22   21  23 2
            23   22  24 1
            24   24  25 1
            25   24  26 1 #Down
            26   25  27 1
            27   26  28 1
            28   26  29 2
            29   27  30 1
            30   30  31 1
            31   30  32 2
            32    7   9 1
            33    8  10 1
            34   19  20 1
///
ENTRY       D00071                      Drug
NAME        Fibronectin (human plasma) (JAN)
REMARK      Same as: C00516
DBLINKS     PubChem: 7847139
///
ENTRY       D00072                      Drug
NAME        Cytochrome c (JAN);
            Cytorest (TN)
REMARK      Same as: C00524
DBLINKS     CAS: 9007-43-6
            PubChem: 7847140
            NIKKAJI: J209.145C
///
ENTRY       D00073                      Drug
NAME        Hydroquinone (USP);
            Eldoquin (TN)
FORMULA     C6H6O2
EXACT_MASS  110.0368
MOL_WEIGHT  110.1106
ACTIVITY    Depigmentor
REMARK      Same as: C00530
            ATC code: D11AX11
COMMENT     Componet of Tri-luma (TN)
TARGET      tyrosinase inhibitor [HSA:7299] [KO:K00505]
  PATHWAY   hsa00350(7299)  Tyrosine metabolism
            hsa00740(7299)  Riboflavin metabolism
            hsa04916(7299)  Melanogenesis
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D11 OTHER DERMATOLOGICAL PREPARATIONS
               D11A OTHER DERMATOLOGICAL PREPARATIONS
                D11AX Other dermatologicals
                 D11AX11 Hydroquinone
                  D00073  Hydroquinone (USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00073  [102977] Hydroquinone
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases
               tyrosinase
                Hydroquinone
                 D00073  Hydroquinone (USP)
DBLINKS     CAS: 123-31-9
            PubChem: 7847141
            LigandBox: D00073
            NIKKAJI: J2.929G
ATOM        8
            1   C8y C    23.5900  -17.5133
            2   C8x C    22.3815  -16.7971
            3   C8x C    24.8050  -16.7971
            4   O1a O    23.5837  -18.9007
            5   C8x C    22.3815  -15.3901
            6   C8x C    24.8050  -15.3901
            7   C8y C    23.5900  -14.6995
            8   O1a O    23.5837  -13.3056
BOND        8
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 2
            6     5   7 2
            7     7   8 1
            8     6   7 1
///
ENTRY       D00074                      Drug
NAME        Nitric oxide (JAN);
            INOmax (TN)
FORMULA     NO
EXACT_MASS  29.998
MOL_WEIGHT  30.0061
REMARK      Same as: C00533
            Therapeutic category: 2190
            ATC code: R07AX01
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R07 OTHER RESPIRATORY SYSTEM PRODUCTS
               R07A OTHER RESPIRATORY SYSTEM PRODUCTS
                R07AX Other respiratory system products
                 R07AX01 Nitric oxide
                  D00074  Nitric oxide (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               219  Miscellaneous
                2190  Miscellaneous
                 D00074  Nitric oxide (JAN)
DBLINKS     CAS: 10102-43-9
            PubChem: 7847142
            DrugBank: DB00435
            LigandBox: D00074
            NIKKAJI: J161.349I
ATOM        2
            1   O3a O    21.4046  -16.1648
            2   N2a N    22.8046  -16.1648 #^
BOND        1
            1     1   2 2
///
ENTRY       D00075                      Drug
NAME        Testosterone (JAN/USP);
            Androderm (TN);
            Androgel (TN);
            Axiron (TN);
            Striant (TN);
            Testim (TN)
FORMULA     C19H28O2
EXACT_MASS  288.2089
MOL_WEIGHT  288.4244
ACTIVITY    Androgen [DS:H00255]
REMARK      Same as: C00535
            ATC code: G03BA03
            Drug group: DG00460
TARGET      androgen receptor agonist [HSA:367] [KO:K08557]
  PATHWAY   hsa05200(367)  Pathways in cancer
            hsa05215(367)  Prostate cancer
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577], CYP3A7 [HSA:1551]
INTERACTION Transporter inhibition: SLC22A2 [HSA:6582]
STR_MAP     map07226  Progesterone, androgen and estrogen receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
               G03B ANDROGENS
                G03BA 3-oxoandrosten (4) derivatives
                 G03BA03 Testosterone
                  D00075  Testosterone (JAN/USP)
            USP drug classification [BR:br08302]
             Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
              Androgens
               Testosterone
                D00075  Testosterone (JAN/USP)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for integumentary system
              61 Other agents for integumentary system
               D00075  Testosterone (JAN/USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 1
              Inorganic and organic chemicals
               Testosterone
                D00075  Testosterone (JAN/USP)
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               3-Ketosteroid receptor
                androgen receptor
                 Testosterone
                  D00075  Testosterone (JAN/USP)
            Cytochrome P450 interactions [BR:br08309]
             Substrates
              CYP3A4
               Testosterone
                D00075  Testosterone (JAN/USP)
              CYP3A5
               Testosterone
                D00075  Testosterone (JAN/USP)
              CYP3A7
               Testosterone
                D00075  Testosterone (JAN/USP)
            Phytochemicals used as drugs [BR:br08306]
             Terpenoids
              Triterpenoids (C30) and related compounds
               Sterols and steroids
                D00075  Testosterone (JAN/USP)
DBLINKS     CAS: 58-22-0
            PubChem: 7847143
            DrugBank: DB00624
            LigandBox: D00075
            NIKKAJI: J4.590J
ATOM        21
            1   C1x C    28.5514  -18.0276
            2   C5x C    28.5514  -19.4309
            3   C2x C    29.7441  -20.1325
            4   C2y C    31.0070  -19.4309
            5   C1z C    31.0070  -18.0276
            6   C1x C    29.7441  -17.3260
            7   C1x C    32.1998  -20.1325
            8   C1x C    33.3925  -19.4309
            9   C1y C    33.3925  -18.0276
            10  C1y C    32.1998  -17.3260
            11  C1y C    34.6554  -17.3260
            12  C1z C    34.6554  -15.9228
            13  C1x C    33.3925  -15.2212
            14  C1x C    32.1998  -15.9228
            15  O5x O    27.3586  -20.1325
            16  C1a C    34.6554  -14.5195
            17  C1a C    31.0070  -16.6244
            18  C1x C    37.0803  -17.3260
            19  C1x C    37.0803  -15.9228
            20  C1y C    35.8678  -15.2228
            21  O1a O    35.8678  -13.8228
BOND        24
            1     1   2 1
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    9  11 1
            13   11  12 1
            14   12  13 1
            15   13  14 1
            16   10  14 1
            17    2  15 2
            18   12  16 1 #Up
            19    5  17 1 #Up
            20   11  18 1
            21   18  19 1
            22   19  20 1
            23   12  20 1
            24   20  21 1 #Up
///
ENTRY       D00076                      Drug
NAME        Noradrenaline (JP16);
            Norepinephrine (INN);
            Nor adrenalin (TN)
FORMULA     C8H11NO3
EXACT_MASS  169.0739
MOL_WEIGHT  169.1778
ACTIVITY    Adrenergic [vasoconstrictor]
REMARK      Same as: C00547
            Therapeutic category: 2451
            ATC code: C01CA03
            Drug group: DG00212
TARGET      alpha1-adrenergic receptor agonist [HSA:146 147 148] [KO:K04137 K04136 K04135];
            alpha2-adrenergic receptor agonist [HSA:150 151 152] [KO:K04138 K04139 K04140];
            beta1-adrenergic receptor agonist [HSA:153] [KO:K04141];
            beta2-adrenergic receptor agonist [HSA:154] [KO:K04142];
            beta3-adrenergic receptor agonist [HSA:155] [KO:K04143]
  PATHWAY   hsa04020(146+147+148+153+154+155)  Calcium signaling pathway
            hsa04080(146+147+148+150+151+152+153+154+155)  Neuroactive ligand-receptor interaction
            hsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes
            hsa04270(146+147+148)  Vascular smooth muscle contraction
            hsa04970(146+147+148+153+154+155)  Salivary secretion
METABOLISM  Enzyme: MAOA [HSA:4128]
INTERACTION  
STR_MAP     map07215  alpha-Adrenergic receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
                C01CA Adrenergic and dopaminergic agents
                 C01CA03 Norepinephrine
                  D00076  Noradrenaline (JP16); Norepinephrine (INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               245  Adrenal hormone preparations
                2451  Epinephrines
                 D00076  Noradrenaline (JP16); Norepinephrine (INN)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                alpha1-adrenergic receptor
                 Norepinephrine
                  D00076  Norepinephrine (INN)
                alpha2-adrenergic receptor
                 Norepinephrine
                  D00076  Norepinephrine (INN)
                beta1-adrenergic receptor
                 Norepinephrine
                  D00076  Norepinephrine (INN)
                beta2-adrenergic receptor
                 Norepinephrine
                  D00076  Norepinephrine (INN)
                beta3-adrenergic receptor
                 Norepinephrine
                  D00076  Norepinephrine (INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00076  Noradrenaline
              D00076  Noradrenaline injection
DBLINKS     CAS: 51-41-2
            PubChem: 7847144
            DrugBank: DB00368
            LigandBox: D00076
            NIKKAJI: J9.223A
ATOM        12
            1   C8y C    25.1107  -17.0137
            2   C8x C    25.1107  -18.4285
            3   C8x C    23.8950  -16.3188
            4   C1c C    26.3149  -16.3188
            5   C8x C    23.8950  -19.1423
            6   C8y C    22.6850  -17.0137
            7   C1b C    27.5246  -17.0080
            8   O1a O    26.3149  -14.9217
            9   C8y C    22.6850  -18.4285
            10  N1a N    28.7227  -16.3130
            11  O1a O    21.4681  -19.1189
            12  O1a O    21.4728  -16.3208
BOND        12
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 2
            6     4   7 1
            7     4   8 1 #Up
            8     5   9 2
            9     7  10 1
            10    9  11 1
            11    6   9 1
            12    6  12 1
///
ENTRY       D00077                      Drug
NAME        Benzyl alcohol (JP16/NF/INN);
            Ulesfia (TN)
FORMULA     C7H8O
EXACT_MASS  108.0575
MOL_WEIGHT  108.1378
ACTIVITY    Pharmaceutic aid [antimicrobial agent]
REMARK      Same as: C00556
BRITE       USP drug classification [BR:br08302]
             Antiparasitics
              Pediculicides/Scabicides
               Benzyl alcohol
                D00077  Benzyl alcohol (JP16/NF/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Benzyl alcohol
                D00077  Benzyl alcohol (JP16/NF/INN)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00077  [001574] Benzyl alcohol
             Base
              D00077  [001574] Benzyl alcohol
             Suspending agent
              D00077  [001574] Benzyl alcohol
             Tonicity agent
              D00077  [001574] Benzyl alcohol
             Antiseptic agent
              D00077  [001574] Benzyl alcohol
             Preserving agent
              D00077  [001574] Benzyl alcohol
             Soothing agent
              D00077  [001574] Benzyl alcohol
             Solubilizer
              D00077  [001574] Benzyl alcohol
             Solubilization agent
              D00077  [001574] Benzyl alcohol
             Solvent
              D00077  [001574] Benzyl alcohol
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00077  Benzyl alcohol
DBLINKS     CAS: 100-51-6
            PubChem: 7847145
            PDB-CCD: 010
            LigandBox: D00077
            NIKKAJI: J4.009F
ATOM        8
            1   C8y C    21.1966  -17.0266
            2   C8x C    19.9953  -17.7167
            3   C8x C    22.4173  -17.7167
            4   C1b C    21.1903  -15.6334
            5   C8x C    19.9953  -19.1226
            6   C8x C    22.4173  -19.1226
            7   O1a O    22.3980  -14.9369
            8   C8x C    21.1966  -19.8383
BOND        8
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 2
            6     4   7 1
            7     5   8 2
            8     6   8 1
///
ENTRY       D00078                      Drug
NAME        Propylene glycol (JP16/USP);
            Propylene glycol (TN)
FORMULA     C3H8O2
EXACT_MASS  76.0524
MOL_WEIGHT  76.0944
ACTIVITY    Pharmaceutic aid [humectant];
            Pharmaceutic aid [solvent];
            Pharmaceutic aid [suspending agent]
REMARK      Same as: C00583
            Therapeutic category: 7139
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             7  Agents not mainly for therapeutic purpose
              71  Dispensing medicines
               713  Solvents
                7139  Others
                 D00078  Propylene glycol (JP16/USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00078  [002328] Propylene glycol
             Plasticizer
              D00078  [002328] Propylene glycol
             Solubilizing agent
              D00078  [002328] Propylene glycol
             Base
              D00078  [002328] Propylene glycol
             Bonding agent
              D00078  [002328] Propylene glycol
             Suspending agent
              D00078  [002328] Propylene glycol
             Coating agent
              D00078  [002328] Propylene glycol
             Wetting agent
              D00078  [002328] Propylene glycol
             Wetting adjuster
              D00078  [002328] Propylene glycol
             Tonicity agent
              D00078  [002328] Propylene glycol
             Flexibilizer
              D00078  [002328] Propylene glycol
             Emulsion
              D00078  [002328] Propylene glycol
             Adhesive
              D00078  [002328] Propylene glycol
             Adhesion-enhancing agent
              D00078  [002328] Propylene glycol
             Tenacious agent
              D00078  [002328] Propylene glycol
             Diluting agent
              D00078  [002328] Propylene glycol
             Dispersant
              D00078  [002328] Propylene glycol
             Preserving agent
              D00078  [002328] Propylene glycol
             Soothing agent
              D00078  [002328] Propylene glycol
             Solubilizer
              D00078  [002328] Propylene glycol
             Solubilization agent
              D00078  [002328] Propylene glycol
             Solvent
              D00078  [002328] Propylene glycol
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00078  Propylene glycol
DBLINKS     CAS: 57-55-6
            PubChem: 7847146
            DrugBank: DB01839
            LigandBox: D00078
            NIKKAJI: J1.918F
ATOM        5
            1   C1c C    21.4977  -15.8200
            2   C1b C    22.7068  -15.1190
            3   C1a C    20.2823  -15.1190
            4   O1a O    21.4977  -17.2219
            5   O1a O    23.9156  -15.8200
BOND        4
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
///
ENTRY       D00079                      Drug
NAME        Dinoprostone (JAN/USP/INN);
            Cervidil (TN);
            Prepidil (TN);
            Prostin E2 (TN)
FORMULA     C20H32O5
EXACT_MASS  352.225
MOL_WEIGHT  352.4651
ACTIVITY    Oxytocic;
            Prostaglandin
REMARK      Same as: C00584
            Therapeutic category: 2499
            ATC code: G02AD02
            Drug group: DG00448
TARGET      prostaglandin E2 receptor agonist [HSA:5732] [KO:K04259]
  PATHWAY   hsa04080(5732)  Neuroactive ligand-receptor interaction
INTERACTION  
STR_MAP     map07035  Prostaglandins
            map07228  Eicosanoid receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G02 OTHER GYNECOLOGICALS
               G02A UTEROTONICS
                G02AD Prostaglandins
                 G02AD02 Dinoprostone
                  D00079  Dinoprostone (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2499  Others
                 D00079  Dinoprostone (JAN/USP/INN)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Prostaglandin
                prostaglandin E2 receptor
                 Dinoprostone
                  D00079  Dinoprostone (JAN/USP/INN)
DBLINKS     CAS: 363-24-6
            PubChem: 7847147
            DrugBank: DB00917
            LigandBox: D00079
            NIKKAJI: J9.243F
ATOM        25
            1   C1y C    26.2804  -14.5224
            2   C1y C    26.2745  -15.8992
            3   C5x C    24.9670  -14.1058
            4   C1b C    27.6803  -12.8017
            5   C1y C    24.9902  -16.3216
            6   C2b C    27.4605  -16.9945
            7   C1x C    24.1745  -15.2223
            8   O5x O    24.5274  -12.7696
            9   C2b C    28.8604  -13.4959
            10  O1a O    24.5563  -17.6696
            11  C2b C    28.6406  -16.3177
            12  C2b C    30.2084  -13.4959
            13  C1c C    29.8150  -16.9945
            14  C1b C    31.3828  -12.8017
            15  C1b C    31.0010  -16.3177
            16  O1a O    29.8150  -18.3598
            17  C1b C    32.5513  -13.4786
            18  C1b C    32.1810  -16.9945
            19  C1b C    33.7315  -12.7961
            20  C1b C    33.3785  -16.3177
            21  C6a C    34.9058  -13.4670
            22  C1b C    34.5471  -16.9945
            23  O6a O    36.1149  -12.7555
            24  O6a O    34.9180  -14.8553
            25  C1a C    35.7388  -16.3177
BOND        25
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     2   6 1 #Up
            6     3   7 1
            7     3   8 2
            8     4   9 1
            9     5  10 1 #Down
            10    6  11 2
            11    9  12 2
            12   11  13 1
            13   12  14 1
            14   13  15 1
            15   13  16 1 #Down
            16   14  17 1
            17   15  18 1
            18   17  19 1
            19   18  20 1
            20   19  21 1
            21   20  22 1
            22   21  23 1
            23   21  24 2
            24   22  25 1
            25    5   7 1
///
ENTRY       D00080                      Drug
NAME        Chondroitin sulfate A (JAN)
FORMULA     (C14H21NO14S)n
REMARK      Same as: C00634
            ATC code: M01AX25
            Drug group: DG00762
COMMENT     Component of Danaparoid sodium [DR:D03644]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
               M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
                M01AX Other antiinflammatory and antirheumatic agents, non-steroids
                 M01AX25 Chondroitin sulfate
                  D00080  Chondroitin sulfate A (JAN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Chondroitin sulfate A
                D00080  Chondroitin sulfate A (JAN)
DBLINKS     CAS: 24967-93-9
            PubChem: 7847148
            NIKKAJI: J290.949I
ATOM        32
            1   C1y C    19.5457  -15.2601
            2   C1y C    20.7462  -14.5666
            3   C1y C    20.7459  -13.1666
            4   O2x O    19.5333  -12.4669
            5   C1y C    18.3328  -13.1604
            6   C1y C    18.3331  -14.5604
            7   C1y C    15.2600  -17.7100
            8   C1x C    15.2600  -19.1100
            9   C1y C    16.4724  -19.8100
            10  C1y C    17.6849  -19.1100
            11  C1y C    17.6849  -17.7100
            12  O2x O    16.4724  -17.0100
            13  Z   *    11.4576  -20.9300
            14  O1a O    18.9160  -19.8210
            15  O1a O    16.4724  -21.2098
            16  C6a C    14.0476  -17.0100
            17  O2a O    19.5460  -17.0690
            18  O1a O    21.9414  -12.4757
            19  C1b C    17.1254  -12.4637
            20  O2a O    17.1262  -15.2576
            21  N1b N    21.9362  -15.2534
            22  O6a O    12.8521  -17.7004
            23  O6a O    14.0475  -15.6102
            24  C5a C    21.9366  -16.6597
            25  C1a C    23.1292  -17.3481
            26  Z   *    25.8537  -14.7677
            27  S4a S    15.9326  -14.5687
            28  O5a O    20.7044  -17.3717
            29  O1d O    14.7201  -13.8687
            30  O1d O    15.2436  -15.7628
            31  O1d O    16.6428  -13.3378
            32  O1a O    17.1254  -11.0637
BOND        33
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     7   8 1
            8     8   9 1
            9     9  10 1
            10   10  11 1
            11   11  12 1
            12    7  12 1
            13    8  13 1 #Down
            14   10  14 1 #Down
            15    9  15 1 #Up
            16    7  16 1 #Up
            17   11  17 1 #Up
            18    1  17 1 #Up
            19    3  18 1 #Up
            20    5  19 1 #Up
            21    6  20 1 #Down
            22    2  21 1 #Down
            23   16  22 1
            24   16  23 2
            25   21  24 1
            26   24  25 1
            27   18  26 1
            28   20  27 1
            29   24  28 2
            30   27  29 1
            31   27  30 2
            32   27  31 2
            33   19  32 1
BRACKET     1    12.6000  -21.7000   12.6000  -10.6400
            1    24.5700  -10.6400   24.5700  -21.7000
            1  n
  ORIGINAL  1    1   2   3   4   5   6   7   8   9  10  11  12  14  15  16  17
            1   18  19  20  21  22  23  24  25  27  28  29  30  31  32
  REPEAT    1 
///
ENTRY       D00081                      Drug
NAME        Dinoprost (JP16/USAN/INN);
            Prosmon (TN)
FORMULA     C20H34O5
EXACT_MASS  354.2406
MOL_WEIGHT  354.481
ACTIVITY    Oxytocic;
            Prostaglandin
REMARK      Same as: C00639
            Therapeutic category: 2499
            ATC code: G02AD01
            Drug group: DG00447
TARGET      prostaglandin F receptor agonist [HSA:5737] [KO:K04262]
  PATHWAY   hsa04020(5737)  Calcium signaling pathway
            hsa04080(5737)  Neuroactive ligand-receptor interaction
INTERACTION  
STR_MAP     map07035  Prostaglandins
            map07228  Eicosanoid receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G02 OTHER GYNECOLOGICALS
               G02A UTEROTONICS
                G02AD Prostaglandins
                 G02AD01 Dinoprost
                  D00081  Dinoprost (JP16/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2499  Others
                 D00081  Dinoprost (JP16/USAN/INN)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Prostaglandin
                prostaglandin F receptor
                 Dinoprost
                  D00081  Dinoprost (JP16/USAN/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00081  Dinoprost
DBLINKS     CAS: 551-11-1
            PubChem: 7847149
            LigandBox: D00081
            NIKKAJI: J9.246K
ATOM        25
            1   C1y C    26.2459  -14.3536
            2   C1y C    26.2400  -15.7232
            3   C1y C    24.9454  -13.9393
            4   C1b C    27.6327  -13.1279
            5   C1y C    24.9626  -16.1432
            6   C2b C    27.6270  -16.8801
            7   C1x C    24.1513  -15.0498
            8   O1a O    24.5023  -12.6101
            9   C2b C    28.8066  -13.8184
            10  O1a O    24.5311  -17.4840
            11  C2b C    28.8010  -16.2069
            12  C2b C    30.1531  -13.8184
            13  C1c C    29.9748  -16.8801
            14  C1b C    31.3213  -13.1279
            15  C1b C    31.1489  -16.2069
            16  O1a O    29.9748  -18.2382
            17  C1b C    32.4837  -13.8013
            18  C1b C    32.3227  -16.8801
            19  C1b C    33.6577  -13.1223
            20  C1b C    33.5138  -16.2069
            21  C6a C    34.8258  -13.7897
            22  C1b C    34.6704  -16.8801
            23  O6a O    36.0226  -13.0818
            24  O6a O    34.8373  -15.1706
            25  C1a C    35.8616  -16.2069
BOND        25
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     2   6 1 #Up
            6     3   7 1
            7     3   8 1 #Down
            8     4   9 1
            9     5  10 1 #Down
            10    6  11 2
            11    9  12 2
            12   11  13 1
            13   12  14 1
            14   13  15 1
            15   13  16 1 #Down
            16   14  17 1
            17   15  18 1
            18   17  19 1
            19   18  20 1
            20   19  21 1
            21   20  22 1
            22   21  23 1
            23   21  24 2
            24   22  25 1
            25    5   7 1
///
ENTRY       D00082                      Drug
NAME        Pyridoxamine phosphate (JAN);
            Pyridoxamine phosphate dihydrate
FORMULA     C8H13N2O5P. 2H2O
EXACT_MASS  284.0773
MOL_WEIGHT  284.2035
DBLINKS     PubChem: 7847150
            LigandBox: D00082
ATOM        18
            1   C8y C    21.8020  -18.7345
            2   C8y C    20.5813  -18.0411
            3   C8x C    21.8020  -20.1443
            4   C1b C    23.0168  -18.0354
            5   C8y C    19.3732  -18.7345
            6   C1b C    20.5753  -16.6430
            7   N5x N    20.5813  -20.8550
            8   O2b O    24.2248  -18.7286
            9   C8y C    19.3732  -20.1443
            10  O1a O    18.1642  -18.0411
            11  N1a N    21.7846  -15.9438
            12  P1b P    25.5763  -18.7460
            13  C1a C    18.1583  -20.8375
            14  O1c O    27.0211  -18.7345
            15  O1c O    25.5355  -20.1326
            16  O1c O    25.5355  -17.3421
            17  O0  O    31.3037  -18.7543
            18  O0  O    31.3037  -18.7543
BOND        16
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     4   8 1
            8     5   9 1
            9     5  10 1
            10    6  11 1
            11    8  12 1
            12    9  13 1
            13   12  14 1
            14   12  15 1
            15   12  16 2
            16    7   9 2
BRACKET     1    29.4000  -19.8100   29.4000  -17.7800
            1    31.8500  -17.7800   31.8500  -19.8100
            1  2
  ORIGINAL  1   17
  REPEAT    1   18
///
ENTRY       D00083                      Drug
NAME        Nitrogen (JP16/NF);
            Nitrogen (TN)
FORMULA     N2
EXACT_MASS  28.0061
MOL_WEIGHT  28.0134
ACTIVITY    Pharmaceutic aid [air displacement]
REMARK      Same as: C00697
            Therapeutic category: 7990
            ATC code: V03AN04
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             V VARIOUS
              V03 ALL OTHER THERAPEUTIC PRODUCTS
               V03A ALL OTHER THERAPEUTIC PRODUCTS
                V03AN Medical gases
                 V03AN04 Nitrogen
                  D00083  Nitrogen (JP16/NF)
            Therapeutic category of drugs in Japan [BR:br08301]
             7  Agents not mainly for therapeutic purpose
              79  Other agents not mainly for therapeutic purpose
               799  Miscellaneous
                7990  Miscellaneous
                 D00083  Nitrogen (JP16/NF)
            Pharmaceutical additives [BR:br08316]
             Propellant
              D00083  [001409] Nitrogen
             Antiseptic agent
              D00083  [001409] Nitrogen
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00083  Nitrogen
DBLINKS     CAS: 7727-37-9
            PubChem: 7847151
            LigandBox: D00083
            NIKKAJI: J44.424C
ATOM        2
            1   N3a N    24.3600  -17.0100
            2   N3a N    25.7600  -17.0100
BOND        1
            1     1   2 3
///
ENTRY       D00084                      Drug
NAME        Dextrin (JP16/NF)
FORMULA     (C12H20O10)n
ACTIVITY    Pharmaceutic aid [suspending agent];
            Pharmaceutic aid [viscosity-increasing agent];
            Pharmaceutic aid [tablet binder];
            Pharmaceutic aid [tablet and capsule diluent]
REMARK      Same as: C00369 C00721 C03018 G10545
BRITE       Pharmaceutical additives [BR:br08316]
             Adsorbent
              D00084  [001422] Dextrin
             Bonding agent
              D00084  [001422] Dextrin
             Adhesive
              D00084  [001422] Dextrin
             Tenacious agent
              D00084  [001422] Dextrin
             Diluting agent
              D00084  [001422] Dextrin
             Dispersant
              D00084  [001422] Dextrin
             Disintegrant
              D00084  [001422] Dextrin
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00084  Dextrin
DBLINKS     CAS: 9004-53-9
            PubChem: 7847152
            NIKKAJI: J578.995H
ATOM        24
            1   C1y C    29.3195  -14.2393
            2   C1y C    29.3195  -12.8936
            3   O2a O    28.1581  -14.9039
            4   C1y C    30.4808  -14.9317
            5   O2x O    30.4808  -12.2236
            6   C1b C    28.1636  -12.2236
            7   C1y C    27.0079  -15.5795
            8   C1y C    31.6478  -14.2393
            9   O1a O    30.4808  -16.2662
            10  C1y C    31.6478  -12.8936
            11  O1a O    28.1636  -10.8891
            12  O2x O    25.8353  -14.9094
            13  C1y C    27.0079  -16.9362
            14  O1a O    32.8093  -14.9094
            15  O1a O    32.8036  -12.2179
            16  C1y C    24.6683  -15.5795
            17  C1y C    25.8353  -17.6120
            18  O1a O    28.1581  -17.5950
            19  Z   *    34.9479  -12.2180
            20  C1x C    24.6683  -16.9362
            21  C1b C    23.5181  -14.9094
            22  O1a O    25.8296  -18.9520
            23  Z   *    21.1381  -18.7150
            24  O1a O    23.5181  -13.5749
BOND        25
            1     1   2 1
            2     1   3 1 #Down
            3     1   4 1
            4     2   5 1
            5     2   6 1 #Up
            6     7   3 1 #Down
            7     4   8 1
            8     4   9 1 #Up
            9     5  10 1
            10    6  11 1
            11    7  12 1
            12    7  13 1
            13    8  14 1 #Down
            14   10  15 1 #Down
            15   12  16 1
            16   13  17 1
            17   13  18 1 #Down
            18   15  19 1
            19   16  20 1
            20   16  21 1 #Up
            21   17  22 1 #Up
            22   20  23 1 #Down
            23   21  24 1
            24    8  10 1
            25   17  20 1
BRACKET     1    22.6100  -19.4600   22.6100  -10.5000
            1    33.8800  -10.5000   33.8800  -19.4600
            1  n
  ORIGINAL  1    1   2   3   4   5   6   7   8   9  10  11  12  13  14  15  16
            1   17  18  20  21  22  24
  REPEAT    1 
///
ENTRY       D00085                      Drug
NAME        Insulin (JAN/USP)
SEQUENCE    (A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr
            Gln Leu Glu Asn Tyr Cys Asn (Disulfide bridge: 6-11)
            (B chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala
            Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Thr
            (Disulfide bridge: A7-B7; A20-B19)
  TYPE      Peptide
ACTIVITY    Antidiabetic [DS:H00408 H00409 H00410]
REMARK      Same as: C00723
COMMENT     Pancreas hormone
TARGET      insulin receptor agonist [HSA:3643] [KO:K04527]
  PATHWAY   hsa04520(3643)  Adherens junction
            hsa04910(3643)  Insulin signaling pathway
            hsa04930(3643)  Type II diabetes mellitus
            hsa04960(3643)  Aldosterone-regulated sodium reabsorption
INTERACTION CYP induction: CYP1A2 [HSA:1544]
STR_MAP     map07051  Antidiabetics
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokine receptors
              Receptor tyrosine kinase
               RTK class II (Insulin receptor family)
                insulin receptor
                 Insulin
                  D00085  Insulin (JAN/USP)
            Cytochrome P450 interactions [BR:br08309]
             Inducers
              CYP1A2
               Insulin
                D00085  Insulin (JAN/USP)
DBLINKS     CAS: 9004-10-8
            PubChem: 7847153
            DrugBank: DB00030
            NIKKAJI: J2.730.443E
///
ENTRY       D00086                      Drug
NAME        Thioctic acid (JAN);
            Thiotomin (TN)
FORMULA     C8H14O2S2
EXACT_MASS  206.0435
MOL_WEIGHT  206.3256
REMARK      Same as: C00725
            Therapeutic category: 3999
            ATC code: A16AX01
            Drug group: DG00146
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AX Various alimentary tract and metabolism products
                 A16AX01 Thioctic acid
                  D00086  Thioctic acid (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D00086  Thioctic acid (JAN)
            Classification of Japanese OTC drugs [BR:br08313]
             Nourishing tonics and health supplements
              43 Vitamin containing supplements
               D00086  Thioctic acid (JAN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Thioctic acid
                D00086  Thioctic acid (JAN)
DBLINKS     CAS: 62-46-4
            PubChem: 7847154
            DrugBank: DB00166
            LigandBox: D00086
            NIKKAJI: J38.321J
ATOM        12
            1   S3x S    26.6107  -18.0677
            2   S3x S    25.2097  -18.0677
            3   C1x C    24.7769  -19.4001
            4   C1x C    25.9102  -20.2236
            5   C1y C    27.0436  -19.4001
            6   C1b C    28.2443  -20.0991
            7   C1b C    29.4576  -19.3986
            8   C1b C    30.6708  -20.0991
            9   C1b C    31.8840  -19.3986
            10  C6a C    33.0974  -20.0991
            11  O6a O    34.3106  -19.3986
            12  O6a O    33.0974  -21.5002
BOND        12
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     1   5 1
            6     5   6 1
            7     6   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11   10  11 1
            12   10  12 2
///
ENTRY       D00087                      Drug
NAME        Ubenimex (JP16/INN);
            Bestatin (TN)
FORMULA     C16H24N2O4
EXACT_MASS  308.1736
MOL_WEIGHT  308.3728
SOURCE      Streptomyces olivoreticuli [TAX:68246]
ACTIVITY    Immunomodulator [DS:H00003]
REMARK      Same as: C00732
            Therapeutic category: 4299
COMMENT     natural product
TARGET      aminopeptidase B inhibitor [HSA:6051] [KO:K01260]
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4299  Others
                 D00087  Ubenimex (JP16/INN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases
               aminopeptidase B
                Ubenimex
                 D00087  Ubenimex (JP16/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00087  Ubenimex
              D00087  Ubenimex capsules
DBLINKS     CAS: 58970-76-6
            PubChem: 7847155
            LigandBox: D00087
            NIKKAJI: J12.831G
ATOM        22
            1   C8y C    18.3176  -16.8700
            2   C1b C    19.5102  -17.5578
            3   C8x C    17.1187  -17.5767
            4   C8x C    18.3176  -15.4881
            5   C1c C    20.6965  -16.8700
            6   C8x C    15.9261  -16.8700
            7   C8x C    17.1187  -14.8004
            8   C1c C    21.8890  -17.5514
            9   N1a N    20.6460  -15.5317
            10  C8x C    15.9261  -15.4881
            11  C5a C    23.0753  -16.8638
            12  N1b N    24.9240  -17.5262
            13  O5a O    23.0689  -15.5581
            14  C1c C    26.1923  -16.8638
            15  C1b C    27.3786  -17.5514
            16  C6a C    26.1476  -15.4945
            17  C1c C    27.3848  -18.9207
            18  O6a O    24.9613  -14.8131
            19  O6a O    27.3338  -14.8067
            20  C1a C    28.5711  -19.6086
            21  C1a C    26.1987  -19.6086
            22  O1a O    21.8931  -18.9699
BOND        22
            1     1   2 1
            2     1   3 1
            3     1   4 2
            4     2   5 1
            5     3   6 2
            6     4   7 1
            7     5   8 1
            8     5   9 1 #Up
            9     6  10 1
            10    7  10 2
            11   11  12 1
            12   11  13 2
            13   14  12 1 #Up
            14   14  15 1
            15   14  16 1
            16   15  17 1
            17   16  18 1
            18   16  19 2
            19   17  20 1
            20   17  21 1
            21    8  11 1
            22    8  22 1 #Up
///
ENTRY       D00088                      Drug
NAME        Hydrocortisone (JP16/USP/INN);
            HC;
            Acticort (TN);
            Anusol HC (TN);
            Colocort (TN);
            Cortef (TN);
            Hytone (TN)
FORMULA     C21H30O5
EXACT_MASS  362.2093
MOL_WEIGHT  362.4599
ACTIVITY    Glucocorticoid
REMARK      Same as: C00735
            Therapeutic category: 2452
            ATC code: A01AC03 A07EA02 C05AA01 D07AA02 D07XA01 H02AB09 S01BA02 S01CB03 S02BA01
            Drug group: DG00012
TARGET      glucocorticoid receptor agonist [HSA:2908] [KO:K05771]
  PATHWAY   hsa04080(2908)  Neuroactive ligand-receptor interaction
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577], CYP3A7 [HSA:1551]
INTERACTION  
STR_MAP     map07225  Glucocorticoid and meneralocorticoid receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A01 STOMATOLOGICAL PREPARATIONS
               A01A STOMATOLOGICAL PREPARATIONS
                A01AC Corticosteroids for local oral treatment
                 A01AC03 Hydrocortisone
                  D00088  Hydrocortisone (JP16/USP/INN)
              A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
               A07E INTESTINAL ANTIINFLAMMATORY AGENTS
                A07EA Corticosteroids acting locally
                 A07EA02 Hydrocortisone
                  D00088  Hydrocortisone (JP16/USP/INN)
             C CARDIOVASCULAR SYSTEM
              C05 VASOPROTECTIVES
               C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
                C05AA Corticosteroids
                 C05AA01 Hydrocortisone
                  D00088  Hydrocortisone (JP16/USP/INN)
             D DERMATOLOGICALS
              D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
               D07A CORTICOSTEROIDS, PLAIN
                D07AA Corticosteroids, weak (group I)
                 D07AA02 Hydrocortisone
                  D00088  Hydrocortisone (JP16/USP/INN)
               D07X CORTICOSTEROIDS, OTHER COMBINATIONS
                D07XA Corticosteroids, weak, other combinations
                 D07XA01 Hydrocortisone
                  D00088  Hydrocortisone (JP16/USP/INN)
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H02 CORTICOSTEROIDS FOR SYSTEMIC USE
               H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
                H02AB Glucocorticoids
                 H02AB09 Hydrocortisone
                  D00088  Hydrocortisone (JP16/USP/INN)
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01B ANTIINFLAMMATORY AGENTS
                S01BA Corticosteroids, plain
                 S01BA02 Hydrocortisone
                  D00088  Hydrocortisone (JP16/USP/INN)
               S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
                S01CB Corticosteroids/antiinfectives/mydriatics in combination
                 S01CB03 Hydrocortisone
                  D00088  Hydrocortisone (JP16/USP/INN)
              S02 OTOLOGICALS
               S02B CORTICOSTEROIDS
                S02BA Corticosteroids
                 S02BA01 Hydrocortisone
                  D00088  Hydrocortisone (JP16/USP/INN)
            USP drug classification [BR:br08302]
             Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
              Hydrocortisone
               D00088  Hydrocortisone (JP16/USP/INN)
              Hydrocortisone
               D00088  Hydrocortisone (JP16/USP/INN)
              Hydrocortisone
               D00088  Hydrocortisone (JP16/USP/INN)
             Inflammatory Bowel Disease Agents
              Glucocorticoids
               Hydrocortisone
                D00088  Hydrocortisone (JP16/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               245  Adrenal hormone preparations
                2452  Cortisones
                 D00088  Hydrocortisone (JP16/USP/INN)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for integumentary system
              57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
               D00088  Hydrocortisone (JP16/USP/INN)
              -- Antipruritic and insect sting remedies
               D00088  Hydrocortisone (JP16/USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Specified Category 2
              Inorganic and organic chemicals
               Hydrocortisone
                D00088  Hydrocortisone (JP16/USP/INN)
             Category 2
              Inorganic and organic chemicals
               Hydrocortisone
                D00088  Hydrocortisone (JP16/USP/INN)
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               3-Ketosteroid receptor
                glucocorticoid receptor
                 Hydrocortisone
                  D00088  Hydrocortisone (JP16/USP/INN)
            Cytochrome P450 interactions [BR:br08309]
             Substrates
              CYP3A4
               Hydrocortisone
                D00088  Hydrocortisone (JP16/USP/INN)
              CYP3A5
               Hydrocortisone
                D00088  Hydrocortisone (JP16/USP/INN)
              CYP3A7
               Hydrocortisone
                D00088  Hydrocortisone (JP16/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00088  Hydrocortisone
DBLINKS     CAS: 50-23-7
            PubChem: 7847156
            DrugBank: DB00741
            LigandBox: D00088
            NIKKAJI: J1.908I
ATOM        26
            1   C1y C    25.3915  -16.8055
            2   C1y C    24.2081  -17.4875
            3   C1z C    25.3915  -15.4414
            4   C1x C    27.7583  -16.8055
            5   C1y C    23.0247  -16.8055
            6   C1x C    24.1965  -18.8575
            7   C1z C    26.5809  -14.7535
            8   C1x C    24.2081  -14.7535
            9   C1a C    25.3858  -14.0713
            10  C1x C    27.7583  -15.4414
            11  C1z C    21.8356  -17.4875
            12  C1y C    23.0247  -15.4414
            13  C1x C    23.0247  -19.5395
            14  C5a C    26.5866  -13.3893
            15  C2y C    21.8356  -18.8575
            16  C1x C    20.6579  -16.8055
            17  C1a C    21.8239  -16.1233
            18  O1a O    21.8356  -14.7535
            19  C1b C    27.7643  -12.7072
            20  O5a O    25.3975  -12.7072
            21  C2x C    20.6579  -19.5395
            22  C1x C    19.4687  -17.4875
            23  O1a O    28.9534  -13.3951
            24  C5x C    19.4687  -18.8575
            25  O5x O    18.2853  -19.5395
            26  O1a O    27.9332  -14.3911
BOND        29
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 1
            8     3   9 1 #Up
            9     4  10 1
            10    5  11 1
            11    5  12 1
            12    6  13 1
            13    7  14 1 #Up
            14   11  15 1
            15   11  16 1
            16   11  17 1 #Up
            17   12  18 1 #Up
            18   14  19 1
            19   14  20 2
            20   15  21 2
            21   16  22 1
            22   19  23 1
            23   21  24 1
            24   24  25 2
            25    7  10 1
            26    8  12 1
            27   13  15 1
            28   22  24 1
            29    7  26 1 #Down
///
ENTRY       D00089                      Drug
NAME        Oxytocin (JP16/USP/INN);
            Oxytocin (TN);
            Pitocin (TN);
            Syntocinon (TN)
FORMULA     C43H66N12O12S2
EXACT_MASS  1006.4365
MOL_WEIGHT  1007.1873
SEQUENCE    Cys Tyr Ile Gln Asn Cys Pro Leu Gly (Disulfide bridge: 1-6)
  TYPE      Peptide
ACTIVITY    Oxytocic
REMARK      Same as: C00746
            Therapeutic category: 2414
            ATC code: H01BB02
COMMENT     Posterior pituitary hormone
TARGET      oxytocin receptor agonist [HSA:5021] [KO:K04229]
  PATHWAY   hsa04020(5021)  Calcium signaling pathway
            hsa04080(5021)  Neuroactive ligand-receptor interaction
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
               H01B POSTERIOR PITUITARY LOBE HORMONES
                H01BB Oxytocin and analogues
                 H01BB02 Oxytocin
                  D00089  Oxytocin (JP16/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               241  Pituitary hormone preparations
                2414  Posterior pituitary hormones
                 D00089  Oxytocin (JP16/USP/INN)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Oxytocin
                oxytocin receptor
                 Oxytocin
                  D00089  Oxytocin (JP16/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00089  Oxytocin
              D00089  Oxytocin injection
DBLINKS     CAS: 50-56-6
            PubChem: 7847157
            DrugBank: DB00107
            LigandBox: D00089
            NIKKAJI: J1.360I
ATOM        69
            1   C8x C    26.7400  -15.1900
            2   C8y C    26.7400  -16.5900
            3   C8x C    27.9300  -17.2900
            4   C8x C    29.1900  -16.5900
            5   C8y C    29.1900  -15.1900
            6   C8x C    27.9300  -14.4900
            7   O1a O    25.5500  -17.2900
            8   C1b C    30.3800  -14.4900
            9   C1y C    32.1300  -15.1900
            10  C5x C    33.3200  -14.4900
            11  N1x N    32.1300  -16.5900
            12  N1x N    34.5100  -15.1900
            13  O5x O    33.3200  -13.0900
            14  C5x C    30.9400  -17.2900
            15  C1y C    30.9400  -18.6900
            16  O5x O    29.7500  -16.5900
            17  N1a N    29.7500  -19.3900
            18  C1x C    32.1300  -19.3900
            19  S3x S    32.1300  -20.7900
            20  S3x S    33.3200  -21.4900
            21  C1x C    34.5100  -20.7900
            22  C1y C    35.7000  -21.4900
            23  N1x N    36.8900  -20.7900
            24  C5a C    35.7000  -22.8900
            25  O5a O    34.5100  -23.5900
            26  N1y N    36.8900  -23.5900
            27  C1y C    36.8900  -24.9900
            28  C1x C    38.2200  -25.4100
            29  C1x C    39.0600  -24.2900
            30  C1x C    38.2200  -23.1700
            31  C5a C    35.7700  -25.8300
            32  N1b N    34.5100  -25.2700
            33  O5a O    35.7700  -27.2300
            34  C5a C    32.1300  -25.2700
            35  C1c C    33.3200  -25.9700
            36  C1b C    33.3200  -27.3700
            37  C1c C    32.1300  -28.0700
            38  C1a C    30.9400  -27.3700
            39  C1a C    32.1300  -29.4700
            40  N1b N    30.9400  -25.9700
            41  O5a O    32.1300  -23.8700
            42  C1b C    29.7500  -25.2700
            43  C5a C    28.5600  -25.9700
            44  N1a N    27.3700  -25.2700
            45  O5a O    28.5600  -27.3700
            46  C5x C    36.8900  -19.3900
            47  O5x O    35.7000  -18.6900
            48  C1y C    38.0800  -18.6900
            49  N1x N    38.0800  -17.2900
            50  C5x C    39.2700  -16.5900
            51  O5x O    40.5300  -17.2900
            52  C1y C    39.2700  -15.1900
            53  N1x N    38.0800  -14.4900
            54  C5x C    36.8900  -15.1900
            55  C1y C    35.7000  -14.4900
            56  O5x O    36.8900  -16.5900
            57  C1c C    35.7000  -13.0900
            58  C1b C    36.8900  -12.3900
            59  C1a C    38.0800  -13.0900
            60  C1a C    34.5100  -12.3900
            61  C1b C    39.3400  -19.3900
            62  C1b C    40.4600  -14.4900
            63  C1b C    41.7200  -15.1900
            64  C5a C    42.9100  -14.4200
            65  N1a N    44.1000  -15.1200
            66  O5a O    42.9100  -13.0200
            67  C5a C    39.3400  -20.7900
            68  N1a N    40.5300  -21.4900
            69  O5a O    38.1500  -21.4900
BOND        71
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     2   7 1
            8     5   8 1
            9     9   8 1 #Up
            10    9  10 1
            11    9  11 1
            12   10  12 1
            13   10  13 2
            14   11  14 1
            15   14  15 1
            16   14  16 2
            17   15  17 1 #Down
            18   15  18 1
            19   18  19 1
            20   19  20 1
            21   20  21 1
            22   21  22 1
            23   22  23 1
            24   22  24 1 #Down
            25   24  25 2
            26   24  26 1
            27   26  27 1
            28   27  28 1 #Up
            29   28  29 1
            30   29  30 1
            31   26  30 1
            32   27  31 1
            33   31  32 1
            34   31  33 2
            35   34  35 1
            36   35  32 1
            37   35  36 1 #Up
            38   36  37 1
            39   37  38 1
            40   37  39 1
            41   34  40 1
            42   34  41 2
            43   40  42 1
            44   42  43 1
            45   43  44 1
            46   43  45 2
            47   23  46 1
            48   46  47 2
            49   46  48 1
            50   48  49 1
            51   49  50 1
            52   50  51 2
            53   50  52 1
            54   52  53 1
            55   53  54 1
            56   55  54 1 #Up
            57   55  12 1
            58   54  56 2
            59   55  57 1
            60   57  58 1
            61   58  59 1
            62   57  60 1 #Up
            63   48  61 1 #Up
            64   52  62 1 #Up
            65   62  63 1
            66   63  64 1
            67   64  65 1
            68   64  66 2
            69   61  67 1
            70   67  68 1
            71   67  69 2
///
ENTRY       D00090                      Drug
NAME        Thrombin (JP16/USP/INN);
            Factor IIa;
            Thrombostat (TN)
ACTIVITY    Hemostatic [local]
REMARK      Same as: C00752
            Therapeutic category: 3323
            ATC code: B02BC06 B02BD30
            Drug group: DG00169
COMMENT     thrombin [HSA:2147] [KO:K01313] [EC:3.4.21.5]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B02 ANTIHEMORRHAGICS
               B02B VITAMIN K AND OTHER HEMOSTATICS
                B02BC Local hemostatics
                 B02BC06 Thrombin
                  D00090  Thrombin (JP16/USP/INN)
                B02BD Blood coagulation factors
                 B02BD30 Thrombin
                  D00090  Thrombin (JP16/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              33  Blood and body fluid agents
               332  Hemostatics
                3323  Hemostatics for organs
                 D00090  Thrombin (JP16/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00090  Thrombin
DBLINKS     CAS: 9002-04-4
            PubChem: 7847158
            NIKKAJI: J247.643F
///
ENTRY       D00091                      Drug
NAME        Vanillin (NF)
FORMULA     C8H8O3
EXACT_MASS  152.0473
MOL_WEIGHT  152.1473
ACTIVITY    Pharmaceutic aid [flavor]
REMARK      Same as: C00755
BRITE       Pharmaceutical additives [BR:br08316]
             Favoring agent, Fragrance
              D00091  [107548] Vanillin
             Refresher
              D00091  [107548] Vanillin
DBLINKS     CAS: 121-33-5
            PubChem: 7847159
            LigandBox: D00091
            NIKKAJI: J2.923H
ATOM        11
            1   C8y C    25.4479  -19.7481
            2   C8x C    25.4479  -18.3491
            3   C8y C    24.2422  -20.4445
            4   O2a O    26.6595  -20.4445
            5   C8y C    24.2422  -17.6467
            6   C8x C    23.0249  -19.7481
            7   O1a O    24.2422  -21.8493
            8   C8x C    23.0249  -18.3491
            9   C4a C    24.2422  -16.2478
            10  O4a O    23.0306  -15.5455
            11  C1a C    27.8796  -19.7351
BOND        11
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     3   6 1
            6     3   7 1
            7     5   8 1
            8     5   9 1
            9     9  10 2
            10    6   8 2
            11    4  11 1
///
ENTRY       D00092            Crude     Drug
NAME        Coptis rhizome (JP16);
            Powdered coptis rhizome (JP16);
            Coptis rhizome (TN)
COMPONENT   Berberine [CPD:C00757], Palmatine [CPD:C05315], Jateorrhizine [CPD:C09553], Coptisine [CPD:C16938], Worenine [CPD:C17083], Magnoflorine [CPD:C09581], Ferulic acid [CPD:C01494], Chlorogenic acid [CPD:C00852], Tetrahydroberberine [CPD:C03329], Tetrahydropalmatine [CPD:C02890]
SOURCE      Coptis japonica [TAX:3442], Coptis chinensis [TAX:261450], Coptis deltoidea [TAX:261449], Coptis teeta [TAX:261448]
REMARK      Same as: E00001
            Therapeutic category: 5100
COMMENT     Ranunculaceae (buttercup family) Coptis rhizome
            Major component: Berberine [CPD:C00757]
INTERACTION  
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             5  Crude drugs and Chinese medicine formulations
              51  Crude drugs
               510  Crude drugs
                5100  Crude drugs
                 D00092  Coptis rhizome (JP16); Powdered coptis rhizome (JP16)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for digestive organs
              11 Stomachics
               D00092  Coptis rhizome (JP16); Powdered coptis rhizome (JP16)
              14 Two or more combinations from antacids, stomachics, digestives, and intestinal regulators
               D00092  Coptis rhizome (JP16); Powdered coptis rhizome (JP16)
              -- Gastrointestinal agents (oral solution)
               D00092  Coptis rhizome (JP16); Powdered coptis rhizome (JP16)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 2
              Crude drugs
               Coptis rhizome
                D00092  Coptis rhizome (JP16); Powdered coptis rhizome (JP16)
             Category 3
              Crude drugs
               Coptis rhizome
                D00092  Coptis rhizome (JP16); Powdered coptis rhizome (JP16)
            Pharmaceutical additives [BR:br08316]
             Flavoring substance
              D00092  [001183] Coptis rhizome
              D00092  [001183] Powdered coptis rhizome
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Crude drugs
              D00092  Coptis rhizome
              D00092  Powdered coptis rhizome
            Traditional Chinese Medicine in Japan [BR:br08304]
             Crude Drugs
              Drugs for clearing heat
               Drugs for clearing heat
                D00092 *Coptis rhizome; Powdered coptis rhizome; Coptis rhizome
              Stomachic and antidiarrheal drugs
               Stomachic and antidiarrheal drugs
                D00092 *Coptis rhizome; Powdered coptis rhizome; Coptis rhizome
              Drugs for external use
               Drugs for external use
                D00092 *Coptis rhizome; Powdered coptis rhizome; Coptis rhizome
            Crude drugs [BR:br08305]
             Dicot plants: others
              Ranunculaceae (buttercup family)
               D00092  Coptis rhizome
            Phytochemicals used as drugs [BR:br08306]
             Alkaloids
              Alkaloids derived from tyrosine
               Isoquinoline alkaloids
                D00092  Coptis rhizome (JP15)
DBLINKS     PubChem: 7847160
///
ENTRY       D00093                      Drug
NAME        Microcrystalline cellulose (JP16);
            Cellulose, microcrystalline (NF);
            Avicel PH (TN)
FORMULA     (C6H10O5)n
ACTIVITY    Pharmaceutic aid [tablet and capsule diluent]
REMARK      Same as: C00760 G10481
BRITE       Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Cellulose
                D00093  Microcrystalline cellulose (JP16); Cellulose, microcrystalline (NF)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00093  [002235] Microcrystalline cellulose
             Lubricating agent
              D00093  [002235] Microcrystalline cellulose
             Base
              D00093  [002235] Microcrystalline cellulose
             Adsorbent
              D00093  [002235] Microcrystalline cellulose
             Bonding agent
              D00093  [002235] Microcrystalline cellulose
             Suspending agent
              D00093  [002235] Microcrystalline cellulose
             Coating agent
              D00093  [002235] Microcrystalline cellulose
             Sugarcoated agent
              D00093  [002235] Microcrystalline cellulose
             Flexibilizer
              D00093  [002235] Microcrystalline cellulose
             Diluting agent
              D00093  [002235] Microcrystalline cellulose
              D00093  [999999] Microcrystalline cellulose (corpuscle)
              D00093  [110913] Microcrystalline cellulose spheres
              D00093  [110538] Powdered cellulose
             Dispersant
              D00093  [002235] Microcrystalline cellulose
             Disintegrant
              D00093  [002235] Microcrystalline cellulose
             Disintegrating adjuvant
              D00093  [002235] Microcrystalline cellulose
             Fluidizer
              D00093  [002235] Microcrystalline cellulose
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00093  Microcrystalline cellulose
DBLINKS     CAS: 9004-34-6
            PubChem: 7847161
            NIKKAJI: J203.734C J335.626D
ATOM        13
            1   C1y C     8.1200  -15.3300
            2   C1x C     8.1200  -16.7300
            3   C1y C     9.3324  -17.4300
            4   C1y C    10.5449  -16.7300
            5   C1y C    10.5449  -15.3300
            6   O2x O     9.3324  -14.6300
            7   C1b C     6.9076  -14.6300
            8   O1a O    11.7760  -14.6190
            9   O1a O     9.3324  -18.8298
            10  O1a O    11.7760  -17.4410
            11  Z   *     2.9876  -18.6900
            12  O1a O     5.7121  -15.3204
            13  Z   *    14.5912  -16.1547
BOND        13
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     1   7 1 #Up
            8     5   8 1 #Up
            9     3   9 1 #Up
            10    4  10 1 #Down
            11    2  11 1 #Down
            12    7  12 1
            13    8  13 1
BRACKET     1     4.5500  -19.2500    4.5500  -13.9300
            1    13.3000  -13.9300   13.3000  -19.2500
            1  n
  ORIGINAL  1    1   2   3   4   5   6   7   8   9  10  12
  REPEAT    1 
///
ENTRY       D00094                      Drug
NAME        Tretinoin (JAN/USP/INN);
            Avita (TN);
            Renova (TN);
            Retin A (TN);
            Tretinoin (TN);
            Vesanoid (TN)
FORMULA     C20H28O2
EXACT_MASS  300.2089
MOL_WEIGHT  300.4351
ACTIVITY    Keratolytic, Treatment of acute promyelocytic leukemia
REMARK      Same as: C00777
            Therapeutic category: 4291
            ATC code: D10AD01 L01XX14
            Drug group: DG00433
COMMENT     Retinoic acid
TARGET      retinoic acid receptor (RAR) agonist [HSA:5914 5915 5916] [KO:K08527 K08528 K08529]
INTERACTION Genomic biomarker: PML-RARA [HSA:5371 5914]
STR_MAP     map07223  Retinoic acid receptor (RAR) and retinoid X receptor (RXR) agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D10 ANTI-ACNE PREPARATIONS
               D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE
                D10AD Retinoids for topical use in acne
                 D10AD01 Tretinoin
                  D00094  Tretinoin (JAN/USP/INN)
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XX Other antineoplastic agents
                 L01XX14 Tretinoin
                  D00094  Tretinoin (JAN/USP/INN)
            USP drug classification [BR:br08302]
             Antineoplastics
              Retinoids
               Tretinoin
                D00094  Tretinoin (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D00094  Tretinoin (JAN/USP/INN)
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Thyroid hormone like receptors
               Retinoic acid receptor (RAR)
                retinoic acid receptor
                 Tretinoin
                  D00094  Tretinoin (JAN/USP/INN)
            Antineoplastics [BR:br08308]
             Molecularly targeted agents
              Retinoic acid receptor expression modification
               Tretinoin
                D00094  Tretinoin (JAN/USP/INN)
DBLINKS     CAS: 302-79-4
            PubChem: 7847162
            DrugBank: DB00755
            LigandBox: D00094
            NIKKAJI: J1.518K
ATOM        22
            1   C1x C    14.4200  -19.8100
            2   C1x C    14.4200  -21.2100
            3   C1x C    15.6324  -21.9100
            4   C2y C    16.8449  -21.2100
            5   C2y C    16.8449  -19.8100
            6   C1z C    15.6324  -19.1100
            7   C1a C    16.4540  -17.9930
            8   C1a C    14.6889  -18.0557
            9   C1a C    18.0760  -21.9210
            10  C2b C    18.0760  -19.0990
            11  C2b C    19.2812  -19.7947
            12  C2c C    20.4635  -19.1119
            13  C2b C    21.6575  -19.8012
            14  C1a C    20.4635  -17.7102
            15  C2b C    22.8454  -19.1152
            16  C2b C    24.0365  -19.8029
            17  C2c C    25.2259  -19.1161
            18  C2b C    26.4162  -19.8034
            19  C6a C    27.6061  -19.1163
            20  O6a O    28.7962  -19.8035
            21  C1a C    25.2260  -17.7102
            22  O6a O    27.6061  -17.7102
BOND        22
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 2
            5     5   6 1
            6     1   6 1
            7     6   7 1
            8     6   8 1
            9     4   9 1
            10    5  10 1
            11   10  11 2
            12   11  12 1
            13   12  13 2
            14   12  14 1
            15   13  15 1
            16   15  16 2
            17   16  17 1
            18   17  18 2
            19   18  19 1
            20   19  20 1
            21   17  21 1
            22   19  22 2
///
ENTRY       D00095                      Drug
NAME        Adrenaline (JP16);
            Epinephrine (USP/INN);
            Adrenalin (TN);
            Auvi-q (TN);
            Epipen (TN)
FORMULA     C9H13NO3
EXACT_MASS  183.0895
MOL_WEIGHT  183.2044
ACTIVITY    Adrenergic [vasoconstrictor]
REMARK      Same as: C00788
            Therapeutic category: 2451
            ATC code: A01AD01 B02BC09 C01CA24 R01AA14 R03AA01 S01EA01
            Drug group: DG00013
TARGET      alpha1-adrenergic receptor agonist [HSA:146 147 148] [KO:K04137 K04136 K04135];
            alpha2-adrenergic receptor agonist [HSA:150 151 152] [KO:K04138 K04139 K04140];
            beta1-adrenergic receptor agonist [HSA:153] [KO:K04141];
            beta2-adrenergic receptor agonist [HSA:154] [KO:K04142];
            beta3-adrenergic receptor agonist [HSA:155] [KO:K04143]
  PATHWAY   hsa04020(146+147+148+153+154+155)  Calcium signaling pathway
            hsa04080(146+147+148+150+151+152+153+154+155)  Neuroactive ligand-receptor interaction
            hsa04144(153+154+155)  Endocytosis
            hsa04261(146+147+148+153+154)  Adrenergic signaling in cardiomyocytes
            hsa04270(146+147+148)  Vascular smooth muscle contraction
            hsa04540(153)  Gap junction
            hsa04970(146+147+148+153+154+155)  Salivary secretion
METABOLISM  Enzyme: COMT [HSA:1312], MAO [HSA:4128 4129]
INTERACTION  
STR_MAP     map07214  beta-Adrenergic receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A01 STOMATOLOGICAL PREPARATIONS
               A01A STOMATOLOGICAL PREPARATIONS
                A01AD Other agents for local oral treatment
                 A01AD01 Epinephrine
                  D00095  Adrenaline (JP16); Epinephrine (USP/INN)
             B BLOOD AND BLOOD FORMING ORGANS
              B02 ANTIHEMORRHAGICS
               B02B VITAMIN K AND OTHER HEMOSTATICS
                B02BC Local hemostatics
                 B02BC09 Epinephrine
                  D00095  Adrenaline (JP16); Epinephrine (USP/INN)
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
                C01CA Adrenergic and dopaminergic agents
                 C01CA24 Epinephrine
                  D00095  Adrenaline (JP16); Epinephrine (USP/INN)
             R RESPIRATORY SYSTEM
              R01 NASAL PREPARATIONS
               R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
                R01AA Sympathomimetics, plain
                 R01AA14 Epinephrine
                  D00095  Adrenaline (JP16); Epinephrine (USP/INN)
              R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
               R03A ADRENERGICS, INHALANTS
                R03AA Alpha- and beta-adrenoreceptor agonists
                 R03AA01 Epinephrine
                  D00095  Adrenaline (JP16); Epinephrine (USP/INN)
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
                S01EA Sympathomimetics in glaucoma therapy
                 S01EA01 Epinephrine
                  D00095  Adrenaline (JP16); Epinephrine (USP/INN)
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Bronchodilators, Sympathomimetic
               Epinephrine
                D00095  Adrenaline (JP16); Epinephrine (USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               245  Adrenal hormone preparations
                2451  Epinephrines
                 D00095  Adrenaline (JP16); Epinephrine (USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 2
              Inorganic and organic chemicals
               Adrenaline (Epinephrine)
                D00095  Adrenaline (JP16); Epinephrine (USP/INN)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                alpha1-adrenergic receptor
                 Epinephrine
                  D00095  Epinephrine (USP/INN)
                alpha2-adrenergic receptor
                 Epinephrine
                  D00095  Epinephrine (USP/INN)
                beta1-adrenergic receptor
                 Epinephrine
                  D00095  Epinephrine (USP/INN)
                beta2-adrenergic receptor
                 Epinephrine
                  D00095  Epinephrine (USP/INN)
                beta3-adrenergic receptor
                 Epinephrine
                  D00095  Epinephrine (USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00095  Adrenaline
              D00095  Adrenaline solution
              D00095  Adrenaline injection
DBLINKS     CAS: 51-43-4
            PubChem: 7847163
            DrugBank: DB00668
            PDB-CCD: ALE
            LigandBox: D00095
            NIKKAJI: J9.224J
ATOM        13
            1   C8y C    21.2028  -17.0133
            2   C8x C    21.2028  -18.4284
            3   C8x C    19.9857  -16.3144
            4   C1c C    22.4083  -16.3144
            5   C8x C    19.9857  -19.1389
            6   C8y C    18.7742  -17.0133
            7   C1b C    23.6196  -17.0075
            8   O1a O    22.4083  -14.9168
            9   C8y C    18.7742  -18.4284
            10  N1b N    24.8191  -16.3087
            11  O1a O    17.5630  -19.1156
            12  O1a O    17.5677  -16.3165
            13  C1a C    26.0284  -17.0006
BOND        13
            1     1   3 1
            2     1   4 1
            3     2   5 1
            4     3   6 2
            5     4   7 1
            6     4   8 1 #Up
            7     5   9 2
            8     7  10 1
            9     9  11 1
            10    6   9 1
            11    6  12 1
            12    1   2 2
            13   10  13 1
///
ENTRY       D00096                      Drug
NAME        D-Sorbitol (JP16);
            Sorbitol (NF);
            Sorbitol 3% in plastic container (TN)
FORMULA     C6H14O6
EXACT_MASS  182.079
MOL_WEIGHT  182.1718
ACTIVITY    Pharmaceutic aid [flavor];
            Pharmaceutic aid [tablet excipient]
REMARK      Same as: C00794
            Therapeutic category: 2519 7990
            ATC code: A06AD18 A06AG07 B05CX02 V04CC01
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A06 DRUGS FOR CONSTIPATION
               A06A DRUGS FOR CONSTIPATION
                A06AD Osmotically acting laxatives
                 A06AD18 Sorbitol
                  D00096  D-Sorbitol (JP16); Sorbitol (NF)
                A06AG Enemas
                 A06AG07 Sorbitol
                  D00096  D-Sorbitol (JP16); Sorbitol (NF)
             B BLOOD AND BLOOD FORMING ORGANS
              B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
               B05C IRRIGATING SOLUTIONS
                B05CX Other irrigating solutions
                 B05CX02 Sorbitol
                  D00096  D-Sorbitol (JP16); Sorbitol (NF)
             V VARIOUS
              V04 DIAGNOSTIC AGENTS
               V04C OTHER DIAGNOSTIC AGENTS
                V04CC Tests for bile duct patency
                 V04CC01 Sorbitol
                  D00096  D-Sorbitol (JP16); Sorbitol (NF)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              25  Urogenital and anal organ agents
               251  Urinary organ agents
                2519  Others
                 D00096  D-Sorbitol (JP16); Sorbitol (NF)
             7  Agents not mainly for therapeutic purpose
              79  Other agents not mainly for therapeutic purpose
               799  Miscellaneous
                7990  Miscellaneous
                 D00096  D-Sorbitol (JP16); Sorbitol (NF)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               D-Sorbitol
                D00096  D-Sorbitol (JP16); Sorbitol (NF)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00096  [002244] D-Sorbitol
              D00096  [002245] D-Sorbitol solution
             Plasticizer
              D00096  [002244] D-Sorbitol
             Sweetening agent
              D00096  [002244] D-Sorbitol
              D00096  [002245] D-Sorbitol solution
             Base
              D00096  [002244] D-Sorbitol
              D00096  [002245] D-Sorbitol solution
             Flavoring substance
              D00096  [002244] D-Sorbitol
              D00096  [002245] D-Sorbitol solution
             Bonding agent
              D00096  [002244] D-Sorbitol
             Suspending agent
              D00096  [002244] D-Sorbitol
             Coating agent
              D00096  [002244] D-Sorbitol
              D00096  [002245] D-Sorbitol solution
             Film
              D00096  [002244] D-Sorbitol
             Wetting agent
              D00096  [002244] D-Sorbitol
              D00096  [002245] D-Sorbitol solution
             Tonicity agent
              D00096  [002244] D-Sorbitol
              D00096  [002245] D-Sorbitol solution
             Emulsion
              D00096  [002244] D-Sorbitol
             Tenacious agent
              D00096  [002245] D-Sorbitol solution
             Diluting agent
              D00096  [002244] D-Sorbitol
              D00096  [002245] D-Sorbitol solution
             Dispersant
              D00096  [002244] D-Sorbitol
             Preserving agent
              D00096  [002244] D-Sorbitol
             Solubilization agent
              D00096  [002244] D-Sorbitol
              D00096  [002245] D-Sorbitol solution
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00096  D-Sorbitol
              D00096  D-Sorbitol solution
DBLINKS     CAS: 50-70-4
            PubChem: 7847164
            DrugBank: DB01638
            LigandBox: D00096
            NIKKAJI: J2.299C
ATOM        12
            1   C1b C    24.2105  -29.3356
            2   C1c C    25.4311  -30.0404
            3   O1a O    22.9898  -30.0404
            4   C1c C    26.6348  -29.3452
            5   C1c C    27.8303  -30.0354
            6   C1c C    29.0296  -29.3427
            7   C1b C    30.2273  -30.0341
            8   O1a O    31.4255  -29.3421
            9   O1a O    29.0296  -27.9262
            10  O1a O    26.6349  -27.9262
            11  O1a O    27.8305  -31.4497
            12  O1a O    25.4312  -31.4497
BOND        11
            1     1   2 1
            2     1   3 1
            3     2   4 1
            4     4   5 1
            5     5   6 1
            6     6   7 1
            7     7   8 1
            8     6   9 1 #Down
            9     4  10 1 #Up
            10    5  11 1 #Up
            11    2  12 1 #Up
///
ENTRY       D00097                      Drug
NAME        Salicylic acid (JP16/USP);
            Salicylic acid (TN)
FORMULA     C7H6O3
EXACT_MASS  138.0317
MOL_WEIGHT  138.1207
ACTIVITY    Keratolytic
REMARK      Same as: C00805
            Therapeutic category: 2652 2661
            ATC code: D01AE12 S01BC08
INTERACTION Transporter inhibition: OAT2 [HSA:10864]
STR_MAP     map07110  Benzoic acid family
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D01 ANTIFUNGALS FOR DERMATOLOGICAL USE
               D01A ANTIFUNGALS FOR TOPICAL USE
                D01AE Other antifungals for topical use
                 D01AE12 Salicylic acid
                  D00097  Salicylic acid (JP16/USP)
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01B ANTIINFLAMMATORY AGENTS
                S01BC Antiinflammatory agents, non-steroids
                 S01BC08 Salicylic acid
                  D00097  Salicylic acid (JP16/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               265  Antiparasitic dermatosis agents
                2652  Salicylic acids for external use
                 D00097  Salicylic acid (JP16/USP)
               266  Emollients
                2661  Organic acids
                 D00097  Salicylic acid (JP16/USP)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for integumentary system
              56 Purulent skin remedies
               D00097  Salicylic acid (JP16/USP)
              58 Ringworm drugs
               D00097  Salicylic acid (JP16/USP)
              59 Skin emollient (incl. pus extrusion)
               D00097  Salicylic acid (JP16/USP)
              -- Corn,  callus and verruca remedies
               D00097  Salicylic acid (JP16/USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Specified Category 2
              Inorganic and organic chemicals
               Salicylic acid
                D00097  Salicylic acid (JP16/USP)
             Category 2
              Inorganic and organic chemicals
               Salicylic acid
                D00097  Salicylic acid (JP16/USP)
            Pharmaceutical additives [BR:br08316]
             Antiseptic agent
              D00097  [001274] Salicylic acid
             Preserving agent
              D00097  [001274] Salicylic acid
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00097  Salicylic acid
              D00097  Salicylic acid spirit
DBLINKS     CAS: 69-72-7
            PubChem: 7847165
            DrugBank: DB00936
            LigandBox: D00097
            NIKKAJI: J2.370A
ATOM        10
            1   C8y C    25.1668  -17.0718
            2   C8y C    26.3896  -17.7698
            3   C8x C    23.9631  -17.7698
            4   C6a C    25.2303  -15.6826
            5   C8x C    26.3896  -19.1783
            6   O1a O    27.5933  -17.0718
            7   C8x C    23.9631  -19.1783
            8   O6a O    26.4403  -14.9847
            9   O6a O    24.0202  -14.9910
            10  C8x C    25.1668  -19.8890
BOND        10
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     4   8 1
            8     4   9 2
            9     5  10 1
            10    7  10 2
///
ENTRY       D00098                      Drug
NAME        dl-Camphor (JP16);
            Camphor (USP)
FORMULA     C10H16O
EXACT_MASS  152.1201
MOL_WEIGHT  152.2334
ACTIVITY    Antipruritic
REMARK      Same as: C18369
            Therapeutic category: 2645
            ATC code: C01EB02
            Drug group: DG00240
COMMENT     Component of Sulfur and comphor [DR:D04811]
TARGET      transient receptor potential cation channel subfamily A member 1 (TRPA1) agonist [HSA:8989] [KO:K04984]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01E OTHER CARDIAC PREPARATIONS
                C01EB Other cardiac preparations
                 C01EB02 Camphora
                  D00098  dl-Camphor (JP16); Camphor (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               264  Analgesics, anti-itchings, astringents, anti-inflammatory agents
                2645  Peppermint rubber and camphor peppermint
                 D00098  dl-Camphor (JP16); Camphor (USP)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for nervous and sensory systems
              02 Cold remedy (external use)
               D00098  dl-Camphor (JP16); Camphor (USP)
             Agents for integumentary system
              56 Purulent skin remedies
               D00098  dl-Camphor (JP16); Camphor (USP)
              57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
               D00098  dl-Camphor (JP16); Camphor (USP)
              -- Analgesic and anti-inflammatory remedies (patches)
               D00098  dl-Camphor (JP16); Camphor (USP)
              -- Analgesic and anti-inflammatory remedies (embrocations)
               D00098  dl-Camphor (JP16); Camphor (USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               dl-Camphor
                D00098  dl-Camphor (JP16); Camphor (USP)
            Pharmaceutical additives [BR:br08316]
             Flavoring substance
              D00098  [001209] dl-Camphor
             Algefacient
              D00098  [001209] dl-Camphor
             Favoring agent, Fragrance
              D00098  [001209] dl-Camphor
             Refresher
              D00098  [001209] dl-Camphor
             Antiseptic agent
              D00098  [001209] dl-Camphor
             Solubilizer
              D00098  [001209] dl-Camphor
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Related to voltage-gated cation channels
               Transient receptor potential family, TRPA (ANKTM1)
                transient receptor potential cation channel, subfamily A, member 1 TRPA1
                 Camphora
                  D00098  dl-Camphor (JP16); Camphor (USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00098  dl-Camphor
            Phytochemicals used as drugs [BR:br08306]
             Terpenoids
              Monoterpenoids (C10)
               D00098  dl-Camphor (JP15)
DBLINKS     CAS: 76-22-2
            PubChem: 7847166
            DrugBank: DB01744
            LigandBox: D00098
            NIKKAJI: J4.364H
ATOM        11
            1   C1z C    25.7158  -15.5316
            2   C1z C    26.4015  -14.2900
            3   C5x C    24.4226  -16.2173
            4   C1x C    27.2182  -15.7933
            5   C1y C    26.4015  -16.6882
            6   C1x C    25.1083  -17.6356
            7   C1x C    27.9495  -17.1193
            8   C1a C    24.7261  -14.5246
            9   C1a C    27.3914  -13.3001
            10  C1a C    25.4116  -13.3001
            11  O5x O    23.1056  -15.7862
BOND        12
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 1
            6     4   7 1
            7     5   6 1
            8     5   7 1
            9     1   8 1
            10    2   9 1
            11    2  10 1
            12    3  11 2
///
ENTRY       D00099                      Drug
NAME        Cetanol (JP16);
            Cetyl alcohol (NF);
            Cetanol (TN)
FORMULA     C16H34O
EXACT_MASS  242.261
MOL_WEIGHT  242.4406
ACTIVITY    Pharmaceutic aid [emulsifying and stiffening agent]
REMARK      Same as: C00823
COMMENT     Component of Absorptive ointment [DR:D05354]
BRITE       Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00099  [002229] Cetanol
             Surfactant
              D00099  [002229] Cetanol
             Lubricating agent
              D00099  [002229] Cetanol
             Base
              D00099  [002229] Cetanol
             Bonding agent
              D00099  [002229] Cetanol
             Suspending agent
              D00099  [002229] Cetanol
             Brightening agent
              D00099  [002229] Cetanol
             Coating agent
              D00099  [002229] Cetanol
             Emulsion
              D00099  [002229] Cetanol
             Tenacious agent
              D00099  [002229] Cetanol
             Diluting agent
              D00099  [002229] Cetanol
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00099  Cetanol
DBLINKS     CAS: 36653-82-4
            PubChem: 7847167
            LigandBox: D00099
            NIKKAJI: J3.499A
ATOM        17
            1   C1a C    31.7939  -16.2881
            2   C1b C    33.0096  -15.5869
            3   C1b C    34.3589  -16.2881
            4   C1b C    35.5746  -15.5869
            5   O1a O    36.7840  -16.2881
            6   C1b C    33.0096  -15.5869
            7   C1b C    34.3589  -16.2881
            8   C1b C    33.0096  -15.5869
            9   C1b C    34.3589  -16.2881
            10  C1b C    33.0096  -15.5869
            11  C1b C    34.3589  -16.2881
            12  C1b C    33.0096  -15.5869
            13  C1b C    34.3589  -16.2881
            14  C1b C    33.0096  -15.5869
            15  C1b C    34.3589  -16.2881
            16  C1b C    33.0096  -15.5869
            17  C1b C    34.3589  -16.2881
BOND        16
            1     4   5 1
            2     1   2 1
            3     2   3 1
            4     3   6 1
            5     6   7 1
            6     7   8 1
            7     8   9 1
            8     9  10 1
            9    10  11 1
            10   11  12 1
            11   12  13 1
            12   13  14 1
            13   14  15 1
            14   15  16 1
            15   16  17 1
            16   17   4 1
BRACKET     1    32.9700  -16.8700   32.9700  -15.2600
            1    34.7900  -15.2600   34.7900  -16.8700
            1  7
  ORIGINAL  1    2   3
  REPEAT    1    6   7   8   9  10  11  12  13  14  15  16  17
///
ENTRY       D00100                      Drug
NAME        Menatetrenone (JP16/INN);
            Vitamin K2 (TN)
FORMULA     C31H40O2
EXACT_MASS  444.3028
MOL_WEIGHT  444.6481
ACTIVITY    Hemostatics
REMARK      Therapeutic category: 3160
INTERACTION  
STR_MAP     map07047  Osteoporosis drugs
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              31  Vitamins
               316  Vitamin K preparations
                3160  Vitamin K preparations
                 D00100  Menatetrenone (JP16/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00100  Menatetrenone
DBLINKS     CAS: 863-61-6
            PubChem: 7847168
            LigandBox: D00100
            NIKKAJI: J3.341C
ATOM        33
            1   C8x C     9.3800  -17.6400
            2   C8x C     9.3800  -19.0400
            3   C8x C    10.5924  -19.7400
            4   C8y C    11.8049  -19.0400
            5   C8y C    11.8049  -17.6400
            6   C8x C    10.5924  -16.9400
            7   C5x C    13.0173  -19.7400
            8   C2y C    14.2297  -19.0400
            9   C2y C    14.2297  -17.6400
            10  C5x C    13.0173  -16.9400
            11  C1b C    15.4224  -19.7400
            12  C2b C    16.6349  -19.0400
            13  C2c C    17.8473  -19.7400
            14  C1b C    19.0597  -19.0400
            15  C1b C    20.2722  -19.7400
            16  C2b C    21.4846  -19.0400
            17  C2c C    22.6970  -19.7400
            18  C1a C    23.9095  -19.0400
            19  O5x O    13.0173  -15.5400
            20  O5x O    13.0173  -21.1400
            21  C1a C    17.8473  -21.1400
            22  C1a C    15.4273  -16.9485
            23  C1a C    22.6970  -21.1399
            24  C1b C    15.4224  -19.7400
            25  C2b C    16.6349  -19.0400
            26  C2c C    17.8473  -19.7400
            27  C1b C    19.0597  -19.0400
            28  C1a C    17.8473  -21.1400
            29  C1b C    15.4224  -19.7400
            30  C2b C    16.6349  -19.0400
            31  C2c C    17.8473  -19.7400
            32  C1b C    19.0597  -19.0400
            33  C1a C    17.8473  -21.1400
BOND        34
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 2
            10    9  10 1
            11    5  10 1
            12   15  16 1
            13   16  17 2
            14   17  18 1
            15   10  19 2
            16    7  20 2
            17    9  22 1
            18   17  23 1
            19    8  11 1
            20   11  12 1
            21   12  13 2
            22   13  14 1
            23   13  21 1
            24   14  24 1
            25   24  25 1
            26   25  26 2
            27   26  27 1
            28   26  28 1
            29   27  29 1
            30   29  30 1
            31   30  31 2
            32   31  32 1
            33   31  33 1
            34   32  15 1
BRACKET     1    15.1900  -21.9800   15.1900  -18.8300
            1    19.3900  -18.8300   19.3900  -21.9800
            1  3
  ORIGINAL  1   11  12  13  14  21
  REPEAT    1   24  25  26  27  28  29  30  31  32  33
///
ENTRY       D00101                      Drug
NAME        Vasopressin (JP16/USP);
            Pitressin (TN)
FORMULA     (C46H65N15O12S2)m. (C46H65N13O12S2)n
ACTIVITY    Hormone [antidiuretic] [DS:H00253]
REMARK      Same as: C00840
            Therapeutic category: 2414
            ATC code: H01BA01
            Drug group: DG00496
COMMENT     Components: Argipressin tannate [DR:D02983], Lypressin [DR:D00366]
TARGET      arginine vasopressin receptor 1A (AVPR1A) agonist [HSA:552] [KO:K04226];
            arginine vasopressin receptor 1B (AVPR1B) agonist [HSA:553] [KO:K04227];
            arginine vasopressin receptor 2 (AVPR2) agonist [HSA:554] [KO:K04228]
  PATHWAY   hsa04020(552+553)  Calcium signaling pathway
            hsa04080(552+553+554)  Neuroactive ligand-receptor interaction
            hsa04270(552+553)  Vascular smooth muscle contraction
            hsa04962(554)  Vasopressin-regulated water reabsorption
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
               H01B POSTERIOR PITUITARY LOBE HORMONES
                H01BA Vasopressin and analogues
                 H01BA01 Vasopressin
                  D00101  Vasopressin (JP16/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               241  Pituitary hormone preparations
                2414  Posterior pituitary hormones
                 D00101  Vasopressin (JP16/USP)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Vasopressin
                arginine vasopressin receptor 1A (AVPR1A)
                 Vasopressin
                  D00101  Vasopressin (JP16/USP)
                arginine vasopressin receptor 1B (AVPR1B)
                 Vasopressin
                  D00101  Vasopressin (JP16/USP)
                arginine vasopressin receptor 2 (AVPR2)
                 Vasopressin
                  D00101  Vasopressin (JP16/USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00101  Vasopressin injection
DBLINKS     CAS: 11000-17-2
            PubChem: 7847169
            DrugBank: DB00067
            LigandBox: D00101
            NIKKAJI: J356.271I
ATOM        148
            1   N1y N     6.3499  -21.3894
            2   C1y C     6.7690  -22.6470
            3   C5a C     6.3499  -20.1319
            4   C1x C     5.0225  -21.4593
            5   C5a C     7.8869  -23.3456
            6   C1x C     5.7211  -23.4854
            7   C1y C     7.4677  -19.4333
            8   O5a O     5.1622  -19.4333
            9   C1x C     4.6033  -22.7168
            10  N1b N     9.0047  -22.6470
            11  O5a O     7.8869  -24.6032
            12  N1x N     7.4677  -18.1058
            13  C1x C     8.5855  -20.1319
            14  C1c C    10.1924  -23.3456
            15  C5x C     8.5855  -17.4771
            16  S3x S     9.7733  -19.4333
            17  C5a C    10.1924  -24.6032
            18  C1b C    11.3102  -22.6470
            19  C1y C     8.5855  -16.1497
            20  O5x O     9.7733  -18.1058
            21  S3x S    10.8910  -20.1319
            22  N1b N    11.3102  -25.3019
            23  O5a O     9.0047  -25.3019
            24  C1b C    12.4281  -23.3456
            25  N1x N     7.4677  -15.4510
            26  C1b C     9.7733  -15.4510
            27  C1x C    12.0089  -19.4333
            28  C1b C    12.4281  -24.6032
            29  C1b C    13.6157  -22.6470
            30  C5x C     7.4677  -14.1934
            31  C5a C    10.8910  -16.1497
            32  C1y C    13.1965  -20.1319
            33  N1b N    14.7336  -23.3456
            34  C1y C     9.4937  -13.4250
            35  O5x O     6.3499  -13.4949
            36  N1a N    12.0089  -15.4510
            37  O5a O    10.8910  -17.4771
            38  C5x C    14.3144  -19.4333
            39  N1a N    13.1965  -21.3894
            40  N1x N    11.3102  -14.1934
            41  C1b C     9.4937  -11.7482
            42  N1x N    15.4322  -20.1319
            43  O5x O    14.3144  -18.1058
            44  C5x C    13.1965  -13.4250
            45  C1b C     8.3760  -11.0496
            46  C1y C    16.6198  -19.4333
            47  C1y C    15.5021  -14.1934
            48  O5x O    13.1965  -12.0976
            49  C5a C     7.1882  -11.6784
            50  C1b C    17.7377  -20.1319
            51  C5x C    16.6198  -18.1058
            52  C1b C    16.7596  -13.4949
            53  N1x N    15.5021  -17.4771
            54  N1a N     6.0704  -11.0496
            55  O5a O     7.1882  -13.0058
            56  C8y C    18.8556  -19.4333
            57  O5x O    17.7377  -17.4771
            58  C8y C    17.9473  -14.1236
            59  C8x C    19.9733  -20.0620
            60  C8x C    18.8556  -18.1058
            61  C8x C    17.9473  -15.4510
            62  C8x C    19.0651  -13.4250
            63  C8x C    21.1610  -19.4333
            64  C8x C    19.9733  -17.4771
            65  C8x C    19.0651  -16.0798
            66  C8x C    20.1830  -14.1236
            67  C8y C    21.1610  -18.1058
            68  C8x C    20.1830  -15.4510
            69  O1a O    22.2789  -17.4771
            70  C2c C    15.9212  -22.5772
            71  N1a N    17.1788  -23.3456
            72  N2a N    15.9212  -21.2498
            73  C5a C    13.6856  -25.3716
            74  N1a N    14.8732  -24.6731
            75  O5a O    13.6856  -26.7689
            76  N1y N    28.1699  -21.0164
            77  C1y C    28.5903  -22.2778
            78  C5a C    28.1699  -19.7550
            79  C1x C    26.8383  -21.0865
            80  C5a C    29.7116  -22.9786
            81  C1x C    27.5391  -23.1188
            82  C1y C    29.2911  -19.0542
            83  O5a O    26.9785  -19.0542
            84  C1x C    26.4179  -22.3479
            85  N1b N    30.8329  -22.2778
            86  O5a O    29.7116  -24.2401
            87  N1x N    29.2911  -17.7227
            88  C1x C    30.4124  -19.7550
            89  C1c C    31.9542  -22.9786
            90  C5x C    30.4124  -17.0919
            91  S3x S    31.5337  -19.0542
            92  C5a C    31.9542  -24.2401
            93  C1b C    33.0754  -22.2778
            94  C1y C    30.4124  -15.8305
            95  O5x O    31.5337  -17.7227
            96  S3x S    32.6549  -19.7550
            97  N1b N    33.0754  -24.9409
            98  O5a O    30.8329  -24.9409
            99  C1b C    34.1967  -22.9786
            100 N1x N    29.2911  -15.1297
            101 C1b C    31.5337  -15.1297
            102 C1x C    33.7762  -19.0542
            103 C1b C    34.1967  -24.2401
            104 C1b C    35.3881  -22.2778
            105 C5x C    29.2911  -13.8683
            106 C5a C    32.6549  -15.8305
            107 C1y C    34.9676  -19.7550
            108 C1b C    36.5093  -22.9786
            109 C1y C    31.3234  -13.0974
            110 O5x O    28.1699  -13.1675
            111 N1a N    33.7762  -15.1297
            112 O5a O    32.6549  -17.0919
            113 C5x C    36.0888  -19.0542
            114 N1a N    34.9676  -21.0164
            115 N1x N    33.0754  -13.8683
            116 C1b C    31.3234  -11.4155
            117 N1x N    37.2101  -19.7550
            118 O5x O    36.0888  -17.7227
            119 C5x C    34.9676  -13.0974
            120 C1b C    30.2022  -10.7147
            121 C1y C    38.4015  -19.0542
            122 C1y C    37.2802  -13.8683
            123 O5x O    34.9676  -11.7659
            124 C5a C    29.0108  -11.3454
            125 C1b C    39.5228  -19.7550
            126 C5x C    38.4015  -17.7227
            127 C1b C    38.5416  -13.1675
            128 N1x N    37.2802  -17.0919
            129 N1a N    27.8895  -10.7147
            130 O5a O    29.0108  -12.6769
            131 C8y C    40.6440  -19.0542
            132 O5x O    39.5228  -17.0919
            133 C8y C    39.7330  -13.7982
            134 C8x C    41.7653  -19.6849
            135 C8x C    40.6440  -17.7227
            136 C8x C    39.7330  -15.1297
            137 C8x C    40.8543  -13.0974
            138 C8x C    42.9567  -19.0542
            139 C8x C    41.7653  -17.0919
            140 C8x C    40.8543  -15.7604
            141 C8x C    41.9755  -13.7982
            142 C8y C    42.9567  -17.7227
            143 C8x C    41.9755  -15.1297
            144 O1a O    44.0779  -17.0919
            145 N1a N    37.7007  -22.2078
            146 C5a C    35.4581  -25.0109
            147 N1a N    36.6495  -24.3101
            148 O5a O    35.4581  -26.4125
BOND        154
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 2
            8     4   9 1
            9     5  10 1
            10    5  11 2
            11    7  12 1
            12    7  13 1
            13   10  14 1
            14   12  15 1
            15   13  16 1
            16   14  17 1
            17   14  18 1
            18   15  19 1
            19   15  20 2
            20   16  21 1
            21   17  22 1
            22   17  23 2
            23   18  24 1
            24   19  25 1
            25   19  26 1
            26   21  27 1
            27   22  28 1
            28   24  29 1
            29   25  30 1
            30   26  31 1
            31   27  32 1
            32   29  33 1
            33   30  34 1
            34   30  35 2
            35   31  36 1
            36   31  37 2
            37   32  38 1
            38   32  39 1
            39   34  40 1
            40   34  41 1
            41   38  42 1
            42   38  43 2
            43   40  44 1
            44   41  45 1
            45   42  46 1
            46   44  47 1
            47   44  48 2
            48   45  49 1
            49   46  50 1
            50   46  51 1
            51   47  52 1
            52   47  53 1
            53   49  54 1
            54   49  55 2
            55   50  56 1
            56   51  57 2
            57   52  58 1
            58   56  59 2
            59   56  60 1
            60   58  61 2
            61   58  62 1
            62   59  63 1
            63   60  64 2
            64   61  65 1
            65   62  66 2
            66   63  67 2
            67   65  68 2
            68   67  69 1
            69    6   9 1
            70   51  53 1
            71   64  67 1
            72   66  68 1
            73   33  70 1
            74   70  71 1
            75   70  72 2
            76   28  73 1
            77   73  74 1
            78   73  75 2
            79   76  77 1
            80   76  78 1
            81   76  79 1
            82   77  80 1
            83   77  81 1
            84   78  82 1
            85   78  83 2
            86   79  84 1
            87   80  85 1
            88   80  86 2
            89   82  87 1
            90   82  88 1
            91   85  89 1
            92   87  90 1
            93   88  91 1
            94   89  92 1
            95   89  93 1
            96   90  94 1
            97   90  95 2
            98   91  96 1
            99   92  97 1
            100  92  98 2
            101  93  99 1
            102  94 100 1
            103  94 101 1
            104  96 102 1
            105  97 103 1
            106  99 104 1
            107 100 105 1
            108 101 106 1
            109 102 107 1
            110 104 108 1
            111 105 109 1
            112 105 110 2
            113 106 111 1
            114 106 112 2
            115 107 113 1
            116 107 114 1
            117 109 115 1
            118 109 116 1
            119 113 117 1
            120 113 118 2
            121 115 119 1
            122 116 120 1
            123 117 121 1
            124 119 122 1
            125 119 123 2
            126 120 124 1
            127 121 125 1
            128 121 126 1
            129 122 127 1
            130 122 128 1
            131 124 129 1
            132 124 130 2
            133 125 131 1
            134 126 132 2
            135 127 133 1
            136 131 134 2
            137 131 135 1
            138 133 136 2
            139 133 137 1
            140 134 138 1
            141 135 139 2
            142 136 140 1
            143 137 141 2
            144 138 142 2
            145 140 143 2
            146 142 144 1
            147  81  84 1
            148 126 128 1
            149 139 142 1
            150 141 143 1
            151 108 145 1
            152 103 146 1
            153 146 147 1
            154 146 148 2
BRACKET     1     3.9900  -27.4400    3.9900   -9.9400
            1    23.5900   -9.9400   23.5900  -27.4400
            1  m
  ORIGINAL  1    1   2   3   4   5   6   7   8   9  10  11  12  13  14  15  16
            1   17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32
            1   33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48
            1   49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64
            1   65  66  67  68  69  70  71  72  73  74  75
  REPEAT    1 
            2    25.6200  -27.3700   25.6200   -9.9400
            2    45.4300   -9.9400   45.4300  -27.3700
            2  n
  ORIGINAL  2   76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91
            2   92  93  94  95  96  97  98  99 100 101 102 103 104 105 106 107
            2  108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123
            2  124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139
            2  140 141 142 143 144 145 146 147 148
  REPEAT    2 
///
ENTRY       D00102                      Drug
NAME        Nitrous oxide (JP16/USP);
            Nitrous oxide (TN)
FORMULA     N2O
EXACT_MASS  44.0011
MOL_WEIGHT  44.0128
ACTIVITY    Anesthetic [inhalation]
REMARK      Same as: C00887
            Therapeutic category: 1116
            ATC code: N01AX13
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N01 ANESTHETICS
               N01A ANESTHETICS, GENERAL
                N01AX Other general anesthetics
                 N01AX13 Nitrous oxide
                  D00102  Nitrous oxide (JP16/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               111  General anesthetics
                1116  Nitrous oxides
                 D00102  Nitrous oxide (JP16/USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00102  Nitrous oxide
DBLINKS     CAS: 10024-97-2
            PubChem: 7847170
            LigandBox: D00102
            NIKKAJI: J98.245H
ATOM        3
            1   N0  N    25.0892  -17.0158 #+
            2   N2a N    23.6453  -17.0100 #-
            3   O3a O    26.4453  -17.0100
BOND        2
            1     1   2 2
            2     1   3 2
///
ENTRY       D00103                      Drug
NAME        Tartaric acid (JP16/NF);
            Tartaric acid (TN)
FORMULA     C4H6O6
EXACT_MASS  150.0164
MOL_WEIGHT  150.0868
ACTIVITY    Pharmaceutic aid [buffering agent]
REMARK      Same as: C00898
            Therapeutic category: 7149
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             7  Agents not mainly for therapeutic purpose
              71  Dispensing medicines
               714  Flavorings, deodorants, coloring agents
                7149  Others
                 D00103  Tartaric acid (JP16/NF)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00103  [001325] Tartaric acid
             Solubilizing agent
              D00103  [001325] Tartaric acid
             Buffering agent
              D00103  [001325] Tartaric acid
             Base
              D00103  [001325] Tartaric acid
             Flavoring substance
              D00103  [001325] Tartaric acid
             Bloating agent
              D00103  [001325] Tartaric acid
             pH regulator
              D00103  [001325] Tartaric acid
             Diluting agent
              D00103  [001325] Tartaric acid
             Solubilizer
              D00103  [001325] Tartaric acid
             Solubilization agent
              D00103  [001325] Tartaric acid
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00103  Tartaric acid
DBLINKS     CAS: 87-69-4
            PubChem: 7847171
            LigandBox: D00103
            NIKKAJI: J31.839F
ATOM        10
            1   O6a O    14.1624  -12.0400
            2   C6a C    15.3749  -12.7400
            3   C1c C    16.5873  -12.0400
            4   C1c C    17.7997  -12.7400
            5   C6a C    19.0122  -12.0400
            6   O6a O    20.2246  -12.7400
            7   O6a O    15.3749  -14.1398
            8   O1a O    16.5873  -10.6400
            9   O1a O    17.7997  -14.1399
            10  O6a O    19.0122  -10.6403
BOND        9
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     2   7 2
            7     3   8 1 #Down
            8     4   9 1 #Down
            9     5  10 2
///
ENTRY       D00104                      Drug
NAME        Chloramphenicol (JP16/USP/INN);
            CP;
            Amphicol (TN);
            Chloromycetin (TN);
            Econochlor (TN)
FORMULA     C11H12Cl2N2O5
EXACT_MASS  322.0123
MOL_WEIGHT  323.1294
SOURCE      Streptomyces venezuelae [TAX:54571], Streptomyces omiyaensis [TAX:68247]
ACTIVITY    Antibacterial;
            Antirickettsial [DS:H00111 H00112 H00312 H00319 H00322 H00324 H00336]
REMARK      Same as: C00918
            Therapeutic category: 1317 1325 2521 2634 6151
            ATC code: D06AX02 D10AF03 G01AA05 J01BA01 S01AA01 S02AA01 S03AA08
            Drug group: DG00399
COMMENT     Natural product
TARGET      23S rRNA of 50S ribosomal subunit, protein synthesis inhibitor [KO:K01980]
  PATHWAY   ko03010(K01980)  Ribosome
METABOLISM  Enzyme: CYP2C19 [HSA:1557]
INTERACTION CYP inhibition: CYP2C19 [HSA:1557], CYP3A4 [HSA:1576], CYP3A5 [HSA:1577], CYP3A7 [HSA:1551]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
               D06A ANTIBIOTICS FOR TOPICAL USE
                D06AX Other antibiotics for topical use
                 D06AX02 Chloramphenicol
                  D00104  Chloramphenicol (JP16/USP/INN)
              D10 ANTI-ACNE PREPARATIONS
               D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE
                D10AF Antiinfectives for treatment of acne
                 D10AF03 Chloramphenicol
                  D00104  Chloramphenicol (JP16/USP/INN)
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
               G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
                G01AA Antibiotics
                 G01AA05 Chloramphenicol
                  D00104  Chloramphenicol (JP16/USP/INN)
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J01 ANTIBACTERIALS FOR SYSTEMIC USE
               J01B AMPHENICOLS
                J01BA Amphenicols
                 J01BA01 Chloramphenicol
                  D00104  Chloramphenicol (JP16/USP/INN)
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01A ANTIINFECTIVES
                S01AA Antibiotics
                 S01AA01 Chloramphenicol
                  D00104  Chloramphenicol (JP16/USP/INN)
              S02 OTOLOGICALS
               S02A ANTIINFECTIVES
                S02AA Antiinfectives
                 S02AA01 Chloramphenicol
                  D00104  Chloramphenicol (JP16/USP/INN)
              S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
               S03A ANTIINFECTIVES
                S03AA Antiinfectives
                 S03AA08 Chloramphenicol
                  D00104  Chloramphenicol (JP16/USP/INN)
            USP drug classification [BR:br08302]
             Antibacterials
              Antibacterials, Other
               Chloramphenicol
                D00104  Chloramphenicol (JP16/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1317  Ophthalmic antibiotics
                 D00104  Chloramphenicol (JP16/USP/INN)
               132  Otic and nasal agents
                1325  Otolaryngologic antibiotics
                 D00104  Chloramphenicol (JP16/USP/INN)
             2  Agents affecting individual organs
              25  Urogenital and anal organ agents
               252  Genital organ agents
                2521  Antibiotics
                 D00104  Chloramphenicol (JP16/USP/INN)
              26  Epidermides
               263  Suppurative dermatosis agents
                2634  Antibiotics for external use
                 D00104  Chloramphenicol (JP16/USP/INN)
             6  Agents against pathologic organisms and parasites
              61  Antibiotics
               615  Acting mainly on gram-positive bacteria, gram-negative bacteria, rickettsia and chlamydia
                6151  Chloramphenicols
                 D00104  Chloramphenicol (JP16/USP/INN)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for integumentary system
              56 Purulent skin remedies
               D00104  Chloramphenicol (JP16/USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 2
              Inorganic and organic chemicals
               Chloramphenicol
                D00104  Chloramphenicol (JP16/USP/INN)
            Antiinfectives [BR:br08307]
             Antibacterials
              Protein biosynthesis inhibitor
               23S rRNA of 50S ribosomal subunit inhibitor
                Amphenicols
                 Chloramphenicol
                  D00104  Chloramphenicol (JP16/USP/INN)
            Cytochrome P450 interactions [BR:br08309]
             Substrates
              CYP2C19
               Chloramphenicol
                D00104  Chloramphenicol (JP16/USP/INN)
              CYP3A4
               Chloramphenicol
                D00104  Chloramphenicol (JP16/USP/INN)
             Inhbitors
              CYP2C19
               Chloramphenicol
                D00104  Chloramphenicol (JP16/USP/INN)
              CYP3A4
               Chloramphenicol
                D00104  Chloramphenicol (JP16/USP/INN)
              CYP3A5
               Chloramphenicol
                D00104  Chloramphenicol (JP16/USP/INN)
              CYP3A7
               Chloramphenicol
                D00104  Chloramphenicol (JP16/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00104  Chloramphenicol
DBLINKS     CAS: 56-75-7
            PubChem: 7847172
            DrugBank: DB00446
            LigandBox: D00104
            NIKKAJI: J2.802I
ATOM        20
            1   C8y C    21.4200  -17.2900
            2   C1c C    21.4200  -18.6900
            3   C8x C    20.2300  -16.5900
            4   C8x C    22.6800  -16.5900
            5   C1c C    22.6100  -19.3900
            6   O1a O    20.2300  -19.3900
            7   C8x C    20.2300  -15.1900
            8   C8x C    22.6800  -15.1900
            9   N1b N    23.8700  -18.6900
            10  C1b C    22.6100  -20.7900
            11  C8y C    21.4200  -14.4900
            12  C5a C    25.0600  -19.3900
            13  O1a O    21.4200  -21.4900
            14  N2b N    21.4200  -13.0900 #+
            15  C1c C    26.2500  -18.6900
            16  O5a O    25.0600  -20.7900
            17  O3a O    20.2300  -12.3900
            18  O3a O    22.6100  -12.3900 #-
            19  X   Cl   27.5100  -19.3900
            20  X   Cl   26.2500  -17.2900
BOND        20
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 1
            5     2   6 1 #Down
            6     3   7 1
            7     4   8 2
            8     5   9 1
            9     5  10 1
            10    7  11 2
            11    9  12 1
            12   10  13 1
            13   11  14 1
            14   12  15 1
            15   12  16 2
            16   14  17 2
            17   14  18 1
            18   15  19 1
            19   15  20 1
            20    8  11 1
///
ENTRY       D00105                      Drug
NAME        Estradiol (JAN/USP/INN);
            Climara (TN);
            Divigel (TN);
            Estrace (TN);
            Estraderm (TN);
            Estrasorb (TN);
            Estring (TN);
            Estrogel (TN);
            Innofem (TN);
            Vagifem (TN);
            Vivelle (TN)
FORMULA     C18H24O2
EXACT_MASS  272.1776
MOL_WEIGHT  272.382
ACTIVITY    Estrogen
REMARK      Same as: C00951
            Therapeutic category: 2473
            ATC code: G03CA03
            Drug group: DG00462
TARGET      estrogen receptor 1 agonist [HSA:2099] [KO:K08550];
            estrogen receptor 2 agonist [HSA:2100] [KO:K08551]
  PATHWAY   hsa04961(2099)  Endocrine and other factor-regulated calcium reabsorption
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP1B1 [HSA:1545], CYP1A2 [HSA:1544]
INTERACTION  
STR_MAP     map07047  Osteoporosis drugs
            map07226  Progesterone, androgen and estrogen receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
               G03C ESTROGENS
                G03CA Natural and semisynthetic estrogens, plain
                 G03CA03 Estradiol
                  D00105  Estradiol (JAN/USP/INN)
            USP drug classification [BR:br08302]
             Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
              Estrogens
               Estradiol
                D00105  Estradiol (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               247  Estrogen and progesterone preparations
                2473  Estradiols
                 D00105  Estradiol (JAN/USP/INN)
            Classification of Japanese OTC drugs [BR:br08313]
             Drugs for women
              51 Other drugs for women
               D00105  Estradiol (JAN/USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Specified Category 2
              Inorganic and organic chemicals
               Estradiol
                D00105  Estradiol (JAN/USP/INN)
             Category 2
              Inorganic and organic chemicals
               Estradiol
                D00105  Estradiol (JAN/USP/INN)
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               Estrogen receptor
                estrogen receptor 1
                 Estradiol
                  D00105  Estradiol (JAN/USP/INN)
                estrogen receptor 2
                 Estradiol
                  D00105  Estradiol (JAN/USP/INN)
            Cytochrome P450 interactions [BR:br08309]
             Substrates
              CYP1A2
               Estradiol
                D00105  Estradiol (JAN/USP/INN)
              CYP1B1
               Estradiol
                D00105  Estradiol (JAN/USP/INN)
              CYP3A4
               Estradiol
                D00105  Estradiol (JAN/USP/INN)
DBLINKS     CAS: 50-28-2
            PubChem: 7847173
            DrugBank: DB00783
            LigandBox: D00105
            NIKKAJI: J4.100I
ATOM        20
            1   C8x C    19.0779  -11.8363
            2   C8y C    19.0779  -13.2006
            3   C8x C    20.2594  -13.8828
            4   C8y C    21.4411  -13.2006
            5   C8y C    21.4411  -11.8363
            6   C8x C    20.2594  -11.1541
            7   C1x C    22.6226  -13.8828
            8   C1x C    23.8041  -13.2006
            9   C1y C    23.8041  -11.8363
            10  C1y C    22.6226  -11.1541
            11  C1y C    24.9857  -11.1541
            12  C1z C    24.9857   -9.7898
            13  C1x C    23.8041   -9.1076
            14  C1x C    22.6226   -9.7898
            15  C1x C    27.3487  -11.1541
            16  C1x C    27.3487   -9.7898
            17  C1y C    26.1672   -9.1076
            18  O1a O    26.1672   -7.7433
            19  O1a O    17.8964  -13.8828
            20  C1a C    24.9857   -8.4255
BOND        23
            1     1   2 1
            2     2   3 2
            3     3   4 1
            4     4   5 2
            5     5   6 1
            6     1   6 2
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    9  11 1
            13   11  12 1
            14   12  13 1
            15   13  14 1
            16   10  14 1
            17   11  15 1
            18   15  16 1
            19   16  17 1
            20   12  17 1
            21   17  18 1 #Up
            22    2  19 1
            23   12  20 1 #Up
///
ENTRY       D00106                      Drug
NAME        Epoprostenol (USAN/INN);
            Prostaglandin I2;
            Prostacyclin;
            Epoprostenol (TN)
FORMULA     C20H32O5
EXACT_MASS  352.225
MOL_WEIGHT  352.4651
ACTIVITY    Inhibitor [platelet]
REMARK      Same as: C01312
            ATC code: B01AC09
            Drug group: DG00157
COMMENT     Eicosanoids
TARGET      prostaglandin I2 receptor agonist [HSA:5739] [KO:K04263]
  PATHWAY   hsa04080(5739)  Neuroactive ligand-receptor interaction
            hsa04270(5739)  Vascular smooth muscle contraction
INTERACTION  
STR_MAP     map07034  Eicosanoids
            map07049  Antithrombosis agents
            map07228  Eicosanoid receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AC Platelet aggregation inhibitors excl. heparin
                 B01AC09 Epoprostenol
                  D00106  Epoprostenol (USAN/INN)
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Pulmonary Antihypertensives
               Epoprostenol
                D00106  Epoprostenol (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Prostacyclin
                prostaglandin I2 receptor
                 Epoprostenol
                  D00106  Epoprostenol (USAN/INN)
DBLINKS     CAS: 35121-78-9
            PubChem: 7847174
            DrugBank: DB01240
            LigandBox: D00106
            NIKKAJI: J17.550A
ATOM        25
            1   C1y C    23.9400  -30.3100
            2   C1y C    22.6100  -29.8900
            3   C1y C    23.9400  -31.7100
            4   C1x C    24.6400  -29.0500
            5   O2x O    22.6100  -28.4200
            6   C1x C    21.8400  -31.0100
            7   C1y C    22.6800  -32.1300
            8   C2b C    25.1300  -32.4100
            9   C2y C    23.9400  -27.7900
            10  O1a O    22.1900  -33.4600
            11  C2b C    26.3200  -31.7100
            12  C2b C    25.1300  -27.0900
            13  C1c C    27.5100  -32.4100
            14  C1b C    28.7700  -31.7100
            15  O1a O    27.5100  -33.7400
            16  C1b C    29.9600  -32.4100
            17  C1b C    31.1500  -31.7100
            18  C1b C    32.3400  -32.4100
            19  C1a C    33.5300  -31.7100
            20  C1b C    25.2000  -25.6900
            21  C1b C    26.3900  -24.9900
            22  C1b C    26.3900  -23.5900
            23  C6a C    27.5800  -22.8900
            24  O6a O    28.8400  -23.5900
            25  O6a O    27.5800  -21.4900
BOND        26
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1 #Down
            5     2   6 1
            6     3   7 1
            7     3   8 1 #Up
            8     4   9 1
            9     7  10 1 #Down
            10    8  11 2
            11    9  12 2
            12   11  13 1
            13   13  14 1
            14   13  15 1 #Down
            15   14  16 1
            16   16  17 1
            17   17  18 1
            18   18  19 1
            19    5   9 1
            20    6   7 1
            21   12  20 1
            22   20  21 1
            23   21  22 1
            24   22  23 1
            25   23  24 2
            26   23  25 1
///
ENTRY       D00107                      Drug
NAME        Tacrolimus hydrate (JP16);
            Tacrolimus (USAN/INN);
            Prograf (TN);
            Protopic (TN)
FORMULA     C44H69NO12. H2O
EXACT_MASS  821.4925
MOL_WEIGHT  822.0334
SOURCE      Streptomyces tsukubaensis [TAX:83656]
ACTIVITY    Immunosuppressant [DS:H00083 H00084]
REMARK      Therapeutic category: 1319 2699 3999
            ATC code: D11AH01 L04AD02
            Drug group: DG00439
COMMENT     Macrolide
            Complex Tacrolimus and FK506 binding protein (FKBP12/12.6) [HSA:2280 2281] [KO:K09568] inhibit calcineurin.
TARGET      calcineurin inhibitor [HSA:5530 5532 5533 5534 5535 11261 63928] [KO:K04348 K06268 K17610 K17611]
  PATHWAY   hsa04660(11261+5530+5532+5533+5534+5535+63928)  T cell receptor signaling pathway
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07046  Immunosuppressive agents
            map07050  Antirheumatics - DMARDs and biological agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D11 OTHER DERMATOLOGICAL PREPARATIONS
               D11A OTHER DERMATOLOGICAL PREPARATIONS
                D11AH Agents for dermatitis, excluding corticosteroids
                 D11AH01 Tacrolimus
                  D00107  Tacrolimus hydrate (JP16); Tacrolimus (USAN/INN)
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AD Calcineurin inhibitors
                 L04AD02 Tacrolimus
                  D00107  Tacrolimus hydrate (JP16); Tacrolimus (USAN/INN)
            USP drug classification [BR:br08302]
             Dermatological Agents
              Tacrolimus
               D00107  Tacrolimus hydrate (JP16); Tacrolimus (USAN/INN)
             Immunological Agents
              Immune Suppressants
               Tacrolimus
                D00107  Tacrolimus hydrate (JP16); Tacrolimus (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1319  Others
                 D00107  Tacrolimus hydrate (JP16); Tacrolimus (USAN/INN)
             2  Agents affecting individual organs
              26  Epidermides
               269  Miscellaneous
                2699  Others
                 D00107  Tacrolimus hydrate (JP16); Tacrolimus (USAN/INN)
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D00107  Tacrolimus hydrate (JP16); Tacrolimus (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases
               calcineurin
                Tacrolimus
                 D00107  Tacrolimus (USAN/INN)
            Cytochrome P450 interactions [BR:br08309]
             Substrates
              CYP3A4
               Tacrolimus
                D00107  Tacrolimus hydrate (JP16); Tacrolimus (USAN/INN)
              CYP3A5
               Tacrolimus
                D00107  Tacrolimus hydrate (JP16); Tacrolimus (USAN/INN)
              CYP3A7
               Tacrolimus
                D00107  Tacrolimus hydrate (JP16); Tacrolimus (USAN/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00107  Tacrolimus hydrate
DBLINKS     CAS: 109581-93-3
            PubChem: 7847175
            DrugBank: DB00864
            LigandBox: D00107
            NIKKAJI: J1.629.005J
ATOM        58
            1   O0  O    31.6167  -21.2567
            2   C2c C    22.3300  -12.4600
            3   C2b C    22.3300  -11.0600
            4   C1y C    21.1400  -10.2900
            5   C1x C    21.1400   -8.8900
            6   C1x C    19.8800   -8.1900
            7   C1y C    18.6900   -8.8900
            8   C1y C    18.6900  -10.2900
            9   C1x C    19.8800  -11.0600
            10  O2a O    17.5000  -11.0600
            11  O1a O    17.5000   -8.1900
            12  C1a C    16.3100  -10.2900
            13  C1c C    23.5900  -13.1600
            14  C1a C    21.1400  -13.1600
            15  C1c C    24.7800  -12.4600
            16  C1c C    25.9700  -13.1600
            17  C1b C    25.9700  -14.5600
            18  C5a C    27.3000  -15.1200
            19  C1c C    27.9300  -16.4500
            20  C2b C    27.2300  -17.7100
            21  C2c C    25.9700  -18.4100
            22  C1a C    24.7800  -17.7100
            23  C1b C    25.9700  -19.8100
            24  C1c C    24.7800  -20.5100
            25  C1a C    23.5900  -19.8100
            26  C1b C    25.4800  -21.7000
            27  C1c C    24.5000  -22.8200
            28  C1y C    23.1700  -22.4000
            29  C1y C    22.1200  -23.4500
            30  C1x C    20.7900  -23.1000
            31  C1y C    20.4400  -21.7000
            32  C1z C    21.4200  -20.7200
            33  O2x O    22.8200  -21.0700
            34  O2a O    22.5400  -24.7800
            35  O2a O    24.8500  -24.1500
            36  C1a C    26.1800  -24.5700
            37  C1a C    21.4900  -25.7600
            38  O1a O    22.6800  -20.0900
            39  C5a C    20.7200  -19.5300
            40  C5a C    21.4200  -18.2700
            41  N1y N    20.7200  -17.0800
            42  C1x C    19.3200  -17.0800
            43  C1y C    21.4200  -15.8900
            44  C1x C    20.7200  -14.6300
            45  C1x C    19.3200  -14.6300
            46  C1x C    18.6200  -15.8200
            47  O5a O    22.8900  -18.2700
            48  O5a O    19.3200  -19.5300
            49  C1a C    19.0400  -21.3500
            50  C7a C    22.8900  -15.8900
            51  O6a O    23.5900  -17.0800
            52  O7a O    23.5900  -14.6300
            53  C1a C    24.7800  -11.0600
            54  O1a O    27.1600  -12.4600
            55  O5a O    28.3500  -14.3500
            56  C1b C    29.3300  -16.4500
            57  C2b C    30.1000  -15.3300
            58  C2a C    31.4300  -15.2600
BOND        60
            1     2   3 2
            2     4   3 1 #Up
            3     4   5 1
            4     5   6 1
            5     6   7 1
            6     7   8 1
            7     8   9 1
            8     4   9 1
            9     8  10 1 #Up
            10    7  11 1 #Down
            11   10  12 1
            12    2  13 1
            13    2  14 1
            14   13  15 1
            15   15  16 1
            16   16  17 1
            17   17  18 1
            18   18  19 1
            19   19  20 1
            20   20  21 2
            21   21  22 1
            22   21  23 1
            23   23  24 1
            24   24  25 1 #Up
            25   24  26 1
            26   26  27 1
            27   27  28 1
            28   28  29 1
            29   29  30 1
            30   30  31 1
            31   31  32 1
            32   32  33 1
            33   33  28 1
            34   29  34 1 #Up
            35   27  35 1 #Down
            36   35  36 1
            37   34  37 1
            38   32  38 1 #Up
            39   32  39 1
            40   39  40 1
            41   42  41 1
            42   41  43 1
            43   43  44 1
            44   44  45 1
            45   45  46 1
            46   42  46 1
            47   40  41 1
            48   40  47 2
            49   39  48 2
            50   31  49 1 #Up
            51   43  50 1
            52   50  51 2
            53   50  52 1
            54   13  52 1 #Down
            55   15  53 1 #Down
            56   16  54 1 #Up
            57   18  55 2
            58   19  56 1 #Down
            59   56  57 1
            60   57  58 2
///
ENTRY       D00108                      Drug
NAME        Iodine (JP16/USP);
            Cadex (TN)
FORMULA     I2
EXACT_MASS  253.8089
MOL_WEIGHT  253.8089
ACTIVITY    Anti-infective, topical
REMARK      Same as: C01382
            Therapeutic category: 2612 2699 2790 7190
            ATC code: D08AG03
            Drug group: DG00425
COMMENT     Component of Compound Iodine glycerin [DR:D04412], Dental iodine glycerin [DR:D04880], Iodine tincture [DR:D04723]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D08 ANTISEPTICS AND DISINFECTANTS
               D08A ANTISEPTICS AND DISINFECTANTS
                D08AG Iodine products
                 D08AG03 Iodine
                  D00108  Iodine (JP16/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               261  Antimicrobial agents
                2612  Iodates
                 D00108  Iodine (JP16/USP)
               269  Miscellaneous
                2699  Others
                 D00108  Iodine (JP16/USP)
              27  Dental preparations
               279  Miscellaneous
                2790  Miscellaneous
                 D00108  Iodine (JP16/USP)
             7  Agents not mainly for therapeutic purpose
              71  Dispensing medicines
               719  Miscellaneous
                7190  Miscellaneous
                 D00108  Iodine (JP16/USP)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for integumentary system
              54 Disinfectants (incl. special bandages)
               D00108  Iodine (JP16/USP)
             Agents for dental and stomatological use
              73 Stomatologic and laryngologic remedies (incl. toche without claims for cough and phlegm)
               D00108  Iodine (JP16/USP)
              -- Intraoral disinfectants
               D00108  Iodine (JP16/USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Iodine
                D00108  Iodine (JP16/USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00108  Iodine
DBLINKS     CAS: 7553-56-2
            PubChem: 7847176
            LigandBox: D00108
            NIKKAJI: J44.423E
ATOM        2
            1   X   I    26.7400  -17.2900
            2   X   I    28.1400  -17.2900
BOND        1
            1     1   2 1
///
ENTRY       D00109                      Drug
NAME        Aspirin (JP16/USP);
            Aspalon (JAN);
            Acetylsalicylic acid;
            Easprin (TN)
FORMULA     C9H8O4
EXACT_MASS  180.0423
MOL_WEIGHT  180.1574
ACTIVITY    Analgesic;
            Antipyretic;
            Antirheumatic
REMARK      Same as: C01405
            Therapeutic category: 1143 3399
            ATC code: A01AD05 B01AC06 N02BA01
            Drug group: DG00015
COMMENT     Name previously used: Acetylsalicylic acid
            nonsteroidal antiinflammatory drug (NSAIDs)
            prodrug, active substance: Salicylic acid [DR:D00097]
TARGET      cyclooxygenase-1 (COX-1) inhibitor [HSA:5742] [KO:K00509];
            cyclooxygenase-2 (COX-2) inhibitor [HSA:5743] [KO:K11987]
  PATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism
            hsa04370(5743)  VEGF signaling pathway
INTERACTION  
STR_MAP     map07048  Antimigraines
            map07049  Antithrombosis agents
            map07110  Benzoic acid family
            map07219  Cyclooxygenase inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A01 STOMATOLOGICAL PREPARATIONS
               A01A STOMATOLOGICAL PREPARATIONS
                A01AD Other agents for local oral treatment
                 A01AD05 Acetylsalicylic acid
                  D00109  Aspirin (JP16/USP); Aspalon (JAN)
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AC Platelet aggregation inhibitors excl. heparin
                 B01AC06 Acetylsalicylic acid
                  D00109  Aspirin (JP16/USP); Aspalon (JAN)
             N NERVOUS SYSTEM
              N02 ANALGESICS
               N02B OTHER ANALGESICS AND ANTIPYRETICS
                N02BA Salicylic acid and derivatives
                 N02BA01 Acetylsalicylic acid
                  D00109  Aspirin (JP16/USP); Aspalon (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               114  Antipyretics and analgesics, anti-inflammatory agents
                1143  Salicylates
                 D00109  Aspirin (JP16/USP); Aspalon (JAN)
             3  Agents affecting metabolism
              33  Blood and body fluid agents
               339  Miscellaneous
                3399  Others
                 D00109  Aspirin (JP16/USP); Aspalon (JAN)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for nervous and sensory systems
              01 Cold remedy (oral use)
               D00109  Aspirin (JP16/USP); Aspalon (JAN)
              03 Antipyretic analgesic agents
               D00109  Aspirin (JP16/USP); Aspalon (JAN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Specified Category 2
              Inorganic and organic chemicals
               Aspirin
                D00109  Aspirin (JP16/USP); Aspalon (JAN)
             Category 2
              Inorganic and organic chemicals
               Aspirin
                D00109  Aspirin (JP16/USP); Aspalon (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases
               cyclooxygenase-1 (COX-1)
                Acetylsalicylic acid
                 D00109  Aspirin (JP16/USP)
               cyclooxygenase-2 (COX-2)
                Acetylsalicylic acid
                 D00109  Aspirin (JP16/USP)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00109  Aspirin
              D00109  Aspirin tablets
DBLINKS     CAS: 50-78-2
            PubChem: 7847177
            DrugBank: DB00945
            PDB-CCD: AIN
            LigandBox: D00109
            NIKKAJI: J2.300K
ATOM        13
            1   C8y C    20.2981  -15.8105
            2   C8y C    21.5226  -16.5029
            3   C8x C    19.0928  -16.5029
            4   C6a C    20.2981  -14.6227
            5   C8x C    21.5226  -17.9133
            6   O7a O    22.7278  -15.8040
            7   C8x C    19.0928  -17.9133
            8   O6a O    21.5033  -13.9240
            9   O6a O    19.0863  -13.9304
            10  C8x C    20.2981  -18.6250
            11  C7a C    23.9396  -16.4964
            12  C1a C    25.1450  -15.7977
            13  O6a O    23.9396  -17.8942
BOND        13
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     4   8 1
            8     4   9 2
            9     5  10 1
            10    6  11 1
            11   11  12 1
            12   11  13 2
            13    7  10 2
///
ENTRY       D00110                      Drug
NAME        Cocaine (USP);
            Cocaine (TN)
FORMULA     C17H21NO4
EXACT_MASS  303.1471
MOL_WEIGHT  303.3529
SOURCE      Erythroxylum coca [TAX:289672]
ACTIVITY    Anesthetic [topical]
REMARK      Same as: C01416
            ATC code: N01BC01 R02AD03 S01HA01 S02DA02
            Drug group: DG00808
TARGET      serotonin transporter inhibitor [HSA:6532] [KO:K05037];
            dopamine transporter inhibitor [HSA:6531] [KO:K05036];
            noradrenalin transporter inhibitor [HSA:6530] [KO:K05035];
            voltage-gated potassium channel (KCNH2) blocker [HSA:3757] [KO:K04905];
            voltage-gated sodium channel (SCN10A) blocker [HSA:6336] [KO:K04842];
            voltage-gated sodium channel (SCN1A) blocker [HSA:6323] [KO:K04833];
            voltage-gated sodium channel (SCN2A) blocker [HSA:6326] [KO:K04834];
            voltage-gated sodium channel (SCN3A) blocker [HSA:6328] [KO:K04836];
            voltage-gated sodium channel (SCN4A) blocker [HSA:6329] [KO:K04837];
            voltage-gated sodium channel (SCN5A) blocker [HSA:6331] [KO:K04838];
            voltage-gated sodium channel (SCN8A) blocker [HSA:6326] [KO:K04834];
            voltage-gated sodium channel (SCN9A) blocker [HSA:6335] [KO:K04841]
  PATHWAY   hsa04726(6532)  Serotonergic synapse
            hsa04728(6323+6531)  Dopaminergic synapse
            hsa05030(6531)  Cocaine addiction
INTERACTION CYP inhibition: CYP2D6 [HSA:1565]
STR_MAP     map07015  Local analgesics
            map07110  Benzoic acid family
            map07231  Sodium channel blocking drugs
            map07234  Neurotransmitter transporter inhibitors
OTHER_MAP   map05030  Cocaine addiction
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N01 ANESTHETICS
               N01B ANESTHETICS, LOCAL
                N01BC Esters of benzoic acid
                 N01BC01 Cocaine
                  D00110  Cocaine (USP)
             R RESPIRATORY SYSTEM
              R02 THROAT PREPARATIONS
               R02A THROAT PREPARATIONS
                R02AD Anesthetics, local
                 R02AD03 Cocaine
                  D00110  Cocaine (USP)
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01H LOCAL ANESTHETICS
                S01HA Local anesthetics
                 S01HA01 Cocaine
                  D00110  Cocaine (USP)
              S02 OTOLOGICALS
               S02D OTHER OTOLOGICALS
                S02DA Analgesics and anesthetics
                 S02DA02 Cocaine
                  D00110  Cocaine (USP)
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated cation channels
               Na+ channel, SCN alpha, NaV1.x
                voltage-gated sodium channel (SCN1A)
                 Cocaine
                  D00110  Cocaine (USP)
                voltage-gated sodium channel (SCN2A)
                 Cocaine
                  D00110  Cocaine (USP)
                voltage-gated sodium channel (SCN3A)
                 Cocaine
                  D00110  Cocaine (USP)
                voltage-gated sodium channel (SCN4A)
                 Cocaine
                  D00110  Cocaine (USP)
                voltage-gated sodium channel (SCN5A)
                 Cocaine
                  D00110  Cocaine (USP)
                voltage-gated sodium channel (SCN8A)
                 Cocaine
                  D00110  Cocaine (USP)
                voltage-gated sodium channel (SCN9A)
                 Cocaine
                  D00110  Cocaine (USP)
                voltage-gated sodium channel (SCN10A)
                 Cocaine
                  D00110  Cocaine (USP)
               K+ channel, KCNH, Kv10-12.x (Ether-a-go-go)
                voltage-gated potassium channel (KCNH2)
                 Cocaine
                  D00110  Cocaine (USP)
             Transporters
              Solute carrier family
               SLC6
                SLC6A2 (noradrenalin transporter)
                 Cocaine
                  D00110  Cocaine (USP)
                SLC6A3 (dopamine transporter)
                 Cocaine
                  D00110  Cocaine (USP)
                SLC6A4 (serotonin transporter)
                 Cocaine
                  D00110  Cocaine (USP)
            Cytochrome P450 interactions [BR:br08309]
             Inhbitors
              CYP2D6
               Cocaine
                D00110  Cocaine (USP)
            Phytochemicals used as drugs [BR:br08306]
             Alkaloids
              Alkaloids derived from ornithine
               Tropane alkaloids
                D00110  Cocaine (USP)
DBLINKS     CAS: 50-36-2
            PubChem: 7847178
            DrugBank: DB00907
            LigandBox: D00110
            NIKKAJI: J43.264D
ATOM        22
            1   C1x C    20.1600  -15.2600
            2   C1x C    20.5100  -14.0700
            3   C1y C    21.3500  -14.9800
            4   C1y C    21.7000  -13.7900
            5   N1y N    20.4400  -12.4600
            6   C1x C    23.2400  -14.9800
            7   C1y C    22.9600  -13.7900
            8   C1y C    24.2900  -15.5400
            9   O7a O    25.3400  -16.3800
            10  C7a C    26.5300  -16.3800
            11  C8y C    27.1600  -15.3300
            12  O6a O    27.1600  -17.5700
            13  C1a C    19.6700  -11.2700
            14  C8x C    28.5600  -15.3300
            15  C8x C    29.2600  -14.0700
            16  C8x C    28.5600  -12.8800
            17  C8x C    27.1600  -12.8800
            18  C8x C    26.4600  -14.1400
            19  C7a C    23.5900  -12.5300
            20  O7a O    24.9900  -12.5300
            21  O6a O    22.8200  -11.3400
            22  C1a C    25.6900  -11.2700
BOND        24
            1     1   2 1
            2     1   3 1
            3     2   4 1
            4     3   5 1
            5     3   6 1
            6     4   7 1
            7     6   8 1
            8     8   9 1
            9     9  10 1
            10   10  11 1
            11   10  12 2
            12    4   5 1
            13    7   8 1
            14    5  13 1
            15   11  14 2
            16   14  15 1
            17   15  16 2
            18   16  17 1
            19   17  18 2
            20   11  18 1
            21    7  19 1 #Up
            22   19  20 1
            23   19  21 2
            24   20  22 1
///
ENTRY       D00111                      Drug
NAME        Lactic acid (JP16/USP);
            Lactate (TN)
FORMULA     C3H6O3
EXACT_MASS  90.0317
MOL_WEIGHT  90.0779
REMARK      Same as: C01432
            Therapeutic category: 2319
            ATC code: G01AD01
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
               G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
                G01AD Organic acids
                 G01AD01 Lactic acid
                  D00111  Lactic acid (JP16/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              23  Digestive organ agents
               231  Antidiarrheals, intestinal regulators
                2319  others
                 D00111  Lactic acid (JP16/USP)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Lactic acid
                D00111  Lactic acid (JP16/USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00111  [001468] Lactic acid
             Solubilizing agent
              D00111  [001468] Lactic acid
             Buffering agent
              D00111  [001468] Lactic acid
             Base
              D00111  [001468] Lactic acid
             Flavoring substance
              D00111  [001468] Lactic acid
             Wetting adjuster
              D00111  [001468] Lactic acid
             pH regulator
              D00111  [001468] Lactic acid
             Solubilizer
              D00111  [001468] Lactic acid
             Solubilization agent
              D00111  [001468] Lactic acid
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00111  Lactic acid
DBLINKS     CAS: 50-21-5
            PubChem: 7847179
            DrugBank: DB04398
            LigandBox: D00111
            NIKKAJI: J1.358G
ATOM        6
            1   C1c C    21.5154  -16.5174
            2   C6a C    22.7246  -15.8226
            3   C1a C    21.5154  -17.9197
            4   O1a O    20.2994  -15.8226
            5   O6a O    23.9406  -16.5174
            6   O6a O    22.7246  -14.5603
BOND        5
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 2
///
ENTRY       D00112                      Drug
NAME        G-Strophanthin (JAN);
            Ouabain;
            Ouabain octahydrate
FORMULA     C29H44O12
EXACT_MASS  584.2833
MOL_WEIGHT  584.6525
SOURCE      Strophanthus gratus [TAX:141614]
ACTIVITY    Cardiotonic
REMARK      Same as: C01443
            ATC code: C01AC01
COMMENT     Cardiotonic glycosides
TARGET      Na+,K+-ATPase inhibitor [HSA:476 477 478 480 23439 481 482 483] [KO:K01539 K01540]
  PATHWAY   hsa04260(23439+476+477+478+480+481+482+483)  Cardiac muscle contraction
METABOLISM  Transporter: SLCO1A2 [HSA:6579]
INTERACTION  
STR_MAP     map07233  Ion transporter inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01A CARDIAC GLYCOSIDES
                C01AC Strophantus glycosides
                 C01AC01 G-strophanthin
                  D00112  G-Strophanthin (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases
               sodium/potassium-transporting ATPase
                G-strophanthin
                 D00112  G-Strophanthin (JAN)
            Phytochemicals used as drugs [BR:br08306]
             Terpenoids
              Triterpenoids (C30) and related compounds
               D00112  G-Strophanthin (JAN)
DBLINKS     CAS: 11018-89-6
            PubChem: 7847180
            DrugBank: DB01092
            LigandBox: D00112
ATOM        41
            1   C1z C    29.9249  -25.8828
            2   C1y C    31.1179  -25.1811
            3   C1z C    29.9249  -27.2628
            4   C1y C    28.7261  -25.1987
            5   C1b C    29.9191  -24.5087
            6   C1y C    32.3284  -25.8653
            7   C1y C    31.0945  -23.8244
            8   C1x C    31.1296  -27.9528
            9   C1x C    28.7261  -27.9588
            10  O1a O    29.9191  -28.6312
            11  C1x C    27.5391  -25.8828
            12  O1a O    27.3929  -24.8361
            13  O1a O    28.7321  -23.8303
            14  C1z C    33.5386  -25.1577
            15  C1x C    32.3107  -27.2043
            16  C1x C    32.3224  -23.0701
            17  O1a O    29.9715  -22.9478
            18  C1y C    27.5391  -27.2628
            19  C1z C    33.5446  -23.7659
            20  C1x C    35.9889  -25.1111
            21  O1a O    33.5386  -26.5202
            22  O2a O    26.3520  -27.9354
            23  C1y C    34.7608  -23.0467
            24  C1a C    33.5386  -22.3918
            25  C1x C    35.9830  -23.7659
            26  C1y C    25.1592  -28.6312
            27  C2y C    34.7608  -21.6958
            28  C1y C    25.1592  -30.0170
            29  O2x O    23.9662  -27.9411
            30  C1x C    34.3282  -20.3568
            31  C2x C    36.1643  -21.6958
            32  C1y C    23.9662  -30.7070
            33  O1a O    26.3520  -30.6895
            34  C1y C    22.7791  -28.6312
            35  O7x O    35.4625  -19.5323
            36  C7x C    36.6028  -20.3568
            37  C1y C    22.7791  -30.0170
            38  O1a O    23.9662  -32.0813
            39  C1a C    21.5921  -27.9411
            40  O6a O    37.9477  -19.9183
            41  O1a O    21.5921  -30.6895
BOND        46
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     1   5 1 #Up
            5     2   6 1
            6     2   7 1
            7     3   8 1
            8     3   9 1
            9     3  10 1 #Up
            10    4  11 1
            11    4  12 1 #Up
            12    5  13 1
            13    6  14 1
            14    6  15 1
            15    7  16 1
            16    7  17 1 #Down
            17    9  18 1
            18   14  19 1
            19   14  20 1
            20   14  21 1 #Up
            21   18  22 1 #Up
            22   19  23 1
            23   19  24 1 #Up
            24   20  25 1
            25   26  22 1 #Up
            26   23  27 1
            27   26  28 1
            28   26  29 1
            29   27  30 1
            30   27  31 2
            31   28  32 1
            32   28  33 1 #Down
            33   29  34 1
            34   30  35 1
            35   31  36 1
            36   32  37 1
            37   32  38 1 #Down
            38   34  39 1 #Down
            39   36  40 2
            40   37  41 1 #Up
            41    8  15 1
            42   11  18 1
            43   16  19 1
            44   23  25 1
            45   34  37 1
            46   35  36 1
///
ENTRY       D00113                      Drug
NAME        Atropine (USP);
            Atropen (TN)
FORMULA     C17H23NO3
EXACT_MASS  289.1678
MOL_WEIGHT  289.3694
SOURCE      Atropa belladonna [TAX:33113]
ACTIVITY    Anticholinergic
REMARK      Same as: C01479
            ATC code: A03BA01 S01FA01
            Drug group: DG00052
COMMENT     belladonna alkaloid
            Indicactions: Cycloplegia, Mydriasis
TARGET      muscarinic cholinergic receptor antagonist [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]
  PATHWAY   hsa04020(1128+1129+1131+1133)  Calcium signaling pathway
            hsa04080(1128+1129+1131+1132+1133)  Neuroactive ligand-receptor interaction
            hsa04725(1128+1129+1131+1132+1133)  Cholinergic synapse
            hsa04810(1128+1129+1131+1132+1133)  Regulation of actin cytoskeleton
            hsa04970(1131)  Salivary secretion
            hsa04971(1131)  Gastric acid secretion
            hsa04972(1131)  Pancreatic secretion
INTERACTION  
STR_MAP     map07220  Cholinergic and anticholinergic drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
               A03B BELLADONNA AND DERIVATIVES, PLAIN
                A03BA Belladonna alkaloids, tertiary amines
                 A03BA01 Atropine
                  D00113  Atropine (USP)
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01F MYDRIATICS AND CYCLOPLEGICS
                S01FA Anticholinergics
                 S01FA01 Atropine
                  D00113  Atropine (USP)
            USP drug classification [BR:br08302]
             Gastrointestinal Agents
              Antispasmodics, Gastrointestinal
               Atropine
                D00113  Atropine (USP)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Acetylcholine (muscarinic)
                muscarinic cholinergic receptor
                 Atropine
                  D00113  Atropine (USP)
            Phytochemicals used as drugs [BR:br08306]
             Alkaloids
              Alkaloids derived from ornithine
               Tropane alkaloids
                D00113  Atropine (USP)
DBLINKS     CAS: 51-55-8
            PubChem: 7847181
            DrugBank: DB00572
            LigandBox: D00113
            NIKKAJI: J231.179H
ATOM        21
            1   C1x C    18.2238  -19.1608
            2   C1x C    18.5519  -17.9891
            3   C1y C    19.3955  -18.8796
            4   C1y C    19.7236  -17.7079
            5   N1y N    18.4582  -16.3956
            6   C1x C    21.2702  -18.8796
            7   C1x C    20.9890  -17.7079
            8   C1y C    22.3013  -19.4420
            9   O7a O    23.3793  -20.3325
            10  C7a C    24.5979  -20.3325
            11  C1c C    25.2072  -19.2545
            12  O6a O    25.2072  -21.4573
            13  C8y C    26.4258  -19.2545
            14  C1b C    24.5979  -18.2234
            15  O1a O    25.2072  -17.1455
            16  C8x C    27.1320  -20.4782
            17  C8x C    28.5320  -20.4785
            18  C8x C    29.2322  -19.2662
            19  C8x C    28.5261  -18.0425
            20  C8x C    27.1261  -18.0422
            21  C1a C    17.7091  -15.2114
BOND        23
            1     1   2 1
            2     1   3 1
            3     2   4 1
            4     3   5 1
            5     3   6 1
            6     4   7 1
            7     6   8 1
            8     8   9 1 #Down
            9     9  10 1
            10   10  11 1
            11   10  12 2
            12   11  13 1
            13   11  14 1
            14   14  15 1
            15    4   5 1
            16    7   8 1
            17   13  16 2
            18   16  17 1
            19   17  18 2
            20   18  19 1
            21   19  20 2
            22   13  20 1
            23    5  21 1
///
ENTRY       D00114                      Drug
NAME        Fructose (JP16/USP);
            D-Fructose;
            Fructon (TN)
FORMULA     C6H12O6
EXACT_MASS  180.0634
MOL_WEIGHT  180.1559
ACTIVITY    Nutrient
REMARK      Same as: C10906
            Therapeutic category: 3232
            ATC code: C01EB07 V06DC02
            Drug group: DG00242
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01E OTHER CARDIAC PREPARATIONS
                C01EB Other cardiac preparations
                 C01EB07 Fructose
                  D00114  Fructose (JP16/USP)
             V VARIOUS
              V06 GENERAL NUTRIENTS
               V06D OTHER NUTRIENTS
                V06DC Carbohydrates
                 V06DC02 Fructose
                  D00114  Fructose (JP16/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              32  Nutrients, tonics
               323  Saccharide preparations
                3232  Fructoses
                 D00114  Fructose (JP16/USP)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00114  [002078] Fructose
             Sweetening agent
              D00114  [002078] Fructose
             Flavoring substance
              D00114  [002078] Fructose
             Bonding agent
              D00114  [002078] Fructose
             Tonicity agent
              D00114  [002078] Fructose
             Adhesion-enhancing agent
              D00114  [002078] Fructose
             Diluting agent
              D00114  [002078] Fructose
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00114  Fructose
              D00114  Fructose injection
DBLINKS     CAS: 57-48-7
            PubChem: 7847182
            DrugBank: DB04173
            LigandBox: D00114
            NIKKAJI: J4.580B
ATOM        12
            1   O1a O    18.0367  -15.9833
            2   C1b C    19.2491  -15.2833
            3   C1c C    20.4615  -15.9833
            4   C1c C    21.6740  -15.2833
            5   C1c C    22.8865  -15.9833
            6   C5a C    24.0989  -15.2833
            7   C1b C    25.3114  -15.9833
            8   O1a O    26.5238  -15.2833
            9   O1a O    20.4615  -17.3833
            10  O1a O    21.6740  -13.8833
            11  O1a O    22.8865  -17.3833
            12  O5a O    24.0989  -13.8833
BOND        11
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     6   7 1
            7     7   8 1
            8     3   9 1 #Down
            9     4  10 1 #Up
            10    5  11 1 #Up
            11    6  12 2
///
ENTRY       D00115                      Drug
NAME        Gelatin (JP16/NF);
            Gelfilm (TN)
ACTIVITY    Pharmaceutic aid [encapsulating agent];
            Pharmaceutic aid [suspending agent];
            Pharmaceutic aid [tablet binder];
            Pharmaceutic aid [tablet coating agent]
REMARK      Same as: C01498
            Therapeutic category: 3322 7990
            ATC code: B05AA06
            Drug group: DG00181
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
               B05A BLOOD AND RELATED PRODUCTS
                B05AA Blood substitutes and plasma protein fractions
                 B05AA06 Gelatin agents
                  D00115  Gelatin (JP16/NF)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              33  Blood and body fluid agents
               332  Hemostatics
                3322  Gelatins
                 D00115  Gelatin (JP16/NF)
             7  Agents not mainly for therapeutic purpose
              79  Other agents not mainly for therapeutic purpose
               799  Miscellaneous
                7990  Miscellaneous
                 D00115  Gelatin (JP16/NF)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Gelatin
                D00115  Gelatin (JP16/NF)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00115  [001382] Gelatin
             Lubricating agent
              D00115  [001382] Gelatin
             Base
              D00115  [001382] Gelatin
             Bonding agent
              D00115  [001382] Gelatin
             Brightening agent
              D00115  [001382] Gelatin
             Coating agent
              D00115  [001382] Gelatin
             Film
              D00115  [001382] Gelatin
             Sugarcoated agent
              D00115  [001382] Gelatin
             Emulsion
              D00115  [001382] Gelatin
             Adhesive
              D00115  [001382] Gelatin
             Tenacious agent
              D00115  [001382] Gelatin
             Diluting agent
              D00115  [001382] Gelatin
             Disintegrant
              D00115  [001382] Gelatin
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00115  Gelatin
DBLINKS     CAS: 9000-70-8
            PubChem: 7847183
            NIKKAJI: J203.765C
///
ENTRY       D00116                      Drug
NAME        Glucagon (JAN/USP/INN);
            Glucagon (genetical recombination) (JAN);
            Glucagon (TN)
FORMULA     C153H225N43O49S
EXACT_MASS  3480.6157
MOL_WEIGHT  3482.7473
SEQUENCE    His Ser Gln Gly Thr Phe Thr Ser Asp Tyr Ser Lys Tyr Leu Asp Ser
            Arg Arg Ala Gln Asp Phe Val Gln Trp Leu Met Asn Thr
  TYPE      Peptide
ACTIVITY    Antidiabetic
REMARK      Same as: C01501
            Therapeutic category: 2492 7229
            ATC code: H04AA01
            Drug group: DG00511
COMMENT     Glucagon is a single-chain polypeptide that contains 29 amino acid residues. 
TARGET      glucagon receptor agonist [HSA:2642] [KO:K04583]
  PATHWAY   hsa04080(2642)  Neuroactive ligand-receptor interaction
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H04 PANCREATIC HORMONES
               H04A GLYCOGENOLYTIC HORMONES
                H04AA Glycogenolytic hormones
                 H04AA01 Glucagon
                  D00116  Glucagon (JAN/USP/INN); Glucagon (genetical recombination) (JAN)
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Glycemic Agents
               Glucagon
                D00116  Glucagon (JAN/USP/INN); Glucagon (genetical recombination) (JAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2492  Pancreatic hormones
                 D00116  Glucagon (JAN/USP/INN); Glucagon (genetical recombination) (JAN)
             7  Agents not mainly for therapeutic purpose
              72  Intracorporeal diagnostic agents
               722  Various function testing reagents
                7229  Others
                 D00116  Glucagon (JAN/USP/INN); Glucagon (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Secretin receptor family
               Glucagon
                glucagon receptor
                 Glucagon
                  D00116  Glucagon (JAN/USP/INN); Glucagon (genetical recombination) (JAN)
DBLINKS     CAS: 9007-92-5
            PubChem: 7847184
            DrugBank: DB00040
            NIKKAJI: J9.063H
///
ENTRY       D00117                      Drug
NAME        Guaiacol (JAN);
            Creodon (TN)
FORMULA     C7H8O2
EXACT_MASS  124.0524
MOL_WEIGHT  124.1372
REMARK      Same as: C01502
            Therapeutic category: 2730
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              27  Dental preparations
               273  Analgesics and sedatives
                2730  Analgesics and sedatives
                 D00117  Guaiacol (JAN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 2
              Inorganic and organic chemicals
               Guaiacol
                D00117  Guaiacol (JAN)
DBLINKS     CAS: 90-05-1
            PubChem: 7847185
            LigandBox: D00117
            NIKKAJI: J3.217D
ATOM        9
            1   C8y C    22.1741  -16.1500
            2   C8y C    20.9515  -15.4522
            3   C8x C    22.1741  -17.5582
            4   O2a O    23.3775  -15.4522
            5   C8x C    19.7481  -16.1500
            6   O1a O    20.9515  -14.2033
            7   C8x C    20.9515  -18.2687
            8   C1a C    24.5872  -16.1435
            9   C8x C    19.7481  -17.5582
BOND        9
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     4   8 1
            8     5   9 1
            9     7   9 2
///
ENTRY       D00118                      Drug
NAME        Naproxen (JP16/USP/INN);
            Naprosyn (TN)
FORMULA     C14H14O3
EXACT_MASS  230.0943
MOL_WEIGHT  230.2592
ACTIVITY    Anti-inflammatory;
            Analgesic;
            Antipyretic
REMARK      Same as: C01517
            Therapeutic category: 1149
            ATC code: G02CC02 M01AE02 M02AA12
            Drug group: DG00455
TARGET      cyclooxygenase-1 (COX-1) inhibitor [HSA:5742] [KO:K00509];
            cyclooxygenase-2 (COX-2) inhibitor [HSA:5743] [KO:K11987]
  PATHWAY   hsa00590(5742+5743)  Arachidonic acid metabolism
            hsa04370(5743)  VEGF signaling pathway
METABOLISM  Enzyme: CYP2C9 [HSA:1559], CYP1A2 [HSA:1544]
INTERACTION  
STR_MAP     map07048  Antimigraines
            map07114  Naphthalene family
            map07219  Cyclooxygenase inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G02 OTHER GYNECOLOGICALS
               G02C OTHER GYNECOLOGICALS
                G02CC Antiinflammatory products for vaginal administration
                 G02CC02 Naproxen
                  D00118  Naproxen (JP16/USP/INN)
             M MUSCULO-SKELETAL SYSTEM
              M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
               M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
                M01AE Propionic acid derivatives
                 M01AE02 Naproxen
                  D00118  Naproxen (JP16/USP/INN)
              M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
               M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
                M02AA Antiinflammatory preparations, non-steroids for topical use
                 M02AA12 Naproxen
                  D00118  Naproxen (JP16/USP/INN)
            USP drug classification [BR:br08302]
             Analgesics
              Nonsteroidal Anti-inflammatory Drugs
               Naproxen
                D00118  Naproxen (JP16/USP/INN)
             Anti-inflammatory Agents
              Nonsteroidal Anti-inflammatory Drugs
               Naproxen
                D00118  Naproxen (JP16/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               114  Antipyretics and analgesics, anti-inflammatory agents
                1149  Others
                 D00118  Naproxen (JP16/USP/INN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases
               cyclooxygenase-1 (COX-1)
                Naproxen
                 D00118  Naproxen (JP16/USP/INN)
               cyclooxygenase-2 (COX-2)
                Naproxen
                 D00118  Naproxen (JP16/USP/INN)
            Cytochrome P450 interactions [BR:br08309]
             Substrates
              CYP1A2
               Naproxen
                D00118  Naproxen (JP16/USP/INN)
              CYP2C9
               Naproxen
                D00118  Naproxen (JP16/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00118  Naproxen
DBLINKS     CAS: 22204-53-1
            PubChem: 7847186
            DrugBank: DB00788
            LigandBox: D00118
            NIKKAJI: J9.289D
ATOM        17
            1   C8y C    24.6254  -20.0866
            2   C8y C    24.6254  -21.4127
            3   C8x C    25.8119  -19.3887
            4   C8x C    23.5087  -19.3887
            5   C8x C    23.5087  -22.1106
            6   C8x C    25.8119  -22.1106
            7   C8y C    26.9983  -20.0866
            8   C8x C    22.3222  -20.0866
            9   C8y C    22.3222  -21.4127
            10  C8x C    26.9983  -21.3429
            11  C1c C    28.1848  -19.3887
            12  O2a O    21.1358  -22.1106
            13  C6a C    29.3015  -20.0866
            14  C1a C    28.1848  -18.0626
            15  C1a C    19.4607  -21.0637
            16  O6a O    30.6974  -19.1793
            17  O6a O    29.3015  -21.4127
BOND        18
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 2
            7     4   8 2
            8     5   9 2
            9     6  10 2
            10    7  11 1
            11    9  12 1
            12   11  13 1
            13   11  14 1 #Down
            14   12  15 1
            15   13  16 1
            16   13  17 2
            17    7  10 1
            18    8   9 1
///
ENTRY       D00119                      Drug
NAME        Stearic acid (JP16/NF);
            Stearic acid (TN)
FORMULA     C18H36O2
EXACT_MASS  284.2715
MOL_WEIGHT  284.4772
ACTIVITY    Pharmaceutic aid [emulsion adjunct];
            Pharmaceutic aid [tablet and/or capsule lubricant]
REMARK      Same as: C01530
BRITE       Risk category of Japanese OTC drugs [BR:br08312]
             Category 3
              Inorganic and organic chemicals
               Stearic acid
                D00119  Stearic acid (JP16/NF)
            Pharmaceutical additives [BR:br08316]
             Stabilizing agent
              D00119  [002220] Stearic acid
             Lubricating agent
              D00119  [002220] Stearic acid
             Base
              D00119  [002220] Stearic acid
             Flavoring substance
              D00119  [002220] Stearic acid
             Bonding agent
              D00119  [002220] Stearic acid
             Brightening agent
              D00119  [002220] Stearic acid
             Coating agent
              D00119  [002220] Stearic acid
             Sugarcoated agent
              D00119  [002220] Stearic acid
             Emulsion
              D00119  [002220] Stearic acid
             Diluting agent
              D00119  [002220] Stearic acid
             Dispersant
              D00119  [002220] Stearic acid
             Disintegrating adjuvant
              D00119  [002220] Stearic acid
             Dampproof agent
              D00119  [002220] Stearic acid
             Fluidizer
              D00119  [002220] Stearic acid
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00119  Stearic acid
DBLINKS     CAS: 57-11-4
            PubChem: 7847187
            DrugBank: DB03193
            LigandBox: D00119
            NIKKAJI: J1.379J
ATOM        20
            1   C1b C    24.5700  -11.6200
            2   C1b C    25.7600  -12.3200
            3   C1b C    23.3100  -12.3200
            4   C1b C    26.9500  -11.6200
            5   C1b C    22.1200  -11.6200
            6   C1b C    28.2100  -12.3200
            7   C1b C    20.8600  -12.3200
            8   C1b C    29.4000  -11.6200
            9   C1b C    19.6700  -11.6200
            10  C1b C    30.5900  -12.3200
            11  C1b C    18.4800  -12.3200
            12  C1b C    31.8500  -11.6200
            13  C6a C    17.2200  -11.6200
            14  C1b C    33.0400  -12.3200
            15  O6a O    16.0300  -12.3200
            16  C1b C    34.2300  -11.6200
            17  C1b C    35.4900  -12.3200
            18  C1b C    36.6800  -11.6200
            19  C1a C    37.9400  -12.3200
            20  O6a O    17.2200  -10.2200
BOND        19
            1    18  19 1
            2     1   2 1
            3     1   3 1
            4     2   4 1
            5     3   5 1
            6     4   6 1
            7     5   7 1
            8     6   8 1
            9     7   9 1
            10    8  10 1
            11    9  11 1
            12   10  12 1
            13   11  13 1
            14   12  14 1
            15   13  15 1
            16   14  16 1
            17   16  17 1
            18   17  18 1
            19   13  20 2
///
ENTRY       D00120                      Drug
NAME        Sulindac (JP16/USP/INN);
            Clinoril (TN)
FORMULA     C20H17FO3S
EXACT_MASS  356.0882
MOL_WEIGHT  356.4106
ACTIVITY    Anti-inflammatory
REMARK      Same as: C01531
            Therapeutic category: 1149
            ATC code: M01AB02
COMMENT     prodrug (metabolism activated form is Sulindac sulfide), active substance: Indometacin [DR:D00141]
TARGET
